N-CSRS 1 d720836dncsrs.htm BLACKROCK CAPITAL APPRECIATION FUND, INC. BlackRock Capital Appreciation Fund, Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number: 811-06669

 

Name of Fund:   BlackRock Capital Appreciation Fund, Inc.

 

Fund Address:   100 Bellevue Parkway, Wilmington, DE 19809

Name and address of agent for service: John M. Perlowski, Chief Executive Officer, BlackRock Capital Appreciation Fund, Inc., 50 Hudson Yards, New York, NY 10001

Registrant’s telephone number, including area code: (800) 441-7762

Date of fiscal year end: 05/31/2024

Date of reporting period: 11/30/2023


Item 1 – Report to Stockholders

(a) The Report to Shareholders is attached herewith.


 

LOGO

  NOVEMBER 30, 2023

 

  

2023 Semi-Annual Report

(Unaudited)

    

 

 

BlackRock Capital Appreciation Fund, Inc.

BlackRock FundsSM

 

·  

BlackRock Health Sciences Opportunities Portfolio

 

·  

BlackRock Infrastructure Sustainable Opportunities Fund

 

·  

BlackRock Mid-Cap Growth Equity Portfolio

 

·  

BlackRock Technology Opportunities Fund

 

 

 

    Not FDIC Insured • May Lose Value • No Bank Guarantee  


 

The Markets in Review

Dear Shareholder,

The combination of continued economic growth and cooling inflation provided a supportive backdrop for investors during the 12-month reporting period ended November 30, 2023. Significantly tighter monetary policy helped to rein in inflation, as the annual increase in the Consumer Price Index declined to its long-term average of approximately 3% in November 2023. Meanwhile, real economic growth proved more resilient than many investors anticipated. A moderating labor market also helped ease inflationary pressure, although wages continued to grow. This robust labor market powered further growth in consumer spending, backstopping the economy. On October 7, 2023, Hamas launched a horrific attack on Israel. The ensuing war will have a significant humanitarian impact and could lead to heightened economic and market volatility. We see geopolitics as a structural market risk going forward. See our geopolitical risk dashboard at blackrock.com for more details.

Equity returns were solid during the period, as interest rates stabilized, and the economy proved to be more resilient than many investors expected. The U.S. economy continued to show strength, and growth further accelerated in the third quarter of 2023. However, equity returns were uneven, as the performance of a few notable technology companies supported gains among large-capitalization U.S. stocks, while small-capitalization U.S. stocks declined overall. Meanwhile, international developed market equities advanced strongly, while emerging market equities posted modest gains.

The 10-year U.S. Treasury yield rose during the reporting period, driving its price down, as investors reacted to elevated inflation and attempted to anticipate interest rate changes. The corporate bond market benefited from improving economic sentiment, although high-yield corporate bond prices fared significantly better than investment-grade bonds as demand from yield-seeking investors remained strong.

The U.S. Federal Reserve (the “Fed”), attempting to manage persistent inflation, raised interest rates five times during the 12-month period, but slowed and then paused its tightening later in the period. The Fed also wound down its bond-buying programs and incrementally reduced its balance sheet by not replacing securities that reach maturity.

Supply constraints appear to have become an embedded feature of the new macroeconomic environment, making it difficult for developed economies to increase production without sparking higher inflation. Geopolitical fragmentation and an aging population risk further exacerbating these constraints, keeping the labor market tight and wage growth high. Although the Fed has decelerated the pace of interest rate hikes and recently opted for several pauses, we believe that the new economic regime means that the Fed will need to maintain high rates for an extended period despite the market’s hopes for interest rate cuts, as reflected in the recent rally. Furthermore, ongoing structural changes may mean that the Fed will be hesitant to cut interest rates in the event of faltering economic activity lest inflation accelerate again.

While we favor an overweight position in developed market equities in the long term, we prefer an underweight stance in the near term. Nevertheless, we are overweight on Japanese stocks in the near term as shareholder-friendly policies generate increased investor interest. We also believe that stocks with an AI tilt should benefit from an investment cycle that is set to support revenues and margins. In credit, there are selective opportunities in the near term despite tightening credit and financial conditions. For fixed income investing with a six- to twelve-month horizon, we see the most attractive investments in short-term U.S. Treasuries, U.S. mortgage-backed securities, and hard-currency emerging market bonds.

Overall, our view is that investors need to think globally, position themselves to be prepared for a decarbonizing economy, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit blackrock.com for further insight about investing in today’s markets.

Sincerely,

 

LOGO

 

Rob Kapito

President, BlackRock Advisors, LLC

LOGO

Rob Kapito

President, BlackRock Advisors, LLC

 

Total Returns as of November 30, 2023
       6-Month       12-Month  

U.S. large cap equities (S&P 500® Index)

  10.17%   13.84%

U.S. small cap equities (Russell 2000® Index)

  4.24    (2.57)

International equities (MSCI Europe, Australasia, Far East Index)

  5.12    12.36  

Emerging market equities (MSCI Emerging Markets Index)

  4.60    4.21

3-month Treasury bills (ICE BofA 3-Month U.S. Treasury Bill Index)

  2.69    4.91

U.S. Treasury securities (ICE BofA 10-Year U.S. Treasury Index)

  (3.98)   (2.27)

U.S. investment grade bonds (Bloomberg U.S. Aggregate Bond Index)

  (0.80)   1.18

Tax-exempt municipal bonds (Bloomberg Municipal Bond Index)

  2.29    4.28

U.S. high yield bonds (Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index)

  5.52    8.69

Past performance is not an indication of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.

 

 

 

 

2  

H I S   A G E   I S   N O T  A R  T   O F  O U R  U N D  E P O R T


 

Table of Contents

 

      Page  

The Markets in Review

     2  

Semi-Annual Report:

  

Fund Summary

     4  

About Fund Performance

     14  

Disclosure of Expenses

     14  

Derivative Financial Instruments

     15  

Financial Statements:

  

Schedules of Investments

     16  

Statements of Assets and Liabilities

     34  

Statements of Operations

     38  

Statements of Changes in Net Assets

     41  

Financial Highlights

     44  

Notes to Financial Statements

     70  

Statement Regarding Liquidity Risk Management Program

     86  

Additional Information

     87  

Glossary of Terms Used in this Report

     89  

 

 

 

 

 

LOGO

 

 

  3


 

Fund Summary as of November 30, 2023

    

   BlackRock Capital Appreciation Fund, Inc.

 

Investment Objective

BlackRock Capital Appreciation Fund, Inc.’s (the “Fund”) investment objective is to seek long-term growth of capital.

The Board of Directors of the Fund had previously approved an Agreement and Plan of Reorganization between the Fund and BlackRock Large Cap Focus Growth Fund, Inc. (the “Acquiring Fund”), pursuant to which the Fund will be reorganized into the Acquiring Fund (the “Reorganization”). The Reorganization was originally expected to occur during the fourth quarter of 2023, but has been postponed. Shareholders will be given at least 60 days’ notice in advance of the closing of the Reorganization.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2023, all of the Fund’s share classes outperformed its benchmark, the Russell 1000® Growth Index. For the same period, all of the Fund’s share classes outperformed the broad-market S&P 500® Index. The following discussion of relative performance pertains to the Russell 1000® Growth Index.

What factors influenced performance?

The largest positive contributors to the Fund’s performance relative to the benchmark over the period included security selection in the information technology and healthcare sectors, along with positioning in consumer staples. In information technology, an overweight position in Intuit, Inc. in the software industry benefited performance. In healthcare, an overweight allocation to the pharmaceuticals industry, most notably to Eli Lilly and Company, contributed to performance. Lastly, a lack of exposure to the consumer staples sector, and particularly the beverages industry, proved beneficial.

The largest detractors from relative performance included stock selection in the consumer discretionary sector, most notably within the hotels, restaurants and leisure, and textiles, apparel and luxury goods sub-sectors. Specifically, off-benchmark positions in online casino technology provider Evolution AB and luxury goods conglomerate LVMH Moët Hennessy Louis Vuitton detracted from relative performance. Within industrials, an off-benchmark position in garbage pickup and dumpster rental company Waste Connections, Inc. within commercial services and supplies weighed on relative performance.

Describe recent portfolio activity.

During the period, the Fund’s allocation to information technology increased driven by greater exposure to the software industry. The allocation to the real estate sector increased as well. Conversely, the allocation to consumer discretionary experienced the biggest decrease as exposure to the hotels, restaurants and leisure sub-sector declined. The Fund’s allocation to the healthcare sector decreased as well.

Describe portfolio positioning at period end.

As of period end, the Fund’s largest overweight position relative to the Russell 1000® Growth Index was in the financials sector, followed by information technology and healthcare. Conversely, the consumer staples sector was the largest underweight, followed by industrials and communication services.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years     10 Years  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    14.53     31.35     N/A       12.92     N/A       12.78     N/A  

Investor A

    14.34       30.99       24.11     12.62       11.41     12.48       11.87

Investor C

    13.92       29.90       28.90       11.72       11.72       11.76       11.76  

Class K

    14.57       31.49       N/A       13.02       N/A       12.90       N/A  

Class R

    14.16       30.59       N/A       12.26       N/A       12.15       N/A  

Russell 1000® Growth Index(c)

    13.14       26.17       N/A       16.36       N/A       14.69       N/A  

S&P 500® Index(d)

    10.17       13.84       N/A       12.51       N/A       11.82       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b) 

The Fund invests primarily in a diversified portfolio consisting primarily of common stock of U.S. companies that Fund management believes have exhibited above-average growth rates in earnings over the long term.

 
(c) 

An index that measures the performance of the large-cap growth segment of the U.S. equity universe. It includes those Russell 1000® Companies with higher price-to-book ratios and higher forecasted growth values.

 
(d) 

An unmanaged index that covers 500 leading companies and captures approximately 80% coverage of available market capitalization.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

 

4  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary as of November 30, 2023 (continued)

    

   BlackRock Capital Appreciation Fund, Inc.

 

Expense Example

 

   

                                   Actual                                   

         

                   Hypothetical 5% Return                  

        
     Beginning
Account Value
(06/01/23)
     Ending
  Account Value
(11/30/23)
     Expenses   
  Paid During   
the Period(a)
          Beginning
Account Value
(06/01/23)
    Ending
  Account Value
(11/30/23)
     Expenses   
  Paid During   
the Period(a)
     Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 1,145.30      $ 4.08          $ 1,000.00     $ 1,021.20      $ 3.84           0.76

Investor A

    1,000.00        1,143.40        5.41            1,000.00       1,019.95        5.10           1.01  

Investor C

    1,000.00        1,139.20        9.91            1,000.00       1,015.74        9.32           1.85  

Class K

    1,000.00        1,145.70        3.54            1,000.00       1,021.70        3.34           0.66  

Class R

    1,000.00        1,141.60        7.27                  1,000.00       1,018.22        6.86           1.36  

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/366 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

 

TEN LARGEST HOLDINGS

 

   
Security(a)   Percent of
Net Assets
 

Microsoft Corp.

    10.2

Apple Inc.

    9.0  

Amazon.com, Inc.

    8.8  

NVIDIA Corp.

    6.3  

Alphabet, Inc., Class A

    4.3  

Intuit, Inc.

    4.2  

Visa, Inc., Class A

    4.1  

Broadcom, Inc.

    3.3  

Eli Lilly & Co.

    2.9  

Tesla, Inc.

    2.8  
SECTOR ALLOCATION

 

   
Sector(b)   Percent of
Net Assets
 

Information Technology

    46.4

Consumer Discretionary

    14.6  

Health Care

    12.8  

Financials

    11.3  

Communication Services

    9.1  

Industrials

    3.2  

Energy

    1.1  

Materials

    1.0  

Other (each representing less than 1%)

    0.6  

Short-Term Securities

    0.1  

Liabilities in Excess of Other Assets

    (0.2
 

 

(a) 

Excludes short-term securities.

 
(b) 

For Fund compliance purposes, the Fund’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

 

 

U N D   S U M M A R Y

  5


 

Fund Summary as of November 30, 2023 

    

   BlackRock Health Sciences Opportunities Portfolio

 

Investment Objective

BlackRock Health Sciences Opportunities Portfolio’s (the “Fund”) investment objective is to provide long-term growth of capital.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2023, the Fund’s Class K Shares outperformed its benchmark, the Russell 3000® Health Care Index, while the Investor A, Investor C, Class R and Service Shares underperformed. For the same period, the Fund’s Institutional Shares performed in line.

What factors influenced performance?

An underweight position in Bristol-Myers Squibb Co. was the largest contributor to relative performance at the individual stock level. The pharmaceutical company reported consistently weak earnings over the reporting period, citing slow growth for a few key products. An underweight in Pfizer, which was negatively impacted by waning COVID vaccine and Paxlovid sales, was another large contributor to results. An out-of-benchmark position in McKesson Corp., a drug distributor that reported strong earnings behind robust demand, was an additional contributor of note.

An overweight position in Biogen, Inc. was the largest detractor. The biopharma company saw weaker-than-expected demand for its Alzheimer’s drug Leqembi. An overweight in Penumbra, Inc. was another large detractor from relative returns. Shares of the medical device manufacturer came under pressure on concerns that the growth of GLP-1 weight loss drugs would negatively impact demand for the company’s products. An overweight in Sarepta Therapeutics, Inc., which failed to receive FDA approval for its much-anticipated Duchenne Muscular Dystrophy gene therapy was also a key detractor.

Describe recent portfolio activity.

The Fund’s allocations to the healthcare providers (17.4% to 22.3%), biotechnology (22.8% to 24.1%), and pharmaceuticals (19.9% to 20.6%) subsectors increased. Conversely, its weighting in the medical devices and supplies (37.4% to 28.8%) subsector decreased.

Describe portfolio positioning at period end.

The investment adviser continued to seek opportunities in stocks with attractive valuations, stable growth and promising product pipelines over the medium to long term. It also sought select growth companies in the biotechnology, pharmaceuticals and medical devices industries with the potential to benefit from innovation and technological developments. The investment adviser continued to have a positive view on the long-term secular drivers of growth in the healthcare sector, particularly aging demographics and innovations in medical science and technology.

The Fund was overweight in the and biotechnology healthcare providers and services subsectors at the end of the reporting period, and it was underweight in pharmaceuticals and medical devices and supplies.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years     10 Years  
    

6-Month

Total

Returns

    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    1.73     (2.38 )%      N/A       7.76     N/A       11.46     N/A  

Service

    1.58       (2.66     N/A       7.43       N/A       11.13       N/A  

Investor A

    1.60       (2.62     (7.73 )%      7.48       6.33     11.16       10.56

Investor C

    1.22       (3.35     (4.30     6.68       6.68       10.51       10.51  

Class K

    1.78       (2.28     N/A       7.86       N/A       11.46       N/A  

Class R

    1.41       (2.97     N/A       7.11       N/A       10.79       N/A  

Russell 3000® Health Care Index(c)

    1.70       (4.27     N/A       7.58       N/A       10.44       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b) 

Under normal market conditions, the Fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries.

 
(c) 

An unmanaged index that features companies involved in medical services or health care in the Russell 3000® Index, which includes the largest 3,000 U.S. companies as determined by total market capitalization.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

 

6  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary  as of November 30, 2023 (continued)

    

   BlackRock Health Sciences Opportunities Portfolio

 

Expense Example

 

   

                                   Actual                                   

         

                   Hypothetical 5% Return                  

        
     Beginning
Account Value
(06/01/23)
     Ending
  Account Value
(11/30/23)
     Expenses   
  Paid During   
the Period(a)
          Beginning
Account Value
(06/01/23)
    Ending
  Account Value
(11/30/23)
     Expenses   
  Paid During   
the Period(a)
     Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 1,017.30      $ 4.23          $ 1,000.00     $ 1,020.81      $ 4.24           0.84

Service

    1,000.00        1,015.80        5.72            1,000.00       1,019.33        5.70           1.13  

Investor A

    1,000.00        1,016.00        5.48            1,000.00       1,019.57        5.50           1.09  

Investor C

    1,000.00        1,012.20        9.36            1,000.00       1,015.70        9.37           1.86  

Class K

    1,000.00        1,017.80        3.76            1,000.00       1,021.27        3.79           0.75  

Class R

    1,000.00        1,014.10        7.33                  1,000.00       1,017.72        7.36           1.46  

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/366 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

 

TEN LARGEST HOLDINGS

 

   
Security(a)   Percent of
Net Assets
 

UnitedHealth Group, Inc.

    9.9

Eli Lilly & Co.

    9.3  

Boston Scientific Corp.

    4.4  

Merck & Co., Inc.

    4.1  

AbbVie, Inc.

    3.7  

Amgen, Inc.

    3.6  

Danaher Corp.

    3.1  

Abbott Laboratories

    3.0  

Gilead Sciences, Inc.

    2.6  

Elevance Health, Inc.

    2.5  
INDUSTRY ALLOCATION

 

   
Industry(b)   Percent of
Net Assets
 

Biotechnology

    24.1

Health Care Providers & Services

    22.3  

Health Care Equipment & Supplies

    20.9  

Pharmaceuticals

    20.6  

Life Sciences Tools & Services

    7.8  

Other (each representing less than 1%)

    0.2  

Short-Term Securities

    4.7  

Liabilities in Excess of Other Assets

    (0.6
 

 

(a) 

Excludes short-term securities.

 
(b) 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

 

 

 

U N D   S U M M A R Y

  7


 

Fund Summary as of November 30, 2023

    

   BlackRock Infrastructure Sustainable Opportunities Fund

 

Investment Objective

BlackRock Infrastructure Sustainable Opportunities Fund’s (the “Fund”) investment objective is to seek to maximize total return while seeking to invest in issuers which are helping to address certain United Nations Sustainable Development Goals (“SDGs”) through their products and services.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2023, the Fund underperformed its benchmark, the FTSE Developed Core Infrastructure 50/50 Net Tax Index.

What factors influenced performance?

BlackRock Infrastructure Sustainable Opportunities Fund is benchmark agnostic, with a view of infrastructure that looks beyond the traditional benchmarks. The reference benchmark, the FTSE Developed Core Infrastructure 50/50 Net Tax Index, doesn’t incorporate sustainability criteria and has an 11% weighting in the midstream oil and gas sector. In contrast, energy is excluded from the Fund’s sustainable universe.

At the sector level, the U.S. tower, U.S. datacenter and Eurozone toll road sectors made the largest contributions to absolute performance. Among individual stocks, SBA Communications Corp., Digital Realty Trust, Inc. and Enel SpA were the leading contributors. On the other hand, positioning in Eurozone electric utilities, U.K. multi utilities and Canadian electric utilities detracted. Orsted AS, Smart Metering Systems PLC, and Aeroports de Paris SA were the largest detractors at the individual stock level.

The Fund’s cash position had no material impact on performance.

Describe recent portfolio activity.

The investment adviser increased the Fund’s allocation to the Eurozone toll road and U.K. water utilities sectors. It decreased the portfolio’s weighting in U.S. datacenters.

The investment adviser initiated a position in Ferrovial SE, a Spain-listed toll road owner and operator with majority of its assets in North America, given its favorable sustainability characteristics and a potentially attractive opportunity from underappreciated growth in its managed lanes business. It also added a position in United Utilities Group PLC (“United Utilities”), the United Kingdom’s largest listed water and sewage utility. The investment adviser believed United Utilities was poised to see improving growth, and it has a positive view on the company’s new management team. The investment adviser added Xcel Energy, Inc. on the belief that short-term weakness related to regulatory changes was obscuring the company’s longer-term growth opportunities. Portland General Electric Co., the largest electric utility in Oregon, was another new addition based on the investment adviser’s positive view on the company’s growth outlook, balance sheet strength and potential to benefit from unique demographic and decarbonization tailwinds. The investment adviser reduced its position in Eversource Energy after a punitive rate case order against a competitor raised the odds of regulatory challenges.

Describe portfolio positioning at period end.

The Fund’s positioning was balanced across electricity networks (36%), transportation infrastructure (21%), communications infrastructure (19%), transportation infrastructure (17%), renewables energy development (10%), water infrastructure (5%), and social infrastructure (4%). The Fund had a modest cash position to provide the flexibility to capitalize on stock-specific opportunities.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     Since Inception(c)  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    (1.64 )%      1.97     N/A       (3.03 )%      N/A  

Investor A

    (1.84     1.64       (3.70 )%      (3.30     (5.68 )% 

Class K

    (1.62     2.01       N/A       (2.99     N/A  

FTSE Developed Core Infrastructure 50/50 Net Tax Index(d)

    0.59       (3.49     N/A       0.10       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees.

 
(b) 

Under normal circumstances, the Fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in the equity securities of infrastructure-related companies or derivatives with similar economic characteristics.

 
(c) 

The Fund commenced operations on September 30, 2021.

 
(d) 

Gives participants an industry-defined interpretation of infrastructure and adjusts the exposure to certain infrastructure sub-sectors. The constituent weights are adjusted as part of the semi-annual review according to three broad industry sectors: 50% utilities; 30% transportation, including capping of 7.5% for railroads/railways; and a 20% mix of other sectors, including pipelines, satellites and telecommunication towers.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

 

8  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary as of November 30, 2023 (continued)

    

   BlackRock Infrastructure Sustainable Opportunities Fund

 

Expense Example

 

   

                                   Actual                                   

         

                   Hypothetical 5% Return                  

        
     Beginning
Account Value
(06/01/23)
     Ending
  Account Value
(11/30/23)
     Expenses   
  Paid During   
the Period(a)
           Beginning
Account Value
(06/01/23)
    Ending
  Account Value
(11/30/23)
     Expenses   
  Paid During   
the Period(a)
     Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 983.60      $ 4.97          $ 1,000.00     $ 1,019.99      $ 5.05           1.00

Investor A

    1,000.00        981.60        6.20                  1,000.00       1,018.74        6.31           1.25  

Class K

    1,000.00        983.80        4.72                  1,000.00       1,020.24        4.80           0.95  

 

(a)   

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/366 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

 

TEN LARGEST HOLDINGS

 

   
Security(a)   Percent of
Net Assets
 

National Grid PLC

    5.9

SBA Communications Corp.

    5.5  

Terna - Rete Elettrica Nazionale

    4.8  

Clearway Energy, Inc., Class C

    4.5  

SSE PLC

    4.2  

Ferrovial SE

    4.2  

Enel SpA

    4.1  

EDP - Energias de Portugal SA

    3.9  

American Tower Corp.

    3.6  

Cellnex Telecom SA

    3.5  
SECTOR ALLOCATION

 

   
Sector(b)   Percent of
Net Assets
 

Utilities

    48.9

Industrials

    22.1  

Real Estate

    16.5  

Communication Services

    5.0  

Information Technology

    1.6  

Short-Term Securities

    5.0  

Other Assets Less Liabilities

    0.9  
 

 

(a)   

Excludes short-term securities.

(b)   

For Fund compliance purposes, the Fund’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

 

 

U N D   S U M M A R Y

  9


 

Fund Summary as of November 30, 2023

    

   BlackRock Mid-Cap Growth Equity Portfolio

 

Investment Objective

BlackRock Mid-Cap Growth Equity Portfolio’s (the “Fund”) investment objective is long-term capital appreciation.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2023, the Fund’s Institutional and Class K Shares outperformed its benchmark, the Russell Midcap® Growth Index, while its Investor C and Class R Shares underperformed and its Investor A and Service Shares performed in line.

What factors influenced performance?

The largest positive contributors to the Fund’s performance relative to the benchmark over the period included security selection in the financials and information technology sectors, along with positioning in healthcare. In financials, an overweight position in KKR & Co., Inc. in the capital markets industry benefited performance. In information technology, overweighting the software industry, specifically CrowdStrike Holdings, Inc., highlighted positive contributions. Lastly, within healthcare, overweighting the healthcare equipment and supplies industry proved beneficial.

The largest detractors from relative performance were stock selection in the consumer discretionary and industrials sectors, along with positioning in the energy sector. In consumer discretionary, stock selection among hotels, restaurants & leisure, specifically an off-benchmark position in online gaming technology company Evolution AB, detracted from relative performance. In industrials, an overweight position in SiteOne Landscape Supply, Inc. within the trading companies and distributors industry detracted from relative performance. Lastly, within energy an underweight allocation to the oil, gas and consumable fuels industry weighed on performance.

Describe recent portfolio activity.

During the period, the Fund’s allocation to the industrials sector increased with additions to the aerospace and defense industry. The Fund’s allocation to the information technology sector increased as well. Conversely, the allocation to consumer discretionary decreased the most, driven by hotels, restaurants and leisure. Exposure to the communication services sector decreased as well.

Describe portfolio positioning at period end.

Relative to the Russell MidCap® Growth Index, at the end of the reporting period the Fund’s largest overweight allocation was to the information technology sector, followed by industrials and real estate. Conversely, the consumer discretionary sector was the largest underweight, followed by healthcare and consumer staples.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years     10 Years  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    8.84     10.33     N/A       9.20     N/A       11.16     N/A  

Service

    8.72       10.04       N/A       8.93       N/A       10.86       N/A  

Investor A

    8.73       10.03       4.25     8.93       7.76     10.85       10.26

Investor C

    8.31       9.21       8.21       8.12       8.12       10.20       10.20  

Class K

    8.89       10.40       N/A       9.29       N/A       11.24       N/A  

Class R

    8.56       9.77       N/A       8.66       N/A       10.57       N/A  

Russell Midcap® Growth Index(c)

    8.71       9.98       N/A       10.05       N/A       10.11       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b) 

The Fund normally invests at least 80% of its net assets in equity securities issued by U.S. mid-capitalization companies which Fund management believes have above-average earnings growth potential.

 
(c) 

An index that measures the performance of the mid-cap growth segment of the U.S. equity universe. It includes those Russell Midcap® Index companies with higher price-to-book ratios and higher forecasted growth values.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

 

10  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary as of November 30, 2023 (continued)

    

   BlackRock Mid-Cap Growth Equity Portfolio

 

Expense Example

 

   

                                    Actual                                

         

                    Hypothetical 5% Return                   

        
     Beginning
Account Value
(06/01/23)
     Ending
  Account Value
(11/30/23)
     Expenses   
  Paid During   
the  Period(a)
   

 

    Beginning
Account Value
(06/01/23)
    Ending
  Account Value
(11/30/23)
    

Expenses   

  Paid During   
the Period(a)

     Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 1,088.40      $ 4.18          $ 1,000.00     $ 1,021.00      $ 4.04           0.80

Service

    1,000.00        1,087.20        5.48            1,000.00       1,019.75        5.30           1.05  

Investor A

    1,000.00        1,087.30        5.48            1,000.00       1,019.75        5.30           1.05  

Investor C

    1,000.00        1,083.10        9.37            1,000.00       1,016.00        9.07           1.80  

Class K

    1,000.00        1,088.90        3.72            1,000.00       1,021.44        3.59           0.71  

Class R

    1,000.00        1,085.60        6.78                  1,000.00       1,018.50        6.56           1.30  

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/366 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

 

TEN LARGEST HOLDINGS

 

   
Security(a)   Percent of
Net Assets
 

Copart, Inc.

    3.9

Crowdstrike Holdings, Inc., Class A

    3.3  

KKR & Co., Inc., Class A

    3.0  

MSCI, Inc., Class A

    3.0  

CoStar Group, Inc.

    2.8  

West Pharmaceutical Services, Inc.

    2.8  

Monolithic Power Systems, Inc.

    2.7  

Ares Management Corp., Class A

    2.7  

ANSYS, Inc.

    2.6  

Cheniere Energy, Inc.

    2.5  
SECTOR ALLOCATION

 

   
Sector(b)   Percent of
Net Assets
 

Information Technology

    29.9

Industrials

    22.1  

Health Care

    16.2  

Financials

    11.1  

Consumer Discretionary

    9.1  

Communication Services

    4.0  

Real Estate

    2.8  

Energy

    2.5  

Materials

    1.4  

Other (each representing less than 1%)

    0.9  

Short-Term Securities

    3.6  

Liabilities in Excess of Other Assets

    (3.6
 

 

(a) 

Excludes short-term securities.

 
(b) 

For Fund compliance purposes, the Fund’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

 

 

U N D   S U M M A R Y

  11


Fund Summary  as of November 30, 2023

    

   BlackRock Technology Opportunities Fund

 

Investment Objective

BlackRock Technology Opportunities Fund’s (the “Fund”) investment objective is to provide long-term capital appreciation.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2023, all of the Fund’s share classes outperformed its benchmark, the MSCI All-Country World Information Technology Index with the exception of its Investor C Shares, which performed in line.

What factors influenced performance?

An underweight position in Apple Inc., which experienced profit-taking after a strong year-to-date rally amid signs of weakening demand for smartphones, was the largest contributor to relative performance. An overweight in the credit score provider Fair Isaac Corp. was also a top contributor on the strength of growth in its software offerings. An out-of-benchmark holding in MercadoLibre, Inc. further contributed to results. The Latin American e-commerce company saw continued earnings strength with accelerating growth from sustained market share gains in Brazil and Mexico.

An out-of-benchmark position in Adyen NV was the single largest detractor from performance. In August 2023, the Dutch payment company reported the slowest quarter for revenue growth in its history as enterprises opted for lower-cost competitors. An overweight in Wolfspeed, Inc. also detracted, as the silicon carbide wafer manufacturer reported larger-than-anticipated quarterly losses and further delays in the construction of its domestic fabrication facility. An out-of-benchmark holding in the Japanese payment processer GMO Payment Gateway, Inc., which lowered its growth forecast for 2024, was another detractor of note.

Describe recent portfolio activity.

The investment adviser added several companies where it identified both near-term catalysts and long-term growth potential in the supply chain for generative artificial intelligence (“AI”). It also increased its holdings in cybersecurity companies, including those that stand to benefit from the advent of AI-generated malware and the consolidation trend in the cybersecurity industry. On the other hand, the investment adviser sold Chinese internet stocks based on their elevated valuations, an uncertain regulatory environment, and country-specific growth challenges.

Describe portfolio positioning at period end.

The Fund’s largest absolute weightings were in the software and semiconductors sub-sectors. In addition, it maintained an out-of-benchmark allocation to the internet sub-sector. The investment adviser maintained its exposure to long-term secular themes, such as AI, renewable energy, and electric vehicles, as well as to more nascent themes such as space and quantum computing. While high-growth assets were penalized by rising interest rates, the investment adviser believed the fundamentals of its portfolio holdings remained compelling. It viewed the secular growth trends driving technology as multi-year transformations that are likely to persist regardless of the macroeconomic environment or geopolitical developments.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years     10 Years  
    

6-Month

Total

Returns

    Without
Sales
Charge
    With
Sales
Charge
   

Without

Sales
Charge

   

With

Sales

Charge

    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    12.19     30.00     N/A       17.12     N/A       17.59     N/A  

Service

    12.06       29.68       N/A       16.83       N/A       17.31       N/A  

Investor A

    12.03       29.68       22.87     16.82       15.57     17.27       16.64

Investor C

    11.65       28.70       27.70       15.95       15.95       16.55       16.55  

Class K

    12.23       30.07       N/A       17.18       N/A       17.62       N/A  

Class R

    11.92       29.34       N/A       16.54       N/A       16.96       N/A  

MSCI All-Country World Information Technology Index(c)

    11.68       33.17       N/A       20.18       N/A       17.49       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b) 

Under normal market conditions, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities issued by U.S. and non-U.S. technology companies in all market capitalization ranges, selected for their rapid and sustainable growth potential from the development, advancement and use of technology. The Fund’s total returns prior to December 30, 2017 are the returns of the Fund when it followed different investment strategies under the name BlackRock Science & Technology Opportunities Portfolio.

 
(c) 

An index that includes large- and mid-cap securities across certain Developed Markets countries and certain Emerging Markets countries. All securities in the index are classified in the Information Technology sector as per the Global Industry Classification Standard.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

 

12  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary as of November 30, 2023 (continued)

    

   BlackRock Technology Opportunities Fund

 

Expense Example

 

   

                                   Actual                                   

         

                    Hypothetical 5% Return                   

          
    

Beginning

Account Value

(06/01/23)

    

Ending

  Account Value

(11/30/23)

    

Expenses   

  Paid During   

the Period(a)

          Beginning
Account Value
(06/01/23)
     Ending
  Account Value
(11/30/23)
    

Expenses   

  Paid During   

the Period(a)

       Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 1,121.90      $ 4.88          $ 1,000.00      $ 1,020.40      $ 4.65             0.92

Service

    1,000.00        1,120.60        6.20            1,000.00        1,019.15        5.91             1.17  

Investor A

    1,000.00        1,120.30        6.20            1,000.00        1,019.15        5.91             1.17  

Investor C

    1,000.00        1,116.50        10.16            1,000.00        1,015.40        9.67             1.92  

Class K

    1,000.00        1,122.30        4.56            1,000.00        1,020.70        4.34             0.86  

Class R

    1,000.00        1,119.20        7.52                  1,000.00        1,017.90        7.16             1.42  

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/366 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

 

TEN LARGEST HOLDINGS

   
Security(a)   Percent of
Net Assets
 

Microsoft Corp.

    10.3

Apple Inc.

    9.5  

NVIDIA Corp.

    7.9  

Cadence Design Systems, Inc.

    3.6  

Meta Platforms, Inc., Class A

    2.7  

Broadcom, Inc.

    2.7  

Mastercard, Inc., Class A

    2.6  

ASML Holding NV

    2.4  

Amazon.com, Inc.

    2.3  

Alphabet, Inc., Class A

    2.3  

INDUSTRY ALLOCATION

   
Industry(b)   Percent of
Net Assets
 

Software

    31.9

Semiconductors & Semiconductor Equipment

    26.9  

Technology Hardware, Storage & Peripherals

    10.8  

Interactive Media & Services

    5.7  

Financial Services

    5.1  

Broadline Retail

    4.6  

Entertainment

    3.3  

IT Services

    3.0  

Automobiles

    2.1  

Professional Services

    1.6  

Communications Equipment

    1.5  

Ground Transportation

    1.0  

Other (each representing less than 1%)

    2.6  

Short-Term Securities

    1.3  

Liabilities in Excess of Other Assets

    (1.4
 
(a) 

Excludes short-term securities.

 
(b) 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

 

 

U N D   S U M M A R Y

  13


 

About Fund Performance

    

 

Institutional and Class K Shares are not subject to any sales charge. These shares bear no ongoing distribution or service fees and are available only to certain eligible investors. BlackRock Capital Appreciation Fund, Inc.’s Class K Shares performance shown prior to the Class K Shares inception date of August 15, 2016 is that of BlackRock Shares. BlackRock Health Sciences Opportunities Portfolio’s Class K Shares performance shown prior to the Class K Shares inception date of June 8, 2016 is that of Investor A Shares. BlackRock Mid-Cap Growth Equity Portfolio’s Class K Shares performance shown prior to the Class K Shares inception date of March 28, 2016 is that of Institutional Shares. BlackRock Technology Opportunities Fund’s Class K Shares performance shown prior to the Class K Shares inception date of December 10, 2019 is that of Institutional Shares. The performance of each Fund’s Class K Shares would be substantially similar to Investor A Shares or Institutional Shares, as applicable, because the share classes of a Fund invest in the same portfolio of securities and performance would only differ to the extent that Class K Shares and Investor A Shares or Institutional Shares, as applicable, have different expenses. The actual returns of Class K Shares would have been higher than those of the Investor A Shares or Institutional Shares, as applicable, because Class K Shares have lower expenses than the Investor A Shares and Institutional Shares.

Service Shares (not available in BlackRock Capital Appreciation Fund, Inc. and BlackRock Infrastructure Sustainable Opportunities Fund) are not subject to any sales charge. These shares are subject to a service fee of 0.25% per year (but no distribution fee) and are only available to certain eligible investors.

Investor A Shares are subject to a maximum initial sales charge (front-end load) of 5.25% and a service fee of 0.25% per year (but no distribution fee). Certain redemptions of these shares may be subject to a contingent deferred sales charge (“CDSC”) where no initial sales charge was paid at the time of purchase. These shares are generally available through financial intermediaries.

Investor C Shares (not available in BlackRock Infrastructure Sustainable Opportunities Fund) are subject to a 1.00% CDSC if redeemed within one year of purchase. In addition, these shares are subject to a distribution fee of 0.75% per year and a service fee of 0.25% per year. These shares are generally available through financial intermediaries. These shares automatically convert to Investor A Shares after approximately eight years.

Class R Shares (not available in BlackRock Infrastructure Sustainable Opportunities Fund) are not subject to any sales charge. These shares are subject to a distribution fee of 0.25% per year and a service fee of 0.25% per year. These shares are available only to certain employer-sponsored retirement plans.

Past performance is not an indication of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of each Fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Refer to blackrock.com to obtain performance data current to the most recent month-end. Performance results do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Figures shown in the performance tables assume reinvestment of all distributions, if any, at net asset value (“NAV”) on the ex-dividend date or payable date, as applicable. Investment return and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Distributions paid to each class of shares will vary because of the different levels of service, distribution and transfer agency fees applicable to each class, which are deducted from the income available to be paid to shareholders.

BlackRock Advisors, LLC (the “Manager”), each Fund’s investment adviser, has contractually and/or voluntarily agreed to waive and/or reimburse a portion of each Fund’s expenses. Without such waiver(s) and/or reimbursement(s), each Fund’s performance would have been lower. With respect to each Fund’s voluntary waiver(s), if any, the Manager is under no obligation to waive and/or reimburse or to continue waiving and/or reimbursing its fees and such voluntary waiver(s) may be reduced or discontinued at any time. With respect to each Fund’s contractual waiver(s), if any, the Manager is under no obligation to continue waiving and/or reimbursing its fees after the applicable termination date of such agreement. See the Notes to Financial Statements for additional information on waivers and/or reimbursements.

Disclosure of Expenses

Shareholders of each Fund may incur the following charges: (a) transactional expenses, such as sales charges; and (b) operating expenses, including investment advisory fees, administration fees, service and distribution fees, including 12b-1 fees, acquired fund fees and expenses, and other fund expenses. The expense examples shown (which are based on a hypothetical investment of $1,000 invested at the beginning of the period and held through the end of the period) are intended to assist shareholders both in calculating expenses based on an investment in each Fund and in comparing these expenses with similar costs of investing in other mutual funds.

The expense examples provide information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. In order to estimate the expenses a shareholder paid during the period covered by this report, shareholders can divide their account value by $1,000 and then multiply the result by the number corresponding to their Fund and share class under the heading entitled “Expenses Paid During the Period.”

The expense examples also provide information about hypothetical account values and hypothetical expenses based on a Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. In order to assist shareholders in comparing the ongoing expenses of investing in these Funds and other funds, compare the 5% hypothetical examples with the 5% hypothetical examples that appear in shareholder reports of other funds.

The expenses shown in the expense examples are intended to highlight shareholders’ ongoing costs only and do not reflect transactional expenses, such as sales charges, if any. Therefore, the hypothetical examples are useful in comparing ongoing expenses only and will not help shareholders determine the relative total expenses of owning different funds. If these transactional expenses were included, shareholder expenses would have been higher.

 

 

14  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Derivative Financial Instruments

    

 

The Funds may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, the Funds must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. The Funds’ successful use of a derivative financial instrument depends on the investment adviser’s ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation a Fund can realize on an investment and/or may result in lower distributions paid to shareholders. The Funds’ investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.

 

 

E R I V A T I V E   F I N A N C I A L   I N S T R U M E N T S

  15


 

Schedule of Investments (unaudited)

November 30, 2023

    

  

BlackRock Capital Appreciation Fund, Inc.

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   

Aerospace & Defense — 2.0%

   

TransDigm Group, Inc.

    68,453     $        65,911,340  
   

 

 

 
Automobiles — 2.8%            

Tesla, Inc.(a)

    377,734       90,686,379  
   

 

 

 
Broadline Retail — 8.8%            

Amazon.com, Inc.(a)

    1,946,722       284,396,617  
   

 

 

 
Capital Markets — 5.1%            

Blackstone, Inc., Class A, NVS

    354,135       39,794,150  

MSCI, Inc., Class A

    125,558       65,396,884  

S&P Global, Inc.

    144,594       60,126,523  
   

 

 

 
      165,317,557  
Chemicals — 1.0%            

Sherwin-Williams Co. (The)

    121,504       33,875,315  
   

 

 

 
Commercial Services & Supplies — 1.2%            

Copart, Inc.(a)

    309,917       15,564,032  

Waste Connections, Inc.

    179,313       24,295,118  
   

 

 

 
      39,859,150  
Entertainment — 2.4%            

Netflix, Inc.(a)

    166,296       78,819,315  
   

 

 

 
Financial Services — 6.2%            

Mastercard, Inc., Class A

    162,562       67,273,032  

Visa, Inc., Class A

    519,329       133,301,368  
   

 

 

 
      200,574,400  
Health Care Equipment & Supplies — 3.6%  

Boston Scientific Corp.(a)

    556,846       31,122,123  

IDEXX Laboratories, Inc.(a)

    56,207       26,182,345  

Intuitive Surgical, Inc.(a)

    187,409       58,254,213  
   

 

 

 
      115,558,681  
Health Care Providers & Services — 2.8%            

UnitedHealth Group, Inc.

    163,178       90,232,539  
   

 

 

 
Hotels, Restaurants & Leisure — 1.0%            

Chipotle Mexican Grill, Inc.(a)

    3,392       7,470,032  

Evolution AB(b)

    239,333       24,794,911  
   

 

 

 
      32,264,943  
Interactive Media & Services — 5.7%            

Alphabet, Inc., Class A(a)

    1,044,141       138,380,007  

Meta Platforms, Inc., Class A(a)

    141,402       46,259,664  
   

 

 

 
      184,639,671  
IT Services — 1.5%            

MongoDB, Inc., Class A(a)

    20,469       8,509,782  

Shopify, Inc., Class A(a)

    554,121       40,351,091  
   

 

 

 
      48,860,873  
Life Sciences Tools & Services — 2.7%            

Danaher Corp.

    211,356       47,197,908  

Thermo Fisher Scientific, Inc.

    84,750       42,015,660  
   

 

 

 
      89,213,568  
Oil, Gas & Consumable Fuels — 1.1%            

Cheniere Energy, Inc.

    195,568       35,622,711  
   

 

 

 
Pharmaceuticals — 3.7%            

Eli Lilly & Co.

    157,895       93,322,261  

Zoetis, Inc., Class A

    149,433       26,400,328  
   

 

 

 
      119,722,589  
Security   Shares     Value  

 

 

Real Estate Management & Development — 0.6%

 

CoStar Group, Inc.(a)

    238,036     $ 19,766,510  
   

 

 

 
Semiconductors & Semiconductor Equipment — 14.4%  

ASML Holding NV, Registered Shares

    131,028       89,591,705  

Broadcom, Inc.

    116,651       107,987,330  

KLA Corp.

    121,319       66,072,754  

NVIDIA Corp.

    436,029       203,930,764  
   

 

 

 
      467,582,553  
Software — 21.5%            

Cadence Design Systems, Inc.(a)

    259,260       70,847,980  

Intuit, Inc.

    239,481       136,853,812  

Microsoft Corp.

    873,418       330,946,815  

Palo Alto Networks, Inc.(a)

    166,125       49,021,826  

Roper Technologies, Inc.

    102,281       55,052,748  

ServiceNow, Inc.(a)

    82,104       56,301,997  
   

 

 

 
      699,025,178  
Specialty Retail — 0.8%            

Ross Stores, Inc.

    195,314       25,465,039  
   

 

 

 
Technology Hardware, Storage & Peripherals — 9.0%  

Apple Inc.

    1,530,415       290,702,329  
   

 

 

 
Textiles, Apparel & Luxury Goods — 1.3%            

LVMH Moet Hennessy Louis Vuitton SE

    54,403       41,633,476  
   

 

 

 

Total Common Stocks — 99.2%

    (Cost: $1,546,482,231)

      3,219,730,733  
   

 

 

 

Preferred Securities

   

Preferred Stocks — 0.9%

   
Interactive Media & Services — 0.9%            

Bytedance Ltd., Series E-1 (Acquired 11/11/20, cost $19,426,516)(a)(c)(d)

    177,291       31,260,446  
   

 

 

 

Total Long-Term Investments — 100.1%

    (Cost: $1,565,908,747)

      3,250,991,179  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 0.1%

   

BlackRock Liquidity Funds, T-Fund, Institutional Class, 5.26%(e)(f)

    1,635,299       1,635,299  
   

 

 

 

Total Short-Term Securities — 0.1%

    (Cost: $1,635,299)

      1,635,299  
   

 

 

 

Total Investments — 100.2%

    (Cost: $1,567,544,046)

      3,252,626,478  

Liabilities in Excess of Other Assets — (0.2)%

 

    (5,852,295
   

 

 

 
Net Assets — 100.0%         $  3,246,774,183  
   

 

 

 

 

(a)   

Non-income producing security.

(b)   

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(c)   

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(d)   

Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $31,260,446, representing 1.0% of its net assets as of period end, and an original cost of $19,426,516.

(e)   

Affiliate of the Fund.

(f)   

Annualized 7-day yield as of period end.

 

 

 

16  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Capital Appreciation Fund, Inc.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2023 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer  

Value at

05/31/23

    Purchases
at Cost
    Proceeds
from Sale
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
   

Value at

11/30/23

   

Shares

Held at

11/30/23

    Income    

Capital

Gain

Distributions

from Underlying

Funds

 

BlackRock Liquidity Funds, T-Fund,

                 

Institutional Class

  $   1,248,701     $ 386,598 (a)    $     $     $     $   1,635,299       1,635,299     $   80,090     $  

SL Liquidity Series, LLC, Money

                 

Market Series(b)

                (3,536 )(a)      3,536                         5,978 (c)       
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ 3,536     $     $ 1,635,299       $   86,068     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

As of period end, the entity is no longer held.

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Aerospace & Defense

   $ 65,911,340        $        $        $ 65,911,340  

Automobiles

     90,686,379                            90,686,379  

Broadline Retail

     284,396,617                            284,396,617  

Capital Markets

     165,317,557                            165,317,557  

Chemicals

     33,875,315                            33,875,315  

Commercial Services & Supplies

     39,859,150                            39,859,150  

Entertainment

     78,819,315                            78,819,315  

Financial Services

     200,574,400                            200,574,400  

Health Care Equipment & Supplies

     115,558,681                            115,558,681  

Health Care Providers & Services

     90,232,539                            90,232,539  

Hotels, Restaurants & Leisure

     7,470,032          24,794,911                   32,264,943  

Interactive Media & Services

     184,639,671                            184,639,671  

IT Services

     48,860,873                            48,860,873  

Life Sciences Tools & Services

     89,213,568                            89,213,568  

Oil, Gas & Consumable Fuels

     35,622,711                            35,622,711  

Pharmaceuticals

     119,722,589                            119,722,589  

Real Estate Management & Development

     19,766,510                            19,766,510  

Semiconductors & Semiconductor Equipment

     467,582,553                            467,582,553  

Software

     699,025,178                            699,025,178  

Specialty Retail

     25,465,039                            25,465,039  

Technology Hardware, Storage & Peripherals

     290,702,329                            290,702,329  

Textiles, Apparel & Luxury Goods

              41,633,476                   41,633,476  

Preferred Securities

                       31,260,446          31,260,446  

Short-Term Securities

                 

Money Market Funds

     1,635,299                            1,635,299  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $   3,154,937,645        $   66,428,387        $   31,260,446        $   3,252,626,478  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  17


 

Schedule of Investments (unaudited)

November 30, 2023

    

  

BlackRock Health Sciences Opportunities Portfolio

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

 

Biotechnology — 23.7%

 

AbbVie, Inc.

    2,069,520     $      294,678,953  

Abcam PLC, ADR(a)

    1,059,945       25,406,882  

Alnylam Pharmaceuticals, Inc.(a)

    184,507       31,043,303  

Amgen, Inc.

    1,050,915       283,368,721  

Argenx SE, ADR(a)

    161,682       72,855,526  

BeiGene Ltd., ADR(a)(b)

    96,865       18,107,943  

Biogen, Inc.(a)

    596,508       139,630,593  

BioMarin Pharmaceutical, Inc.(a)

    642,970       58,561,708  

Biomea Fusion, Inc.(a)

    137,217       2,067,860  

Blueprint Medicines Corp.(a)

    400,250       27,873,410  

Cabaletta Bio, Inc.(a)(b)

    419,920       6,739,716  

Cerevel Therapeutics Holdings, Inc.(a)

    312,854       8,112,304  

CureVac NV(a)(b)

    310,911       1,678,919  

Exact Sciences Corp.(a)

    280,808       17,971,712  

Frequency Therapeutics, Inc., CVR(a)

    8,560       116  

Genesis Therapeutics, Inc., Series B (Acquired 08/10/23, cost
$4,207,998)(a)(c)(d)

    823,870       4,209,976  

Genmab A/S(a)

    42,470       13,357,469  

Genmab A/S, ADR(a)(b)

    289,405       9,148,092  

Gilead Sciences, Inc.

    2,723,422       208,614,125  

Immuneering Corp., Class A(a)(b)

    264,380       1,734,333  

Immunocore Holdings PLC, ADR(a)(b)

    181,355       9,562,849  

Incyte Corp.(a)

    398,775       21,669,434  

Ionis Pharmaceuticals, Inc.(a)

    365,540       18,083,264  

Kartos Therapeutics, Inc., Series C (Acquired 08/22/23, cost
$6,974,988)(a)(c)(d)

    1,233,856       6,971,286  

Karuna Therapeutics, Inc.(a)(b)

    38,125       7,289,881  

Legend Biotech Corp., ADR(a)

    465,786       28,329,105  

Merus NV(a)

    338,562       8,376,024  

Mirati Therapeutics, Inc.(a)

    228,510       12,967,943  

Moderna, Inc.(a)

    514,004       39,938,111  

MoonLake Immunotherapeutics(a)(b)

    144,884       6,361,856  

Morphic Holding, Inc.(a)(b)

    111,625       2,645,513  

Neurocrine Biosciences, Inc.(a)

    141,165       16,458,427  

Nuvalent, Inc., Class A(a)

    201,512       13,172,839  

Prime Medicine, Inc.(a)(b)

    360,982       2,620,729  

Protagonist Therapeutics, Inc.(a)

    403,935       7,355,656  

PTC Therapeutics, Inc.(a)

    287,575       6,619,977  

Regeneron Pharmaceuticals, Inc.(a)

    132,462       109,123,520  

REVOLUTION Medicines, Inc.(a)(b)

    260,118       6,068,553  

Rhythm Pharmaceuticals, Inc.(a)(b)

    690,347       23,078,300  

Rocket Pharmaceuticals, Inc.(a)

    266,176       6,209,886  

Sarepta Therapeutics, Inc.(a)

    526,617       42,803,430  

Seagen, Inc.(a)

    341,700       72,853,857  

Tenaya Therapeutics, Inc.(a)

    431,076       810,423  

Ultragenyx Pharmaceutical, Inc.(a)

    203,611       7,910,287  

Vaxcyte, Inc.(a)

    405,425       20,988,852  

Vertex Pharmaceuticals, Inc.(a)

    396,229       140,586,012  

Viking Therapeutics, Inc.(a)

    251,795       3,076,935  

Xenon Pharmaceuticals, Inc.(a)

    448,099       16,391,461  
   

 

 

 
      1,883,486,071  
Health Care Equipment & Supplies — 20.9%  

Abbott Laboratories

    2,298,783       239,740,079  

ABIOMED INC, CVR(a)(c)

    243,643       662,709  

Alcon, Inc.

    1,276,433       96,536,628  

Align Technology, Inc.(a)

    128,790       27,535,302  

Baxter International, Inc.

    857,481       30,937,914  

Becton Dickinson & Co.

    557,620       131,698,692  

Boston Scientific Corp.(a)

    6,262,123       349,990,054  

Cooper Cos., Inc. (The)

    197,962       66,697,357  
Security   Shares     Value  

 

 
Health Care Equipment & Supplies (continued)  

Dexcom, Inc.(a)

    486,545     $        56,205,678  

Envista Holdings Corp.(a)(b)

    322,825       7,324,899  

GE HealthCare Technologies, Inc.(b)

    610,150       41,770,869  

IDEXX Laboratories, Inc.(a)(b)

    109,065       50,804,658  

Inspire Medical Systems, Inc.(a)

    83,905       12,192,236  

Intuitive Surgical, Inc.(a)

    595,159       184,999,224  

Masimo Corp.(a)

    218,960       20,529,690  

Medtronic PLC

    1,139,497       90,327,927  

Orchestra BioMed Holdings, Inc.(a)(b)

    262,308       1,631,556  

Penumbra, Inc.(a)

    169,035       37,540,983  

STERIS PLC

    145,075       29,151,371  

Stryker Corp.

    600,360       177,904,679  
   

 

 

 
      1,654,182,505  
Health Care Providers & Services — 22.3%  

Cencora, Inc.

    884,445       179,869,580  

Centene Corp.(a)

    1,082,935       79,790,651  

Cigna Group (The)

    440,846       115,889,596  

Elevance Health, Inc.

    407,647       195,462,660  

Guardant Health, Inc.(a)

    219,046       5,513,388  

HCA Healthcare, Inc.

    315,226       78,957,808  

Humana, Inc.

    222,420       107,842,561  

Laboratory Corp. of America Holdings

    93,970       20,383,033  

McKesson Corp.

    367,850       173,095,496  

Quest Diagnostics, Inc.

    162,538       22,305,090  

UnitedHealth Group, Inc.

    1,420,784       785,650,928  
   

 

 

 
      1,764,760,791  
Life Sciences Tools & Services — 7.8%  

10X Genomics, Inc., Class A(a)(b)

    212,123       9,231,593  

Agilent Technologies, Inc.

    340,743       43,546,955  

Avantor, Inc.(a)(b)

    1,282,066       27,154,158  

Bio-Techne Corp.

    185,865       11,690,909  

Danaher Corp.

    1,086,677       242,665,841  

IQVIA Holdings, Inc.(a)(b)

    128,342       27,478,022  

Mettler-Toledo International, Inc.(a)

    14,110       15,407,132  

Nautilus Biotechnology, Inc.(a)

    308,716       848,969  

QIAGEN NV(a)

    506,921       20,864,868  

Rapid Micro Biosystems, Inc., Class A(a)

    377,456       441,624  

Repligen Corp.(a)(b)

    117,900       18,539,775  

Thermo Fisher Scientific, Inc.

    270,197       133,952,865  

West Pharmaceutical Services, Inc.

    201,490       70,674,632  
   

 

 

 
      622,497,343  
Pharmaceuticals — 20.5%            

AstraZeneca PLC

    246,769       31,760,750  

Catalent, Inc.(a)

    302,607       11,756,282  

Daiichi Sankyo Co. Ltd.

    504,500       13,670,511  

Elanco Animal Health, Inc.(a)

    1,398,355       16,472,622  

Eli Lilly & Co.

    1,252,586       740,328,429  

Johnson & Johnson

    1,013,858       156,803,278  

Merck & Co., Inc.

    3,204,144       328,360,677  

Novo Nordisk A/S, Class B

    956,675       97,738,372  

Pfizer, Inc.

    3,951,494       120,402,022  

Sanofi SA

    388,736       36,255,440  

Structure Therapeutics, Inc. (Acquired 09/29/23,cost $6,024,914)(a)(d)

    482,379       8,954,562  

Structure Therapeutics, Inc., ADR(a)(b)

    213,033       11,863,808  

Zoetis, Inc., Class A

    294,631       52,052,459  
   

 

 

 
      1,626,419,212  
   

 

 

 

Total Common Stocks — 95.2%

    (Cost: $4,694,176,948)

      7,551,345,922  
   

 

 

 
 

 

 

18  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Health Sciences Opportunities Portfolio

(Percentages shown are based on Net Assets)

 

Security  

Par

(000)

    Value  

 

 

Other Interests(a)(c)(d)(e)

   

Afferent Pharmaceuticals, Inc., Series C (Acquired 06/30/15, cost $0)

  USD 3,421     $ 718,334  

Affinivax Inc. (Acquired 08/19/22,
cost $0)

    123       1,648,298  
   

 

 

 
Total Other Interests — 0.0%
    (Cost: $0)
                 2,366,632  
   

 

 

 
    Shares        

 

 

Preferred Securities

   

Preferred Stocks — 0.7%

   
Biotechnology — 0.3%            

Adarx Pharmaceuticals, Inc., Series C (Acquired 08/02/23, cost $6,399,994)(a)(c)(d)

    769,230       6,399,994  

Cellarity, Inc., Series B (Acquired 01/15/21, cost $5,149,998)(a)(c)(d)

    858,333       2,849,665  

Goldfinch Bio, Inc., Series B (Acquired 06/26/20 - 03/21/22, cost $4,152,184)(a)(c)(d)

    3,518,800       1,196,392  

Laronde, Inc., Series B (Acquired 07/28/21, cost $10,822,560)(a)(c)(d)

    386,520       10,822,560  

Neurogene, Inc., Series B (Acquired 12/14/20 - 09/22/21, cost $5,099,600)(a)(c)(d)

    2,090,000       2,319,900  
   

 

 

 
      23,588,511  
Health Care Equipment & Supplies — 0.1%  

Exo Imaging, Inc., Series C (Acquired 06/24/21,cost $11,178,997)(a)(c)(d)

    1,908,330       5,037,991  

Swift Health Systems, Inc., Series D (Acquired 08/27/21, cost $5,271,070)(a)(c)(d)

    1,700,345       1,411,287  
   

 

 

 
      6,449,278  
Health Care Providers & Services — 0.0%  

Quanta Dialysis Technologies Ltd., Series D (Acquired 06/18/21, cost $9,727,321)(a)(c)(d)

    80,024,425       5,354,422  
   

 

 

 
Pharmaceuticals — 0.1%            

Insitro, Series C (Acquired 03/10/21, cost $10,839,964)(a)(c)(d)

    592,636       6,187,120  
   

 

 

 
Software — 0.2%            

Carbon Health Technologies, Inc. (Acquired 07/09/21, cost $16,855,000)(a)(c)(d)

    1,670,499       13,647,977  
   

 

 

 

Total Preferred Securities — 0.7%

    (Cost: $85,496,687)

      55,227,308  
   

 

 

 

 

Security   Shares     Value  

 

 

Warrants(a)

   

Biotechnology — 0.0%

   

Nuvation Bio, Inc. (Issued/Exercisable 08/17/20, 1 Share for 1 Warrant, Expires 07/07/27, Strike Price USD 0.00)

    77,354     $ 3,868  
   

 

 

 
Health Care Providers & Services — 0.0%  

CareMax, Inc. (Issued/Exercisable 09/15/20, 1 Share for 1 Warrant, Expires 07/16/25, Strike Price USD 0.00)(b)

    88,432       2,697  
   

 

 

 

Total Warrants — 0.0%

    (Cost: $306,235)

      6,565  
   

 

 

 

Total Long-Term Investments — 95.9%

    (Cost: $4,779,979,870)

      7,608,946,427  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 4.7%

   

BlackRock Liquidity Funds, T-Fund, Institutional Class, 5.26%(f)(g)

    313,146,239       313,146,239  

SL Liquidity Series, LLC, Money Market Series, 5.56%(f)(g)(h)

    58,834,212       58,857,746  
   

 

 

 

Total Short-Term Securities — 4.7%

    (Cost: $371,965,352)

      372,003,985  
   

 

 

 

Total Investments — 100.6%

    (Cost: $5,151,945,222)

      7,980,950,412  

Liabilities in Excess of Other Assets — (0.6)%

 

    (50,501,576
   

 

 

 

Net Assets — 100.0%

    $   7,930,448,836  
   

 

 

 

 

(a)   

Non-income producing security.

(b)   

All or a portion of this security is on loan.

(c)   

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(d)   

Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $77,729,764, representing 1.0% of its net assets as of period end, and an original cost of $102,704,587.

(e)   

Other interests represent beneficial interests in liquidation trusts and other reorganization or private entities.

(f)   

Affiliate of the Fund.

(g)   

Annualized 7-day yield as of period end.

(h)   

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  19


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Health Sciences Opportunities Portfolio

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2023 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer  

Value at

05/31/23

   

Purchases

at Cost

    Proceeds
from Sale
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
   

Value at

11/30/23

   

Shares

Held at

11/30/23

    Income    

Capital

Gain

Distributions

from Underlying

Funds

 

BlackRock Liquidity Funds, T-Fund, Institutional Class

  $   211,473,753     $   101,672,486 (a)    $     $     $     $   313,146,239       313,146,239     $   4,641,903     $  

SL Liquidity Series, LLC, Money Market Series

    47,521,743       11,310,032 (a)            20,603       5,368       58,857,746       58,834,212       425,410 (b)       
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ 20,603     $ 5,368     $ 372,003,985       $ 5,067,313     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Forward Foreign Currency Exchange Contracts

 

Currency Purchased      Currency Sold      Counterparty    Settlement
Date
     Unrealized
Appreciation
 (Depreciation)
 

USD

     88,893,484      EUR      82,488,400      Goldman Sachs International      12/14/23      $ (954,026

USD

     72,404,938      EUR      67,184,700      HSBC Bank PLC      12/14/23        (773,570

USD

     53,114,363      GBP      42,539,100      Standard Chartered Bank      12/14/23        (596,462
                 

 

 

 
                  $ (2,324,058
                 

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

      Commodity
Contracts
     Credit
Contracts
     Equity
Contracts
     Foreign
Currency
Exchange
Contracts
     Interest
Rate
Contracts
     Other
Contracts
     Total  

Liabilities — Derivative Financial Instruments

                    

Forward foreign currency exchange contracts

                    

Unrealized depreciation on forward foreign currency exchange contracts

   $  —      $  —      $  —      $  2,324,058      $  —      $  —      $  2,324,058  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

For the period ended November 30 2023, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

      Commodity
Contracts
     Credit
Contracts
     Equity
Contracts
     Foreign
Currency
Exchange
Contracts
     Interest
Rate
Contracts
     Other
Contracts
     Total  

Net Realized Gain (Loss) from:

                    

Forward foreign currency exchange contracts

   $  —      $  —      $  —      $   (2,386,899 )    $  —      $  —      $   (2,386,899
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

                    

Forward foreign currency exchange contracts

   $      $      $      $ 94,083      $      $      $ 94,083  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

 

20  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Health Sciences Opportunities Portfolio

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

Forward foreign currency exchange contracts

 

Average amounts purchased — in USD

       $176,104,930

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments – Offsetting as of Period End

The Fund’s derivative assets and liabilities (by type) were as follows:

 

      Assets      Liabilities  

Derivative Financial Instruments

     

Forward foreign currency exchange contracts

   $      $   2,324,058  
  

 

 

    

 

 

 

Total derivative assets and liabilities in the Statements of Assets and Liabilities

   $      $ 2,324,058  
  

 

 

    

 

 

 

Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”)

             
  

 

 

    

 

 

 

Total derivative assets and liabilities subject to an MNA

   $      $ 2,324,058  
  

 

 

    

 

 

 

The following table presents the Fund’s derivative assets and liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral received and pledged by the Fund:

 

Counterparty   

Derivative
Liabilities

Subject to

an MNA by

Counterparty

     Derivatives
Available
for Offset(a)
     Non-
Cash
Collateral
Pledged(b)
     Cash
Collateral
Pledged(b)
    

Net

Amount of
Derivative
Liabilities(c)(d)

 

Goldman Sachs International

   $ 954,026      $      $      $      $ 954,026  

HSBC Bank PLC

     773,570                             773,570  

Standard Chartered Bank

     596,462                             596,462  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 2,324,058      $      $      $      $ 2,324,058  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

The amount of derivatives available for offset is limited to the amount of derivative assets and/or liabilities that are subject to an MNA.

 
  (b) 

Excess of collateral received/pledged, if any, from the individual counterparty is not shown for financial reporting purposes.

 
  (c) 

Net amount may also include forward foreign currency exchange contracts that are not required to be collateralized.

 
  (d) 

Net amount represents the net amount payable due to the counterparty in the event of default.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Biotechnology

   $   1,858,947,224        $ 13,357,585        $ 11,181,262        $ 1,883,486,071  

Health Care Equipment & Supplies

     1,653,519,796                   662,709          1,654,182,505  

Health Care Providers & Services

     1,764,760,791                            1,764,760,791  

Life Sciences Tools & Services

     622,497,343                            622,497,343  

Pharmaceuticals

     1,438,039,577          188,379,635                   1,626,419,212  

Other Interests

                       2,366,632          2,366,632  

Preferred Securities

                       55,227,308          55,227,308  

Warrants

     6,565                            6,565  

Short-Term Securities

                 

Money Market Funds

     313,146,239                            313,146,239  

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  21


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Health Sciences Opportunities Portfolio

 

Fair Value Hierarchy as of Period End (continued)

 

      Level 1        Level 2        Level 3        Total  

Liabilities

                 

Unfunded Commitments(a)

   $        $        $ (1,108,365      $ (1,108,365
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 7,650,917,535        $ 201,737,220        $ 68,329,546          7,920,984,301  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments valued at NAV(b)

                    58,857,746  
                 

 

 

 
                  $ 7,979,842,047  
                 

 

 

 

Derivative Financial Instruments(c)

                 

Liabilities

                 

Foreign Currency Exchange Contracts

   $        $ (2,324,058      $        $ (2,324,058
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

Unfunded commitments are valued at the unrealized appreciation (depreciation) on the commitment.

 
  (b) 

Certain investments of the Fund were fair valued using NAV as a practical expedient as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 
  (c) 

Derivative financial instruments are forward foreign currency exchange contracts. Forward foreign currency exchange contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

22  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Schedule of Investments (unaudited)

November 30, 2023

    

  

BlackRock Infrastructure Sustainable Opportunities Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Commercial Services & Supplies — 1.0%

 

Smart Metering Systems PLC

    10,666     $ 86,986  
   

 

 

 
Construction & Engineering — 4.2%            

Ferrovial SE

    10,808       373,787  
   

 

 

 
Diversified Telecommunication Services — 5.0%  

Cellnex Telecom SA(a)

    8,143       310,888  

Infrastrutture Wireless Italiane SpA(a)

    10,926       135,108  
   

 

 

 
      445,996  
Electric Utilities — 29.0%  

EDP - Energias de Portugal SA

    72,234       345,461  

Enel SpA

    52,125       368,359  

Eversource Energy

    2,265       134,564  

Exelon Corp.

    2,338       90,036  

Hydro One Ltd.(a)

    6,065       168,593  

Orsted AS(a)

    4,584       215,850  

Portland General Electric Co.

    5,043       207,065  

SSE PLC

    16,176       374,806  

Terna - Rete Elettrica Nazionale

    52,557       423,458  

Xcel Energy, Inc.

    4,146       252,243  
   

 

 

 
        2,580,435  
Ground Transportation — 4.8%  

Canadian Pacific Kansas City Ltd.

    2,526       181,853  

CSX Corp.

    5,037       162,695  

West Japan Railway Co.

    2,200       86,949  
   

 

 

 
      431,497  
Health Care REITs — 2.4%  

Aedifica SA

    1,446       90,537  

Physicians Realty Trust

    10,719       125,198  
   

 

 

 
      215,735  
Independent Power and Renewable Electricity Producers — 7.9%  

Boralex, Inc., Class A

    8,343       189,554  

Clearway Energy, Inc., Class C

    15,963       398,596  

EDP Renovaveis SA

    6,231       113,804  
   

 

 

 
      701,954  
IT Services — 1.6%            

NEXTDC Ltd.(b)

    16,351       140,405  
   

 

 

 
Multi-Utilities — 6.9%            

National Grid PLC

    40,715       528,044  

REN - Redes Energeticas Nacionais SGPS SA

    31,694       84,122  
   

 

 

 
      612,166  
Security   Shares     Value  

Office REITs — 1.5%

   

Alexandria Real Estate Equities, Inc.

    1,234     $ 135,000  
   

 

 

 
Specialized REITs — 12.6%            

American Tower Corp.

    1,540       321,521  

Digital Realty Trust, Inc.

    648       89,929  

Equinix, Inc.

    272       221,683  

SBA Communications Corp.

    1,978       488,487  
   

 

 

 
      1,121,620  
Transportation Infrastructure — 12.0%            

Aena SME SA(a)

    525       90,288  

Aeroports de Paris SA

    705       86,928  

Enav SpA(a)

    20,993       75,026  

Flughafen Zurich AG, Registered Shares

    425       90,063  

Fraport AG Frankfurt Airport Services Worldwide(b)

    3,188       182,348  

Getlink SE

    15,125       276,381  

Salik Co. PJSC

    110,325       96,129  

Transurban Group

    20,632       176,280  
   

 

 

 
      1,073,443  
Water Utilities — 5.2%            

Severn Trent PLC

    6,320       207,526  

United Utilities Group PLC

    18,866       259,971  
   

 

 

 
      467,497  
   

 

 

 
Total Long-Term Investments — 94.1%
    (Cost: $8,628,884)
        8,386,521  
   

 

 

 

Short-Term Securities

 

Money Market Funds — 5.0%            

BlackRock Liquidity Funds, T-Fund, Institutional Class, 5.26%(c)(d)

    440,923       440,923  
   

 

 

 

Total Short-Term Securities — 5.0%

    (Cost: $440,923)

      440,923  
   

 

 

 

Total Investments — 99.1%

    (Cost: $9,069,807)

      8,827,444  

Other Assets Less Liabilities — 0.9%

      82,054  
   

 

 

 

Net Assets — 100.0%

    $   8,909,498  
   

 

 

 

 

(a) 

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(b) 

Non-income producing security.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  23


Schedule of Investments  (unaudited) (continued)

November 30, 2023

    

  

BlackRock Infrastructure Sustainable Opportunities Fund

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2023 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
05/31/23
     Purchases
at Cost
     Proceeds
from Sale
     Net
Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
11/30/23
     Shares
Held at
11/30/23
     Income     

Capital

Gain
Distributions
from Underlying
Funds

 

BlackRock Liquidity Funds, T-Fund, Institutional Class

   $  733,814      $      $  (292,891 )(a)     $      $      $ 440,923        440,923      $ 12,323      $  

SL Liquidity Series, LLC, Money Market Series(b)

                   (1 )(a)       1                             12 (c)        
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ 1      $      $  440,923         $ 12,335      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

As of period end, the entity is no longer held.

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

OTC Total Return Swaps

 

 

 
Reference Entity   

Payment  

Frequency

   Counterparty(a)      Termination
Date
     Net
Notional
     Accrued
Unrealized
Appreciation
(Depreciation)
     Net Value of
Reference
Entity
    

Gross Notional 

Amount 

Net Asset 

Percentage 

 

 

 

Equity Securities Long/Short

   Monthly        Goldman Sachs Bank USA (c)       08/19/26      $   95,210      $ 3,562 (b)     $ 98,917        1.1
              

 

 

    

 

 

    

 

  (a) 

The Fund receives the total return on a portfolio of long positions underlying the total return swap. The Fund pays the total return on a portfolio of short positions underlying the total return swap. In addition, the Fund pays or receives a variable rate of interest, based on a specified benchmark. The benchmark and spread are determined based upon the country and/or currency of the individual underlying positions.

 
  (b) 

Amount includes $(145) of net dividends and financing fees.

 

The following are the specified benchmarks (plus or minus a range) used in determining the variable rate of interest:

 

 

(c)

Range:   26 basis points
Benchmarks:   Euro Short-Term Rate:
      EUR 1 Day

 

The following table represents the individual long positions and related values of equity securities underlying the total return swap with Goldman Sachs Bank USA, as of period end, termination date August 19, 2026:

 

 

 
       Shares        Value        % of
Basket
Value
 

 

 

Reference Entity — Long

 

    
Common Stocks               

Electric Utilities

              

EDP - Energias de Portugal SA

       20,683        $ 98,917          100.0
         

 

 

      

 

 

 

Net Value of Reference Entity — Goldman Sachs Bank USA

          $   98,917       
         

 

 

      

    

 

 

 

 

24  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

 

BlackRock Infrastructure Sustainable Opportunities Fund

 

Balances Reported in the Statements of Assets and Liabilities for OTC Swaps

 

     Swap
Premiums
Paid
     Swap
Premiums
Received
     Unrealized
Appreciation
     Unrealized
Depreciation
 

OTC Swaps

  $      $      $ 3,562      $  —  

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

    

Commodity

Contracts

    

Credit

Contracts

     Equity
Contracts
    

Foreign

Currency
Exchange
Contracts

     Interest
Rate
Contracts
     Other
Contracts
     Total  

Assets — Derivative Financial Instruments

                   

Swaps — OTC

                   

Unrealized appreciation on OTC swaps;

                   

Swap premiums paid

  $      $      $ 3,562      $      $      $      $ 3,562  
 

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

For the period ended November 30, 2023, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

      Commodity
Contracts
       Credit
Contracts
       Equity
Contracts
       Foreign
Currency
Exchange
Contracts
       Interest
Rate
Contracts
       Other
Contracts
       Total  

Net Realized Gain (Loss) from:

                                

Swaps

   $        $        $ (16,173      $        $        $        $   (16,173
  

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

                                

Swaps

   $        $        $ 10,325        $        $        $        $ 10,325  
  

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

Total return swaps

        

Average notional amount

   $ 93,862  

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments – Offsetting as of Period End

The Fund’s derivative assets and liabilities (by type) were as follows:

 

      Assets        Liabilities  

Derivative Financial Instruments

       

Swaps — OTC(a)

   $   3,562        $  
  

 

 

      

 

 

 

Total derivative assets and liabilities in the Statements of Assets and Liabilities

   $ 3,562        $  
  

 

 

      

 

 

 

Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”)

               
  

 

 

      

 

 

 

Total derivative assets and liabilities subject to an MNA

   $ 3,562        $  
  

 

 

      

 

 

 

 

  (a) 

Includes unrealized appreciation (depreciation) on OTC swaps and swap premiums (paid/received) in the Statements of Assets and Liabilities.

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  25


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Infrastructure Sustainable Opportunities Fund

 

The following table presents the Fund’s derivative assets by counterparty net of amounts available for offset under an MNA and net of the related collateral received by the Fund:

 

Counterparty   

Derivative

Assets

Subject to

an MNA by

Counterparty

      

Derivatives

Available

for Offset(a)

      

Non-

Cash

Collateral

Received(b)

      

Cash

Collateral

Received(b)

      

Net

Amount of

Derivative

Assets(c)

 

Goldman Sachs Bank USA

   $ 3,562        $        $        $        $ 3,562  
  

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

The amount of derivatives available for offset is limited to the amount of derivative assets and/or liabilities that are subject to an MNA.

 
  (b) 

Excess of collateral received/pledged, if any, from the individual counterparty is not shown for financial reporting purposes.

 
  (c) 

Net amount represents the net amount receivable from the counterparty in the event of default.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Commercial Services & Supplies

   $ 86,986        $        $        $ 86,986  

Construction & Engineering

              373,787                   373,787  

Diversified Telecommunication Services

              445,996                   445,996  

Electric Utilities

     852,501          1,727,934                   2,580,435  

Ground Transportation

     344,548          86,949                   431,497  

Health Care REITs

     125,198          90,537                   215,735  

Independent Power and Renewable Electricity Producers

     588,150          113,804                   701,954  

IT Services

              140,405                   140,405  

Multi-Utilities

              612,166                   612,166  

Office REITs

     135,000                            135,000  

Specialized REITs

     1,121,620                            1,121,620  

Transportation Infrastructure

     96,129          977,314                   1,073,443  

Water Utilities

     207,526          259,971                   467,497  

Short-Term Securities

                 

Money Market Funds

     440,923                            440,923  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $   3,998,581        $   4,828,863        $        $   8,827,444  
  

 

 

      

 

 

      

 

 

      

 

 

 

Derivative Financial Instruments(a)

                 

Assets

                 

Equity Contracts

   $        $ 3,562        $        $ 3,562  
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are swaps. Swaps are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

26  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Schedule of Investments (unaudited)

November 30, 2023

    

  

BlackRock Mid-Cap Growth Equity Portfolio

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Aerospace & Defense — 6.4%

 

Axon Enterprise, Inc.(a)(b)

    1,076,251     $ 247,397,818  

HEICO Corp.(b)

    1,348,302       230,600,091  

TransDigm Group, Inc.

    263,206       253,433,161  
   

 

 

 
    731,431,070  
Automobiles — 2.4%  

Ferrari NV

    756,113       271,414,322  
   

 

 

 
Beverages — 0.9%  

Davide Campari-Milano NV

    9,461,757       103,344,433  
   

 

 

 
Capital Markets — 11.1%  

Ares Management Corp., Class A

    2,727,142       306,121,689  

KKR & Co., Inc., Class A

    4,561,044       345,909,577  

MarketAxess Holdings, Inc.

    44,234       10,621,468  

MSCI, Inc., Class A

    662,859       345,250,110  

Tradeweb Markets, Inc., Class A

    2,794,116       270,749,841  
   

 

 

 
        1,278,652,685  
Commercial Services & Supplies — 7.3%  

Cintas Corp.

    162,383       89,838,395  

Copart, Inc.(a)

    9,016,463       452,806,772  

Rollins, Inc.

    4,142,297       168,757,180  

Waste Connections, Inc.

    945,368       128,087,910  
   

 

 

 
    839,490,257  
Communications Equipment — 0.3%  

Motorola Solutions, Inc.

    104,761       33,824,184  
   

 

 

 
Construction & Engineering — 0.9%  

WillScot Mobile Mini Holdings Corp.(a)

    2,550,246       106,396,263  
   

 

 

 
Construction Materials — 1.4%  

Vulcan Materials Co.

    745,868       159,287,570  
   

 

 

 
Distributors — 0.1%  

Pool Corp.

    39,515       13,724,350  
   

 

 

 
Electronic Equipment, Instruments & Components — 1.6%  

Teledyne Technologies, Inc.(a)(b)

    468,133       188,638,874  
   

 

 

 
Entertainment — 3.7%  

Liberty Media Corp. - Liberty Formula One, Class C(a)

    3,224,865       205,294,906  

Live Nation Entertainment, Inc.(a)(b)

    2,688,199       226,400,120  
   

 

 

 
    431,695,026  
Ground Transportation — 3.2%  

Old Dominion Freight Line, Inc.

    718,484       279,533,385  

Saia, Inc.(a)(b)

    235,976       92,122,671  
   

 

 

 
    371,656,056  
Health Care Equipment & Supplies — 7.7%  

Alcon, Inc.

    2,662,178       201,340,522  

Align Technology, Inc.(a)

    691,284       147,796,519  

IDEXX Laboratories, Inc.(a)

    503,062       234,336,341  

STERIS PLC

    823,779       165,530,152  

Teleflex, Inc.(b)

    588,330       132,780,198  
   

 

 

 
    881,783,732  
Hotels, Restaurants & Leisure — 3.1%  

Evolution AB(c)

    14,296       1,481,066  

Planet Fitness, Inc., Class A(a)(b)

    3,293,988       223,793,545  

Vail Resorts, Inc.

    598,486       130,056,993  
   

 

 

 
    355,331,604  
Interactive Media & Services — 0.2%  

Match Group, Inc.(a)(b)

    834,672       27,026,679  
   

 

 

 
Security     Shares     Value  

IT Services — 5.2%

 

 

Globant SA(a)

 

    1,043,251     $ 230,349,821  

MongoDB, Inc., Class A(a)(b)

 

    662,478       275,418,604  

VeriSign, Inc.(a)

 

    447,846       95,032,921  
     

 

 

 
    600,801,346  
Life Sciences Tools & Services — 8.5%        

Agilent Technologies, Inc.

 

    110,063       14,066,052  

Bio-Techne Corp.(b)

 

    3,717,902       233,856,036  

Charles River Laboratories International, Inc.(a)(b)

 

    920,235       181,359,914  

Mettler-Toledo International, Inc.(a)

 

    9,510       10,384,254  

Repligen Corp.(a)(b)

 

    1,390,677       218,683,958  

West Pharmaceutical Services, Inc.

 

    909,195       318,909,238  
     

 

 

 
    977,259,452  
Machinery — 0.8%        

IDEX Corp.

 

    433,118       87,351,238  
     

 

 

 
Oil, Gas & Consumable Fuels — 2.5%        

Cheniere Energy, Inc.

 

    1,589,821       289,585,895  
     

 

 

 
Professional Services — 2.3%        

Equifax, Inc.

 

    1,243,672       270,759,831  
     

 

 

 
Real Estate Management & Development — 2.8%        

CoStar Group, Inc.(a)(b)

 

    3,939,749       327,156,757  
     

 

 

 
Semiconductors & Semiconductor Equipment — 8.3%  

ASM International NV

 

    500,064       256,839,393  

Entegris, Inc.

 

    2,721,392       284,113,325  

Monolithic Power Systems, Inc.

 

    569,156       312,307,280  

ON Semiconductor Corp.(a)(b)

 

    1,448,900       103,350,037  
     

 

 

 
    956,610,035  
Software — 14.5%        

ANSYS, Inc.(a)

 

    1,008,490       295,850,626  

Aspen Technology, Inc.(a)(b)

 

    985,941       185,613,253  

Cadence Design Systems, Inc.(a)

 

    1,015,041       277,380,254  

Crowdstrike Holdings, Inc., Class A(a)

 

    1,612,701       382,194,010  

HubSpot, Inc.(a)

 

    578,408       285,693,064  

Roper Technologies, Inc.

 

    397,968       214,206,276  

Tyler Technologies, Inc.(a)

 

    62,010       25,352,168  
     

 

 

 
    1,666,289,651  
Specialty Retail — 2.0%        

Floor & Decor Holdings, Inc., Class A(a)(b)

 

    2,451,300       224,808,723  

Tractor Supply Co.

 

    10,783       2,189,057  
     

 

 

 
    226,997,780  
Textiles, Apparel & Luxury Goods — 1.6%        

Lululemon Athletica, Inc.(a)

 

    247,146       110,424,833  

On Holding AG, Class A(a)

 

    2,584,276       74,969,846  
     

 

 

 
    185,394,679  
Trading Companies & Distributors — 1.2%        

SiteOne Landscape Supply, Inc.(a)(b)

 

    948,359       133,547,914  
     

 

 

 
Total Common Stocks — 100.0%        

    (Cost: $8,341,523,567)

 

    11,515,451,683  
     

 

 

 
      

Par

(000)

        

Other Interests(a)(d)(e)

 

 

GCI Liberty, Inc., Class A

    USD       1,529       15  
     

 

 

 

Total Other Interests — 0.0%

    (Cost: $0)

 

 

    15  
     

 

 

 

Total Long-Term Investments — 100.0%

    (Cost: $8,341,523,567)

 

 

      11,515,451,698  
     

 

 

 
 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  27


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Mid-Cap Growth Equity Portfolio

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Short-Term Securities

   
Money Market Funds — 3.6%            

BlackRock Liquidity Funds, T-Fund, Institutional Class, 5.26%(f)(g)

    15,765,491     $ 15,765,491  

SL Liquidity Series, LLC, Money Market Series, 5.56%(f)(g)(h)

    400,343,774       400,503,912  
   

 

 

 
Total Short-Term Securities — 3.6%
    (Cost: $416,029,094)
        416,269,403  
   

 

 

 
Total Investments — 103.6%
    (Cost: $8,757,552,661)
        11,931,721,101  

Liabilities in Excess of Other Assets — (3.6)%

 

    (414,945,498
   

 

 

 
Net Assets — 100.0%         $  11,516,775,603  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(d) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(e) 

Other interests represent beneficial interests in liquidation trusts and other reorganization or private entities.

(f) 

Affiliate of the Fund.

 
(g) 

Annualized 7-day yield as of period end.

(h) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

    

 

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2023 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer   Value at
05/31/23
    Purchases at
Cost
    Proceeds
from Sale
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
11/30/23
   

Shares

Held at

11/30/23

    Income    

Capital

Gain

Distributions

from Underlying

Funds

 

BlackRock Liquidity Funds, T-Fund, Institutional Class

  $ 34,969,706     $     $ (19,204,215 )(a)    $     $     $ 15,765,491       15,765,491     $ 370,799     $  

SL Liquidity Series, LLC, Money Market Series

    248,967,968       151,403,592 (a)            10,515       121,837       400,503,912       400,343,774       218,709 (b)       
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ 10,515     $ 121,837     $   416,269,403       $   589,508     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

 

 

28  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Mid-Cap Growth Equity Portfolio

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Aerospace & Defense

   $ 731,431,070        $        $        $ 731,431,070  

Automobiles

     271,414,322                            271,414,322  

Beverages

              103,344,433                   103,344,433  

Capital Markets

     1,278,652,685                            1,278,652,685  

Commercial Services & Supplies

     839,490,257                            839,490,257  

Communications Equipment

     33,824,184                            33,824,184  

Construction & Engineering

     106,396,263                            106,396,263  

Construction Materials

     159,287,570                            159,287,570  

Distributors

     13,724,350                            13,724,350  

Electronic Equipment, Instruments & Components

     188,638,874                            188,638,874  

Entertainment

     431,695,026                            431,695,026  

Ground Transportation

     371,656,056                            371,656,056  

Health Care Equipment & Supplies

     881,783,732                            881,783,732  

Hotels, Restaurants & Leisure

     353,850,538          1,481,066                   355,331,604  

Interactive Media & Services

     27,026,679                            27,026,679  

IT Services

     600,801,346                            600,801,346  

Life Sciences Tools & Services

     977,259,452                            977,259,452  

Machinery

     87,351,238                            87,351,238  

Oil, Gas & Consumable Fuels

     289,585,895                            289,585,895  

Professional Services

     270,759,831                            270,759,831  

Real Estate Management & Development

     327,156,757                            327,156,757  

Semiconductors & Semiconductor Equipment

     699,770,642          256,839,393                   956,610,035  

Software

     1,666,289,651                            1,666,289,651  

Specialty Retail

     226,997,780                            226,997,780  

Textiles, Apparel & Luxury Goods

     185,394,679                            185,394,679  

Trading Companies & Distributors

     133,547,914                            133,547,914  

Other Interests

                       15          15  

Short-Term Securities

                 

Money Market Funds

     15,765,491                            15,765,491  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $   11,169,552,282        $   361,664,892        $ 15          11,531,217,189  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments valued at NAV(a)

                    400,503,912  
                 

 

 

 
                  $   11,931,721,101  
                 

 

 

 

 

  (a) 

Certain investments of the Fund were fair valued using NAV as a practical expedient as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  29


 

Schedule of Investments (unaudited) 

November 30, 2023

    

  

BlackRock Technology Opportunities Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   

Automobiles — 2.1%

   

Tesla, Inc.(a)

    398,316     $        95,627,705  
   

 

 

 
Broadline Retail — 4.6%            

Amazon.com, Inc.(a)

    745,743       108,945,595  

Coupang, Inc., Class A(a)

    1,334,882       20,396,997  

MercadoLibre, Inc.(a)

    52,783       85,532,740  
   

 

 

 
      214,875,332  
Capital Markets — 0.7%            

S&P Global, Inc.

    79,421       33,025,634  
   

 

 

 
Communications Equipment — 1.5%            

Arista Networks, Inc.(a)

    181,544       39,887,032  

Motorola Solutions, Inc.

    98,385       31,765,565  
   

 

 

 
      71,652,597  
Diversified Consumer Services — 0.0%            

Think & Learn Private Ltd. (Acquired 09/30/20, cost $3,427,642)(a)(b)(c)

    2,241       468,893  
   

 

 

 
Electrical Equipment — 0.4%            

NEXTracker, Inc., Class A(a)

    520,857       21,167,629  
   

 

 

 
Electronic Equipment, Instruments & Components — 0.7%  

Flex Ltd.(a)

    1,239,000       31,532,550  
   

 

 

 
Entertainment — 3.3%            

Netflix, Inc.(a)

    69,785       33,075,996  

Nintendo Co. Ltd.

    458,800       21,385,780  

Spotify Technology SA(a)

    212,902       39,410,289  

Take-Two Interactive Software, Inc.(a)

    161,570       25,560,374  

Warner Music Group Corp., Class A

    966,652       32,005,848  
   

 

 

 
      151,438,287  
Financial Services — 5.1%  

Mastercard, Inc., Class A

    290,735       120,314,865  

Visa, Inc., Class A

    402,067       103,202,557  

Wise PLC, Class A(a)

    1,516,708       15,003,950  
   

 

 

 
      238,521,372  
Ground Transportation — 1.0%  

Uber Technologies, Inc.(a)

    829,414       46,762,361  
   

 

 

 
Household Durables — 0.6%            

Sony Group Corp.

    319,300       27,456,938  
   

 

 

 
Interactive Media & Services — 5.0%  

Alphabet, Inc., Class A(a)

    803,740       106,519,662  

Meta Platforms, Inc., Class A(a)

    381,990       124,968,029  
   

 

 

 
      231,487,691  
IT Services — 3.0%            

Farmer’s Business Network, Inc.(a)(b)

    194,200       844,770  

Fujitsu Ltd.

    127,000       18,082,989  

Klarna Holdings AB (Acquired 09/15/20, cost $11,017,172)(a)(b)(c)

    25,600       5,936,654  

MongoDB, Inc., Class A(a)(d)

    154,828       64,368,193  

Shopify, Inc., Class A(a)(d)

    424,730       30,928,838  

Snowflake, Inc., Class A(a)

    93,578       17,562,719  
   

 

 

 
      137,724,163  
Professional Services — 1.6%  

RELX PLC

    1,068,873       41,133,256  

Thomson Reuters Corp.

    238,526       33,324,558  
   

 

 

 
      74,457,814  
Semiconductors & Semiconductor Equipment — 26.6%  

Advanced Micro Devices, Inc.(a)

    851,855       103,210,752  

Applied Materials, Inc.

    134,830       20,194,837  
Security   Shares     Value  

 

 
Semiconductors & Semiconductor Equipment (continued)  

ARM Holdings PLC, ADR(a)(d)

    478,242     $        29,411,883  

ASM International NV

    89,480       45,958,095  

ASML Holding NV

    165,388       112,716,330  

Broadcom, Inc.

    134,803       124,791,181  

Lam Research Corp.

    105,997       75,885,372  

Marvell Technology, Inc.

    1,088,794       60,678,490  

Micron Technology, Inc.

    796,999       60,667,564  

Monolithic Power Systems, Inc.

    95,508       52,407,150  

NVIDIA Corp.

    783,066       366,239,968  

QUALCOMM, Inc.

    143,105       18,467,700  

Renesas Electronics Corp.(a)

    816,900       14,237,718  

SOITEC(a)

    328,849       59,659,000  

STMicroelectronics NV

    594,007       28,197,100  

Taiwan Semiconductor Manufacturing Co. Ltd., ADR

    308,546       30,024,611  

Wolfspeed, Inc.(a)

    896,379       33,040,530  
   

 

 

 
      1,235,788,281  
Software — 30.9%            

Adobe, Inc.(a)

    73,565       44,948,951  

Altium Ltd.

    1,532,415       45,463,217  

ANSYS, Inc.(a)

    116,793       34,262,394  

Aspen Technology, Inc.(a)(d)

    112,991       21,271,686  

Autodesk, Inc.(a)

    114,433       24,995,600  

Cadence Design Systems, Inc.(a)

    614,542       167,935,892  

Constellation Software, Inc.

    22,107       51,926,483  

Crowdstrike Holdings, Inc., Class A(a)

    195,324       46,289,835  

Databricks, Inc. (Acquired 07/24/20 - 09/02/20, cost $5,122,891)(a)(b)(c)

    319,983       23,518,751  

Fair Isaac Corp.(a)(d)

    74,842       81,398,159  

Intuit, Inc.

    156,855       89,636,358  

Microsoft Corp.

    1,268,225       480,543,135  

Oracle Corp.

    856,532       99,537,584  

Palo Alto Networks, Inc.(a)(d)

    129,084       38,091,398  

Salesforce, Inc.(a)

    260,796       65,694,512  

SAP SE

    212,888       33,864,226  

ServiceNow, Inc.(a)(d)

    85,065       58,332,473  

Unqork, Inc. (Acquired 03/05/21, cost $4,093,769)(a)(b)(c)

    149,520       705,734  

Xero Ltd.(a)

    384,816       26,236,465  
   

 

 

 
      1,434,652,853  
Specialty Retail — 0.0%            

AceVector Ltd. (Acquired 05/07/14 - 10/29/14, cost $1,414,399)(a)(b)(c)

    304,000       180,883  
   

 

 

 
Technology Hardware, Storage & Peripherals — 10.8%  

Apple Inc.

    2,319,932       440,671,083  

Quanta Computer, Inc.

    4,215,000       27,284,347  

Samsung Electronics Co. Ltd.

    608,509       34,312,446  
   

 

 

 
      502,267,876  
   

 

 

 

Total Common Stocks — 97.9%
(Cost: $2,388,994,849)

      4,549,088,859  
   

 

 

 

Preferred Securities

   
Preferred Stocks — 2.2%            
Diversified Consumer Services — 0.1%  

FlixMobility GmbH, Series F (Acquired 07/26/19, cost $2,490,608)(a)(b)(c)

    125       3,586,559  

Think & Learn Private Ltd., Series F (Acquired 09/30/20, cost $6,867,746)(a)(b)(c)

    2,371       496,093  
   

 

 

 
          4,082,652  
 

 

 

30  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Technology Opportunities Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Interactive Media & Services — 0.8%

   

Bytedance Ltd., Series E-1 (Acquired 11/11/20, cost $22,196,442)(a)(b)(c)

    202,570     $        35,717,710  
   

 

 

 
Semiconductors & Semiconductor Equipment — 0.3%  

PsiQuantum Corp., Series C (Acquired 09/09/19, cost $2,698,453)(a)(b)(c)

    581,814       13,928,627  
   

 

 

 
Software — 1.0%            

Databricks, Inc.

   

Series F, 0.00% (Acquired 10/22/19, cost $3,700,005)(a)(b)(c)

    258,450       18,996,075  

Series G, 0.00% (Acquired 02/01/21, cost $12,500,003)(a)(b)(c)

    211,425       15,539,738  

SambaNova Systems, Inc., Series C (Acquired 02/20/20, cost $9,804,574)(a)(b)(c)

    184,153       11,763,694  

Unqork, Inc.

   

Series A, 0.00% (Acquired 03/05/21, cost $194,941)(a)(b)(c)

    7,120       35,742  

Series B, 0.00% (Acquired 03/05/21, cost $314,316)(a)(b)(c)

    11,480       64,173  

Series C, 0.00% (Acquired 09/18/20, cost $8,323,340)(a)(b)(c)

    304,000       2,149,280  

Series Seed, 0.00% (Acquired 03/05/21, cost $489,544)(a)(b)(c)

    17,880       85,645  

Series Seed A, 0.00% (Acquired 03/05/21, cost $180,704)(a)(b)(c)

    6,600       31,482  
   

 

 

 
      48,665,829  
   

 

 

 
Total Preferred Securities — 2.2%
    (Cost: $69,762,327)
        102,394,818  
   

 

 

 

Warrants(a)(b)

   
Software — 0.0%            

Constellation Software, Inc. (Issued/Exercisable, 1 Share for 1 Warrant, Expires 03/31/40, Strike Price CAD 0.00)

    22,107        
   

 

 

 
Total Warrants — 0.0%
    (Cost: $0)
         
   

 

 

 
Total Long-Term Investments — 100.1%
    (Cost: $2,458,757,176)
        4,651,483,677  
   

 

 

 
Security   Shares     Value  

 

 

Short-Term Securities

   

Money Market Funds — 1.3%

   

SL Liquidity Series, LLC, Money Market Series, 5.56%(e)(f)(g)

    58,980,638     $ 59,004,230  
   

 

 

 

Total Short-Term Securities — 1.3%
(Cost: $58,994,550)

      59,004,230  
   

 

 

 

Total Investments — 101.4%
(Cost: $2,517,751,726)

      4,710,487,907  

Liabilities in Excess of Other Assets — (1.4)%

 

    (63,893,143
   

 

 

 

Net Assets — 100.0%

    $   4,646,594,764  
   

 

 

 

 

(a) 

Non-income producing security.

 
(b) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

 
(c) 

Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $133,205,733, representing 2.9% of its net assets as of period end, and an original cost of $94,838,200.

 
(d) 

All or a portion of this security is on loan.

 
(e) 

Affiliate of the Fund.

 
(f) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 
(g) 

Annualized 7-day yield as of period end.

 
 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  31


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Technology Opportunities Fund

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2023 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer   Value at
05/31/23
    Purchases
at Cost
   

Proceeds

from Sale

    Net
Realized
Gain (Loss)
   

Change in
Unrealized
Appreciation

(Depreciation)

   

Value at

11/30/23

   

Shares

Held at
11/30/23

    Income    

Capital

Gain

Distributions

from Underlying

Funds

 

BlackRock Liquidity Funds, T-Fund(a)

  $ 37,081,328     $     $   (37,081,328 )(b)    $     $     $           $ 466,562     $  

SL Liquidity Series, LLC, Money Market Series

    148,567,014             (89,577,084 )(b)      32,367       (18,067     59,004,230       58,980,638       51,996 (c)       
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $   32,367     $   (18,067   $   59,004,230       $   518,558     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

As of period end, the entity is no longer held.

 
  (b) 

Represents net amount purchased (sold).

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Automobiles

   $ 95,627,705        $        $        $        95,627,705

Broadline Retail

     214,875,332                          214,875,332

Capital Markets

     33,025,634                          33,025,634

Communications Equipment

     71,652,597                          71,652,597

Diversified Consumer Services

                       468,893        468,893

Electrical Equipment

     21,167,629                          21,167,629

Electronic Equipment, Instruments & Components

     31,532,550                          31,532,550

Entertainment

     130,052,507          21,385,780                 151,438,287

Financial Services

     223,517,422          15,003,950                 238,521,372

Ground Transportation

     46,762,361                          46,762,361

Household Durables

              27,456,938                 27,456,938

Interactive Media & Services

     231,487,691                          231,487,691

IT Services

     112,859,750          18,082,989          6,781,424        137,724,163

Professional Services

     33,324,558          41,133,256                 74,457,814

Semiconductors & Semiconductor Equipment

     975,020,038          260,768,243                 1,235,788,281

Software

     1,304,864,460          105,563,908          24,224,485        1,434,652,853

Specialty Retail

                       180,883        180,883

Technology Hardware, Storage & Peripherals

     440,671,083          61,596,793                 502,267,876

Preferred Securities

                       102,394,818        102,394,818

Warrants

                             
  

 

 

      

 

 

      

 

 

      

 

   $  3,966,441,317        $  550,991,857        $  134,050,503        4,651,483,677
  

 

 

      

 

 

      

 

 

      

 

Investments valued at NAV(a)

                  59,004,230
                 

 

                  $   4,710,487,907
                 

 

 

  (a) 

Certain investments of the Fund were fair valued using NAV as a practical expedient as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

 

 

32  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

November 30, 2023

    

  

BlackRock Technology Opportunities Fund

 

A reconciliation of Level 3 financial instruments is presented when the Fund had a significant amount of Level 3 investments at the beginning and/or end of the year in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:

 

      Common
Stocks
       Preferred
Stocks
       Warrants        Total            

Assets

                      

Opening Balance, as of May 31, 2023

   $ 27,801,094        $ 103,069,338        $        $ 130,870,432                            

Transfers into Level 3

                                      

Transfers out of Level 3

                                      

Accrued discounts/premiums

                                      

Net realized gain (loss)

                                      

Net change in unrealized appreciation (depreciation)(a)(b)

     (2,565,001        5,745,072          (c)          3,180,071       

Purchases

     6,419,592                            6,419,592       

Sales

              (6,419,592                 (6,419,592     
  

 

 

      

 

 

      

 

 

      

 

 

      

Closing Balance, as of November 30, 2023

   $     31,655,685        $   102,394,818        $ (c)        $   134,050,503       
  

 

 

      

 

 

      

 

 

      

 

 

      

Net change in unrealized appreciation (depreciation) on investments still held at November 30, 2023(b)

   $ (2,565,001      $ 7,176,985        $ (c)        $ 4,611,984       
  

 

 

      

 

 

      

 

 

      

 

 

      

 

  (a) 

Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations.

 
  (b) 

Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at November 30, 2023, is generally due to investments no longer held or categorized as Level 3 at period end.

 
  (c) 

Rounds to less than $1.

 

The following table summarizes the valuation approaches used and unobservable inputs utilized by the BlackRock Valuation Committee (the “Valuation Committee”) to determine the value of certain of the Fund’s Level 3 investments as of period end.

 

      Value        Valuation Approach       

Unobservable

Inputs

     Range of
Unobservable Inputs
Utilized(a)
      

Weighted Average of
Unobservable Inputs

Based on Fair Value

Assets

                      

Common Stocks

   $ 31,655,685          Market        Revenue Multiple        1.00x - 27.59x        11.22x
             Volatility        70%       
             Time to Exit        3.0 years       

Preferred Stocks

     102,394,818          Market        Revenue Multiple        1.00x - 27.59x        14.48x
             Volatility        50% - 70%        53%
             Time to Exit        3.0 - 4.0 years        3.9 years
             Market Adjustment Multiple        1.20x       
  

 

 

                     
   $   134,050,503                      
  

 

 

                     

 

  (a) 

A significant change in unobservable input would have resulted in a correlated (inverse) significant change to value.

 

See notes to financial statements.

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  33


Statements of Assets and Liabilities (unaudited)

November 30, 2023

 

    

BlackRock

Capital

Appreciation

Fund,

Inc.

    

BlackRock

Health

Sciences

Opportunities

Portfolio

     BlackRock
Infrastructure
Sustainable
Opportunities
Fund
 

ASSETS

       

Investments, at value — unaffiliated(a)(b)

  $ 3,250,991,179      $ 7,608,946,427      $ 8,386,521  

Investments, at value — affiliated(c)

    1,635,299        372,003,985        440,923  

Cash

    3,930                

Foreign currency, at value(d)

                  100,737  

Receivables:

       

Investments sold

           64,383,172        104,712  

Securities lending income — affiliated

    1,189        22,872         

Capital shares sold

    1,193,307        3,717,367         

Dividends — unaffiliated

    1,617,688        9,928,952        37,892  

Dividends — affiliated

    10,279        1,445,830        1,669  

From the Manager

                  17,115  

Unrealized appreciation on OTC swaps

                  3,562  

Prepaid expenses

    27,436        114,828        32,026  
 

 

 

    

 

 

    

 

 

 

Total assets

    3,255,480,307        8,060,563,433        9,125,157  
 

 

 

    

 

 

    

 

 

 

LIABILITIES

       

Collateral on securities loaned

           58,830,898         

Payables:

       

Investments purchased

           45,230,636        104,450  

Accounting services fees

    90,159        205,321        15,461  

Administration fees

           353,384         

Capital shares redeemed

    5,735,372        14,457,159         

Investment advisory fees

    1,611,886        4,306,105         

Directors’ and Officer’s fees

    8,215        21,307        2,216  

Other accrued expenses

    208,800        72,716        3,602  

Printing fees

    16,571        26,757        16,756  

Professional fees

    69,252        114,026        73,140  

Service and distribution fees

    417,408        927,907        34  

Transfer agent fees

    548,461        2,135,958         

Unrealized depreciation on:

       

Forward foreign currency exchange contracts

           2,324,058         

Unfunded commitments

           1,108,365         
 

 

 

    

 

 

    

 

 

 

Total liabilities

    8,706,124        130,114,597        215,659  
 

 

 

    

 

 

    

 

 

 

Commitments and contingent liabilities

       

NET ASSETS

  $ 3,246,774,183      $ 7,930,448,836      $ 8,909,498  
 

 

 

    

 

 

    

 

 

 

NET ASSETS CONSIST OF:

       

Paid-in capital

  $ 1,484,068,122      $ 4,949,649,414      $ 10,059,838  

Accumulated earnings (loss)

    1,762,706,061        2,980,799,422        (1,150,340
 

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 3,246,774,183      $ 7,930,448,836      $ 8,909,498  
 

 

 

    

 

 

    

 

 

 

(a) Investments, at cost — unaffiliated

  $ 1,565,908,747      $ 4,779,979,870      $ 8,628,884  

(b) Securities loaned, at value

  $      $ 58,419,090      $  

(c) Investments, at cost — affiliated

  $ 1,635,299      $ 371,965,352      $ 440,923  

(d) Foreign currency, at cost

  $      $      $ 100,279  

 

 

34  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Assets and Liabilities (unaudited) (continued)

November 30, 2023

 

    

BlackRock
Capital
Appreciation
Fund,

Inc.

    

BlackRock

Health

Sciences

Opportunities

Portfolio

     BlackRock
Infrastructure
Sustainable
Opportunities
Fund
 

NET ASSET VALUE

       
Institutional                    

Net assets

  $ 714,737,760      $ 4,143,312,308      $ 98,006  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    19,998,360        60,619,018        11,143  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 35.74      $ 68.35      $ 8.80  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ 0.001  
 

 

 

    

 

 

    

 

 

 
Service                    

Net assets

  $ N/A      $ 30,893,695      $ N/A  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    N/A        481,504        N/A  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ N/A      $ 64.16      $ N/A  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    N/A        Unlimited        N/A  
 

 

 

    

 

 

    

 

 

 

Par value

  $ N/A      $ 0.001      $ N/A  
 

 

 

    

 

 

    

 

 

 
Investor A                    

Net assets

  $ 1,879,798,458      $ 2,742,400,436      $ 184,727  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    60,241,666        42,957,866        21,034  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 31.20      $ 63.84      $ 8.78  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ 0.001  
 

 

 

    

 

 

    

 

 

 
Investor C                    

Net assets

  $ 38,198,274      $ 333,046,809      $ N/A  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    2,229,791        6,348,856        N/A  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 17.13      $ 52.46      $ N/A  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        N/A  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ N/A  
 

 

 

    

 

 

    

 

 

 
Class K                    

Net assets

  $ 589,248,285      $ 447,232,206      $ 8,626,765  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    16,278,342        6,529,351        980,620  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 36.20      $ 68.50      $ 8.80  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ 0.001  
 

 

 

    

 

 

    

 

 

 
Class R                    

Net assets

  $ 24,791,406      $ 233,563,382      $ N/A  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    1,120,821        3,784,200        N/A  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 22.12      $ 61.72      $ N/A  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    500 million        Unlimited        N/A  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ N/A  
 

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  35


Statements of Assets and Liabilities (unaudited) (continued)

November 30, 2023

 

    

BlackRock

Mid-Cap

Growth

Equity

Portfolio

     BlackRock
Technology
Opportunities
Fund
 

ASSETS

    

Investments, at value — unaffiliated(a)(b)

  $ 11,515,451,698      $ 4,651,483,677  

Investments, at value — affiliated(c)

    416,269,403        59,004,230  

Foreign currency, at value(d)

           4,625  

Receivables:

    

Investments sold

    24,524,490        2,042,778  

Securities lending income — affiliated

    61,556        8,019  

Capital shares sold

    16,184,368        5,759,829  

Dividends — unaffiliated

    3,920,278        1,926,674  

Dividends — affiliated

    35,536        17,075  

From the Manager

    183,702        70,313  

Prepaid expenses

    136,514        96,561  
 

 

 

    

 

 

 

Total assets

    11,976,767,545        4,720,413,781  
 

 

 

    

 

 

 

LIABILITIES

    

Collateral on securities loaned

    400,513,804        59,165,797  

Payables:

    

Investments purchased

    22,318,377         

Accounting services fees

    283,932        120,273  

Administration fees

    378,234        138,441  

Capital shares redeemed

    27,526,093        9,176,627  

Investment advisory fees

    5,703,589        2,848,457  

Directors’ and Officer’s fees

    23,202        9,249  

Other accrued expenses

    49,084        244,677  

Printing fees

    29,115        24,586  

Professional fees

    107,938        148,510  

Service and distribution fees

    515,496        572,177  

Transfer agent fees

    2,543,078        1,370,223  
 

 

 

    

 

 

 

Total liabilities

    459,991,942        73,819,017  
 

 

 

    

 

 

 

Commitments and contingent liabilities

    

NET ASSETS

  $ 11,516,775,603      $ 4,646,594,764  
 

 

 

    

 

 

 

NET ASSETS CONSIST OF:

    

Paid-in capital

  $ 10,692,192,342      $ 3,137,863,609  

Accumulated earnings

    824,583,261        1,508,731,155  
 

 

 

    

 

 

 

NET ASSETS

  $ 11,516,775,603      $ 4,646,594,764  
 

 

 

    

 

 

 

(a) Investments, at cost — unaffiliated

  $ 8,341,523,567      $ 2,458,757,176  

(b) Securities loaned, at value

  $ 391,835,218      $ 57,642,998  

(c) Investments, at cost — affiliated

  $ 416,029,094      $ 58,994,550  

(d) Foreign currency, at cost

  $      $ 5,274  

 

 

36  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Assets and Liabilities (unaudited) (continued)

November 30, 2023

 

    

BlackRock

Mid-Cap

Growth

Equity

Portfolio

   

BlackRock

Technology

Opportunities

Fund

 

NET ASSET VALUE

       

Institutional

       

Net assets

    $ 5,199,993,412       $ 2,405,811,934  
   

 

 

     

 

 

 

Shares outstanding

      145,691,062         44,919,821  
   

 

 

     

 

 

 

Net asset value

    $ 35.69       $ 53.56  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Service

       

Net assets

    $ 61,884,658       $ 47,996,080  
   

 

 

     

 

 

 

Shares outstanding

      1,947,267         963,538  
   

 

 

     

 

 

 

Net asset value

    $ 31.78       $ 49.81  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Investor A

       

Net assets

    $ 1,609,750,528       $ 1,702,256,246  
   

 

 

     

 

 

 

Shares outstanding

      53,161,281         35,030,130  
   

 

 

     

 

 

 

Net asset value

    $ 30.28       $ 48.59  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Investor C

       

Net assets

    $ 190,583,357       $ 262,850,503  
   

 

 

     

 

 

 

Shares outstanding

      8,502,904         6,808,425  
   

 

 

     

 

 

 

Net asset value

    $ 22.41       $ 38.61  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Class K

       

Net assets

    $ 4,362,853,957       $ 190,425,622  
   

 

 

     

 

 

 

Shares outstanding

      121,579,772         3,547,308  
   

 

 

     

 

 

 

Net asset value

    $ 35.88       $ 53.68  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Class R

       

Net assets

    $ 91,709,691       $ 37,254,379  
   

 

 

     

 

 

 

Shares outstanding

      3,115,951         766,278  
   

 

 

     

 

 

 

Net asset value

    $ 29.43       $ 48.62  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  37


Statements of Operations (unaudited)

Six Months Ended November 30, 2023

 

 

    

BlackRock

Capital

Appreciation

Fund,

Inc.

   

BlackRock

Health

Sciences

Opportunities

Portfolio

   

BlackRock

Infrastructure

Sustainable

Opportunities

Fund

 

INVESTMENT INCOME

     

Dividends — unaffiliated

  $ 11,066,291     $ 47,928,216     $ 155,227  

Dividends — affiliated

    80,090       4,641,903       12,323  

Securities lending income — affiliated — net

    5,978       425,410       12  

Foreign taxes withheld

    (80,128     (408,300     (8,028
 

 

 

   

 

 

   

 

 

 

Total investment income

    11,072,231       52,587,229       159,534  
 

 

 

   

 

 

   

 

 

 

EXPENSES

     

Investment advisory

    9,940,456       27,896,402       34,809  

Service and distribution — class specific

    2,511,699       6,061,794       200  

Transfer agent — class specific

    1,381,292       4,046,886       657  

Registration

    120,873       98,332       31,306  

Accounting services

    106,196       245,993       18,538  

Custodian

    51,083       83,737       4,665  

Professional

    20,631       61,975       75,331  

Printing and postage

    16,635       26,926       20,448  

Directors and Officer

    15,578       34,928       3,385  

Administration

          1,444,820       1,849  

Administration — class specific

          831,918       870  

Miscellaneous

    233,417       88,641       4,225  
 

 

 

   

 

 

   

 

 

 

Total expenses excluding interest expense

    14,397,860       40,922,352       196,283  

Interest expense

          729       4  
 

 

 

   

 

 

   

 

 

 

Total expenses

    14,397,860       40,923,081       196,287  

Less:

     

Administration fees waived

                (1,849

Administration fees waived by the Manager — class specific

                (870

Fees waived and/or reimbursed by the Manager

    (1,160     (66,885     (151,312

Transfer agent fees waived and/or reimbursed by the Manager — class specific

                (593
 

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    14,396,700       40,856,196       41,663  
 

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    (3,324,469     11,731,033       117,871  
 

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

     

Net realized gain (loss) from:

     

Investments — unaffiliated

    92,463,864       165,848,940       (250,986

Investments — affiliated

    3,536       20,603       1  

Forward foreign currency exchange contracts

          (2,386,899      

Foreign currency transactions

    (2,161     (115,292     329  

Swaps

                (16,173
 

 

 

   

 

 

   

 

 

 
    92,465,239       163,367,352       (266,829
 

 

 

   

 

 

   

 

 

 

 

 

38  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Operations (unaudited) (continued)

Six Months Ended November 30, 2023

 

    

BlackRock

Capital

Appreciation

Fund,

Inc.

    

BlackRock

Health

Sciences

Opportunities

Portfolio

   

BlackRock

Infrastructure

Sustainable

Opportunities

Fund

 

Net change in unrealized appreciation (depreciation) on:

      

Investments — unaffiliated

  $ 336,741,646      $ (33,112,048   $ (11,230

Investments — affiliated

           5,368        

Forward foreign currency exchange contracts

           94,083        

Foreign currency translations

    2,531        132,252       1,274  

Swaps

                 10,325  

Unfunded commitments

           (1,108,365      
 

 

 

    

 

 

   

 

 

 
    336,744,177        (33,988,710     369  
 

 

 

    

 

 

   

 

 

 

Net realized and unrealized gain (loss)

    429,209,416        129,378,642       (266,460
 

 

 

    

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $ 425,884,947      $ 141,109,675     $ (148,589)  
 

 

 

    

 

 

   

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  39


Statements of Operations (unaudited) (continued)

Six Months Ended November 30, 2023

 

    

BlackRock

Mid-Cap

Growth

Equity

Portfolio

   

BlackRock

Technology

Opportunities

Fund

 

INVESTMENT INCOME

   

Dividends — unaffiliated

  $ 32,677,573     $ 10,158,144  

Dividends — affiliated

    370,799       466,562  

Securities lending income — affiliated — net

    218,709       51,996  

Foreign taxes withheld

    (68,843     (320,525
 

 

 

   

 

 

 

Total investment income

    33,198,238       10,356,177  
 

 

 

   

 

 

 

EXPENSES

   

Investment advisory

    36,484,514       17,307,624  

Transfer agent — class specific

    6,131,582       2,607,174  

Service and distribution — class specific

    3,325,313       3,497,380  

Administration

    1,980,619       823,139  

Administration — class specific

    1,161,812       449,113  

Accounting services

    336,261       141,225  

Custodian

    277,885       54,641  

Registration

    195,304       138,028  

Professional

    48,119       60,475  

Directors and Officer

    44,879       19,088  

Printing and postage

    41,743       28,473  

Miscellaneous

    42,806       36,623  
 

 

 

   

 

 

 

Total expenses excluding interest expense

    50,070,837       25,162,983  

Interest expense

          132  
 

 

 

   

 

 

 

Total expenses

    50,070,837       25,163,115  

Less:

   

Administration fees waived by the Manager — class specific

    (729,141     (431,037

Fees waived and/or reimbursed by the Manager

    (5,423     (6,911

Transfer agent fees waived and/or reimbursed by the Manager — class specific

    (1,460,372     (642,160
 

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    47,875,901       24,083,007  
 

 

 

   

 

 

 

Net investment loss

    (14,677,663     (13,726,830
 

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

   

Net realized gain (loss) from:

   

Investments — unaffiliated

    (14,249,908     59,216,593  

Investments — affiliated

    10,515       32,367  

Foreign currency transactions

    (147,559     139,166  
 

 

 

   

 

 

 
    (14,386,952     59,388,126  
 

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

   

Investments — unaffiliated

    1,000,822,858       467,361,305  

Investments — affiliated

    121,837       (18,067

Foreign currency translations

    46,539       9,922  
 

 

 

   

 

 

 
    1,000,991,234       467,353,160  
 

 

 

   

 

 

 

Net realized and unrealized gain

    986,604,282       526,741,286  
 

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 971,926,619     $ 513,014,456  
 

 

 

   

 

 

 

See notes to financial statements.

 

 

40  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Changes in Net Assets

 

   

BlackRock Capital Appreciation Fund, Inc.

    BlackRock Health Sciences Opportunities Portfolio  
    

Six Months

Ended

11/30/23

(unaudited)

   

Year Ended

05/31/23

   

Six Months

Ended

11/30/23

(unaudited)

   

Year Ended

05/31/23

 

INCREASE (DECREASE) IN NET ASSETS

            

OPERATIONS

            

Net investment income (loss)

    $ (3,324,469   $ (4,530,704      $ 11,731,033     $ 30,828,045  

Net realized gain

      92,465,239       110,626,983          163,367,352       353,953,705  

Net change in unrealized appreciation (depreciation)

      336,744,177       44,745,953          (33,988,710     (204,225,469
   

 

 

   

 

 

      

 

 

   

 

 

 

Net increase in net assets resulting from operations

      425,884,947       150,842,232          141,109,675       180,556,281  
   

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

            

Institutional

      (10,825,340     (60,013,923        (85,481,994     (349,006,342

Service

                     (677,165     (2,578,561

Investor A

      (32,101,332     (137,177,573        (58,863,655     (224,765,771

Investor C

      (1,309,811     (5,779,913        (9,720,375     (43,035,902

Class K

      (10,479,396     (42,620,608        (8,871,925     (31,126,901

Class R

      (624,211     (2,479,998        (5,111,805     (18,314,016
   

 

 

   

 

 

      

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

      (55,340,090     (248,072,015        (168,726,919     (668,827,493
   

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

            

Net decrease in net assets derived from capital share transactions

      (235,879,616     (324,095,316        (511,184,926     (536,587,817
   

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

            

Total increase (decrease) in net assets

      134,665,241       (421,325,099        (538,802,170     (1,024,859,029

Beginning of period

      3,112,108,942       3,533,434,041          8,469,251,006       9,494,110,035  
   

 

 

   

 

 

      

 

 

   

 

 

 

End of period

    $     3,246,774,183     $     3,112,108,942        $     7,930,448,836     $     8,469,251,006  
   

 

 

   

 

 

      

 

 

   

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  41


Statements of Changes in Net Assets  (continued)

    

 

    BlackRock Infrastructure Sustainable Opportunities Fund            BlackRock Mid-Cap Growth Equity Portfolio  
    

Six Months

Ended

11/30/23

(unaudited)

   

Year Ended

05/31/23

   

Six Months

Ended

11/30/23

(unaudited)

   

Year Ended

05/31/23

 

INCREASE (DECREASE) IN NET ASSETS

   

    

            

OPERATIONS

            

Net investment income (loss)

    $ 117,871     $ 146,746        $ (14,677,663   $ (34,115,341

Net realized loss

      (266,829     (697,724        (14,386,952     (1,145,834,520

Net change in unrealized appreciation (depreciation)

      369       5,508          1,000,991,234       1,071,226,878  
   

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

      (148,589     (545,470        971,926,619       (108,722,983
   

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

            

Institutional

      (1,083     (4,103               

Investor A

      (1,539     (3,968               

Class K

      (95,768     (378,721               
   

 

 

   

 

 

      

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

      (98,390     (386,792               
   

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

            

Net increase (decrease) in net assets derived from capital share transactions

      32,095       64,099          (943,729,601     (2,206,262,520
   

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

            

Total increase (decrease) in net assets

      (214,884     (868,163        28,197,018       (2,314,985,503

Beginning of period

      9,124,382       9,992,545          11,488,578,585       13,803,564,088  
   

 

 

   

 

 

      

 

 

   

 

 

 

End of period

    $     8,909,498     $     9,124,382        $     11,516,775,603     $     11,488,578,585  
   

 

 

   

 

 

      

 

 

   

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

42  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Changes in Net Assets  (continued)

  

 

          BlackRock Technology Opportunities Fund  
           

Six Months

Ended

11/30/23

(unaudited)

   

Year Ended

05/31/23

 

INCREASE (DECREASE) IN NET ASSETS

       

OPERATIONS

       

Net investment loss

    $ (13,726,830     $ (19,097,180

Net realized gain (loss)

      59,388,126         (264,055,854

Net change in unrealized appreciation (depreciation)

      467,353,160         408,231,300  
   

 

 

     

 

 

 

Net increase in net assets resulting from operations

      513,014,456         125,078,266  
   

 

 

     

 

 

 

CAPITAL SHARE TRANSACTIONS

       

Net decrease in net assets derived from capital share transactions

      (255,480,167       (893,403,112
   

 

 

     

 

 

 

NET ASSETS

       

Total increase (decrease) in net assets

      257,534,289         (768,324,846

Beginning of period

      4,389,060,475         5,157,385,321  
   

 

 

     

 

 

 

End of period

    $     4,646,594,764       $     4,389,060,475  
   

 

 

     

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  43


Financial Highlights

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc.  
    Institutional  
   

Six Months

Ended

11/30/23

(unaudited)

         

Year Ended

05/31/23

    

Year Ended

05/31/22

    

Period from

10/01/20

to 05/31/21

   

Year Ended

09/30/20

    

Year Ended

09/30/19

    

Year Ended

09/30/18

 
                 

Net asset value, beginning of period

  $ 31.69       $ 31.98      $ 43.32      $ 38.32     $ 30.52      $ 33.72      $ 29.08  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income (loss)(a)

    (0.01       0.00 (b)       (0.09      (0.06     (0.07      (0.05      0.00 (b)(c) 

Net realized and unrealized gain (loss)

    4.58         1.82        (6.14      7.06       10.81        0.23        7.97  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    4.57         1.82        (6.23      7.00       10.74        0.18        7.97  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(d)

    (0.52       (2.11      (5.11      (2.00     (2.94      (3.38      (3.33
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 35.74       $ 31.69      $ 31.98      $ 43.32     $ 38.32      $ 30.52      $ 33.72  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(e)

                   

Based on net asset value

    14.53 %(f)        6.81      (17.30 )%       18.72 %(f)      38.17      1.77      30.19
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                   

Total expenses

    0.76 %(h)        0.73      0.70      0.72 %(h)      0.75      0.75      0.76
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    0.76 %(h)        0.73      0.70      0.72 %(h)      0.75      0.75      0.76
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income (loss)

    (0.07 )%(h)        0.01      (0.21 )%       (0.21 )%(h)      (0.22 )%       (0.17 )%       0.01 %(c) 
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

  $ 714,738       $ 678,965      $ 943,275      $ 1,072,833     $ 911,484      $ 644,983      $ 600,032  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    9       43      55      25     42      48      42
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Amount is less than $0.005 per share.

(c) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.21%, respectively, resulting from a special dividend.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

44  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)  
    Investor A  
    Six Months
Ended
11/30/23
(unaudited)
          Year Ended
05/31/23
     Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
 
                 

Net asset value, beginning of period

  $ 27.77       $ 28.38      $ 39.00      $ 34.74     $ 27.99      $ 31.25      $ 27.16  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss(a)

    (0.05       (0.07      (0.18      (0.11     (0.14      (0.12      (0.08 )(b) 

Net realized and unrealized gain (loss)

    4.00         1.57        (5.39      6.37       9.83        0.18        7.41  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    3.95         1.50        (5.57      6.26       9.69        0.06        7.33  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(c)

    (0.52       (2.11      (5.05      (2.00     (2.94      (3.32      (3.24
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 31.20       $ 27.77      $ 28.38      $ 39.00     $ 34.74      $ 27.99      $ 31.25  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(d)

                   

Based on net asset value

    14.34 %(e)        6.53      (17.51 )%       18.51 %(e)      37.84      1.48      29.85
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(f)

                   

Total expenses

    1.01 %(g)        1.00      0.97      0.97 %(g)      1.01      1.01      1.04
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    1.01 %(g)        1.00      0.97      0.97 %(g)      1.01      1.01      1.04
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss

    (0.31 )%(g)        (0.27 )%       (0.48 )%       (0.46 )%(g)      (0.48 )%       (0.43 )%       (0.28 )%(b) 
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

  $ 1,879,798       $ 1,723,973      $ 1,871,340      $ 2,551,211     $ 2,195,906      $ 1,692,630      $ 1,751,581  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    9       43      55      25     42      48      42
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  45


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)  
    Investor C  
    Six Months
Ended
11/30/23
(unaudited)
          Year Ended
05/31/23
     Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
 
                 

Net asset value, beginning of period

  $ 15.52       $ 17.01      $ 25.27      $ 23.27     $ 19.81      $ 23.29      $ 20.88  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss(a)

    (0.09       (0.16      (0.29      (0.20     (0.25      (0.24      (0.23 )(b) 

Net realized and unrealized gain (loss)

    2.22         0.78        (3.05      4.20       6.65        0.04        5.56  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    2.13         0.62        (3.34      4.00       6.40        (0.20      5.33  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(c)

    (0.52       (2.11      (4.92      (2.00     (2.94      (3.28      (2.92
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 17.13       $ 15.52      $ 17.01      $ 25.27     $ 23.27      $ 19.81      $ 23.29  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(d)

                   

Based on net asset value

    13.92 %(e)        5.62      (18.18 )%       17.89 %(e)      36.73      0.72      28.77
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(f)

                   

Total expenses

    1.85 %(g)        1.84      1.76      1.77 %(g)      1.79      1.81      1.84
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    1.85 %(g)        1.84      1.76      1.77 %(g)      1.79      1.81      1.84
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss

    (1.17 )%(g)        (1.11 )%       (1.28 )%       (1.27 )%(g)      (1.26 )%       (1.23 )%       (1.09 )%(b) 
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

  $ 38,198       $ 39,581      $ 48,332      $ 72,075     $ 89,336      $ 195,908      $ 276,097  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    9       43      55      25     42      48      42
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

See notes to financial statements.

 

 

46  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)  
    Class K  
    Six Months
Ended
11/30/23
(unaudited)
          Year Ended
05/31/23
     Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
 
                 

Net asset value, beginning of period

  $ 32.08       $ 32.32      $ 43.71      $ 38.63     $ 30.71      $ 33.91      $ 29.24  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income (loss)(a)

    0.00 (b)        0.02        (0.06      (0.03     (0.04      (0.02      0.04 (c) 

Net realized and unrealized gain (loss)

    4.64         1.85        (6.20      7.11       10.90        0.23        8.01  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    4.64         1.87        (6.26      7.08       10.86        0.21        8.05  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(d)

    (0.52       (2.11      (5.13      (2.00     (2.94      (3.41      (3.38
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 36.20       $ 32.08      $ 32.32      $ 43.71     $ 38.63      $ 30.71      $ 33.91  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(e)

                   

Based on net asset value

    14.57 %(f)        6.90      (17.22 )%       18.78 %(f)      38.33      1.86      30.36
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                   

Total expenses

    0.66 %(h)        0.65      0.64      0.63 %(h)      0.64      0.65      0.65
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    0.66 %(h)        0.65      0.63      0.63 %(h)      0.64      0.64      0.65
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income (loss)

    0.01 %(h)        0.08      (0.15 )%       (0.13 )%(h)      (0.11 )%       (0.06 )%       0.14 %(c) 
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

  $ 589,248       $ 645,860      $ 646,115      $ 845,106     $ 682,107      $ 552,523      $ 568,169  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    9       43      55      25     42      48      42
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Amount is less than $0.005 per share.

(c) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.21%, respectively, resulting from a special dividend.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  47


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)  
    Class R  
    Six Months
Ended
11/30/23
(unaudited)
          Year Ended
05/31/23
     Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
 
                 

Net asset value, beginning of period

  $ 19.86       $ 21.02      $ 30.12      $ 27.30     $ 22.65      $ 26.00      $ 23.12  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss(a)

    (0.07       (0.11      (0.23      (0.15     (0.17      (0.16      (0.13 )(b) 

Net realized and unrealized gain (loss)

    2.85         1.06        (3.88      4.97       7.76        0.09        6.19  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    2.78         0.95        (4.11      4.82       7.59        (0.07      6.06  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(c)

    (0.52       (2.11      (4.99      (2.00     (2.94      (3.28      (3.18
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 22.12       $ 19.86      $ 21.02      $ 30.12     $ 27.30      $ 22.65      $ 26.00  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(d)

                   

Based on net asset value

    14.16 %(e)        6.17      (17.82 )%       18.26 %(e)      37.45      1.19      29.49
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(f)

                   

Total expenses

    1.36 %(g)        1.37      1.33      1.30 %(g)      1.28      1.29      1.30
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    1.36 %(g)        1.36      1.33      1.30 %(g)      1.28      1.29      1.30
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss

    (0.66 )%(g)        (0.63 )%       (0.85 )%       (0.80 )%(g)      (0.75 )%       (0.71 )%       (0.54 )%(b) 
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

  $ 24,791       $ 23,731      $ 24,371      $ 36,933     $ 37,741      $ 54,828      $ 84,484  
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    9       43      55      25     42      48      42
 

 

 

     

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

See notes to financial statements.

 

 

48  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio  
    Institutional  
    Six Months
Ended
11/30/23
(unaudited)
          Year Ended
05/31/23
     Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
     Year Ended
09/30/18
 
                 

Net asset value, beginning of period

  $ 68.47              $ 72.10      $ 81.77     $ 75.37     $ 61.55     $ 67.67      $ 57.28  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net investment income(a)

    0.15         0.34        0.24       0.13       0.19       0.28        0.24  

Net realized and unrealized gain (loss)

    1.07         1.07        (2.75     9.66       16.26       (1.64      12.18  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net increase (decrease) from investment operations

    1.22         1.41        (2.51     9.79       16.45       (1.36      12.42  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Distributions(b)

                 

From net investment income

            (0.38      (0.16     (0.13     (0.32     (0.23      (0.02

From net realized gain

    (1.34       (4.66      (7.00     (3.26     (2.31     (4.53      (2.01
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total distributions

    (1.34       (5.04      (7.16     (3.39     (2.63     (4.76      (2.03
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net asset value, end of period

  $ 68.35       $ 68.47      $ 72.10     $ 81.77     $ 75.37     $ 61.55      $ 67.67  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total Return(c)

                 

Based on net asset value

    1.73 %(d)        2.25      (3.55 )%(e)      13.37 %(d)      27.34 %(f)      (1.84 )%       22.47
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                 

Total expenses

    0.84 %(h)        0.84      0.85     0.84 %(h)      0.85     0.85      0.87
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    0.84 %(h)        0.84      0.85     0.84 %(h)      0.85     0.84      0.86
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net investment income

    0.43 %(h)        0.49      0.31     0.24 %(h)      0.28     0.45      0.40
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Supplemental Data

                 

Net assets, end of period (000)

  $ 4,143,312       $ 4,436,816      $ 5,062,514     $ 5,990,131     $ 5,133,191     $ 3,095,352      $ 2,944,146  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Portfolio turnover rate

    17       29      51     19     28     41      39
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  49


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Service  
    Six Months
Ended
11/30/23
(unaudited)
          Year Ended
05/31/23
     Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
     Year Ended
09/30/18
 
                 

Net asset value, beginning of period

  $ 64.44       $ 68.16      $ 77.63     $ 71.63     $ 58.66     $ 64.73      $ 54.90  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net investment income (loss)(a)

    0.04         0.13        0.01       (0.03     (0.01     0.08        0.05  

Net realized and unrealized gain (loss)

    1.02         1.00        (2.61     9.18       15.48       (1.57      11.67  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net increase (decrease) from investment operations

    1.06         1.13        (2.60     9.15       15.47       (1.49      11.72  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Distributions(b)

                 

From net investment income

            (0.19                  (0.19     (0.05       

From net realized gain

    (1.34       (4.66      (6.87     (3.15     (2.31     (4.53      (1.89
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total distributions

    (1.34       (4.85      (6.87     (3.15     (2.50     (4.58      (1.89
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net asset value, end of period

  $ 64.16       $ 64.44      $ 68.16     $ 77.63     $ 71.63     $ 58.66      $ 64.73  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total Return(c)

                 

Based on net asset value

    1.58 %(d)        1.94      (3.83 )%(e)      13.15 %(d)      26.96 %(f)      (2.16 )%       22.10
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                 

Total expenses

    1.14 %(h)        1.14      1.14     1.14 %(h)      1.15     1.15      1.17
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    1.13 %(h)        1.14      1.14     1.14 %(h)      1.15     1.15      1.16
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net investment income (loss)

    0.13 %(h)        0.19      0.02     (0.07 )%(h)      (0.02 )%      0.14      0.10
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Supplemental Data

                 

Net assets, end of period (000)

  $ 30,894       $ 33,055      $ 36,625     $ 43,825     $ 40,252     $ 34,708      $ 39,325  
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Portfolio turnover rate

    17       29      51     19     28     41      39
 

 

 

     

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

50  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Investor A  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 64.11     $ 67.84     $ 77.31     $ 71.37     $ 58.45     $ 64.50     $ 54.70  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)(a)

    0.06       0.16       0.05       (0.01     0.01       0.10       0.06  

Net realized and unrealized gain (loss)

    1.01       0.99       (2.59     9.15       15.42       (1.56     11.63  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    1.07       1.15       (2.54     9.14       15.43       (1.46     11.69  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

             

From net investment income

          (0.22                 (0.20     (0.06      

From net realized gain

    (1.34     (4.66     (6.93     (3.20     (2.31     (4.53     (1.89
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (1.34     (4.88     (6.93     (3.20     (2.51     (4.59     (1.89
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 63.84     $ 64.11     $ 67.84     $ 77.31     $ 71.37     $ 58.45     $ 64.50  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    1.60 %(d)      1.99     (3.78 )%(e)      13.18 %(d)      26.99 %(f)      (2.11 )%      22.13
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

             

Total expenses

    1.09 %(h)      1.09     1.09     1.10 %(h)      1.11     1.12     1.15
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.09 %(h)      1.09     1.09     1.10 %(h)      1.11     1.12     1.14
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    0.18 %(h)      0.24     0.07     (0.02 )%(h)      0.01     0.17     0.11
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 2,742,400     $ 2,865,706     $ 3,151,912     $ 3,496,818     $ 3,135,882     $ 2,598,888     $ 2,767,303  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    17     29     51     19     28     41     39
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  51


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Investor C  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 53.11     $ 57.24     $ 66.15     $ 61.38     $ 50.74     $ 56.55     $ 48.54  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.16     (0.27     (0.43     (0.33     (0.40     (0.28     (0.30

Net realized and unrealized gain (loss)

    0.85       0.80       (2.17     7.85       13.34       (1.38     10.20  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    0.69       0.53       (2.60     7.52       12.94       (1.66     9.90  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain

    (1.34     (4.66     (6.31     (2.75     (2.30     (4.15     (1.89
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 52.46     $ 53.11     $ 57.24     $ 66.15     $ 61.38     $ 50.74     $ 56.55  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    1.22 %(d)      1.22     (4.50 )%(e)      12.61 %(d)      26.09 %(f)      (2.82 )%      21.22
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

             

Total expenses

    1.86 %(h)      1.85     1.84     1.84 %(h)      1.85     1.85     1.87
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.86 %(h)      1.85     1.84     1.84 %(h)      1.85     1.85     1.87
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.59 )%(h)      (0.51 )%      (0.68 )%      (0.77 )%(h)      (0.72 )%      (0.56 )%      (0.61 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 333,047     $ 404,306     $ 542,880     $ 719,525     $ 773,522     $ 745,636     $ 1,017,205  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    17     29     51     19     28     41     39
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

52  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Class K  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 68.58     $ 72.21     $ 81.91     $ 75.50     $ 61.63     $ 67.75     $ 57.37  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.18       0.40       0.33       0.18       0.27       0.34       0.32  

Net realized and unrealized gain (loss)

    1.08       1.08       (2.77     9.68       16.28       (1.65     12.17  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    1.26       1.48       (2.44     9.86       16.55       (1.31     12.49  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

             

From net investment income

          (0.45     (0.26     (0.19     (0.37     (0.28     (0.10

From net realized gain

    (1.34     (4.66     (7.00     (3.26     (2.31     (4.53     (2.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (1.34     (5.11     (7.26     (3.45     (2.68     (4.81     (2.11
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 68.50     $ 68.58     $ 72.21     $ 81.91     $ 75.50     $ 61.63     $ 67.75  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    1.78 %(d)      2.34     (3.44 )%(e)      13.45 %(d)      27.47 %(f)      (1.75 )%      22.58
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

             

Total expenses

    0.75 %(h)      0.75     0.74     0.74 %(h)      0.75     0.75     0.77
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.75 %(h)      0.75     0.74     0.74 %(h)      0.75     0.75     0.76
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    0.53 %(h)      0.59     0.42     0.34 %(h)      0.39     0.55     0.53
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 447,232     $ 487,287     $ 436,984     $ 464,179     $ 344,822     $ 171,517     $ 130,129  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    17     29     51     19     28     41     39
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  53


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Class R  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 62.14     $ 65.94     $ 75.28     $ 69.54     $ 57.05     $ 63.09     $ 53.71  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.06     (0.08     (0.21     (0.18     (0.20     (0.09     (0.11

Net realized and unrealized gain (loss)

    0.98       0.96       (2.52     8.91       15.05       (1.53     11.38  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    0.92       0.88       (2.73     8.73       14.85       (1.62     11.27  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

             

From net investment income

          (0.02                 (0.05            

From net realized gain

    (1.34     (4.66     (6.61     (2.99     (2.31     (4.42     (1.89
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (1.34     (4.68     (6.61     (2.99     (2.36     (4.42     (1.89
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 61.72     $ 62.14     $ 65.94     $ 75.28     $ 69.54     $ 57.05     $ 63.09  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    1.41 %(d)      1.62     (4.12 )%(e)      12.91 %(d)      26.60 %(f)      (2.44 )%      21.75
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

             

Total expenses

    1.46 %(h)      1.46     1.45     1.44 %(h)      1.45     1.45     1.46
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.46 %(h)      1.46     1.45     1.44 %(h)      1.45     1.45     1.46
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.19 )%(h)      (0.13 )%      (0.29 )%      (0.37 )%(h)      (0.32 )%      (0.15 )%      (0.20 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 233,563     $ 242,080     $ 263,195     $ 289,676     $ 260,488     $ 224,862     $ 241,495  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    17     29     51     19     28     41     39
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

54  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  

(For a share outstanding throughout each period)

 

    BlackRock Infrastructure Sustainable Opportunities
Fund
 
    Institutional  
     

Six Months

Ended

11/30/23

(unaudited

 

 

 

   

Year Ended

05/31/23

 

 

   

Period from

09/30/21

to 05/31/22

 

(a) 

 

Net asset value, beginning of period

  $ 9.04     $ 9.97     $ 10.00  
 

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.11       0.14       0.07  

Net realized and unrealized loss

    (0.25     (0.68     (0.02
 

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.14     (0.54     0.05  
 

 

 

   

 

 

   

 

 

 

Distributions(c)

     

From net investment income

    (0.10     (0.13     (0.04

From net realized gain

          (0.26     (0.04
 

 

 

   

 

 

   

 

 

 

Total distributions

    (0.10     (0.39     (0.08
 

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 8.80     $ 9.04     $ 9.97  
 

 

 

   

 

 

   

 

 

 

Total Return(d)

     

Based on net asset value

    (1.64 )%(e)      (5.32 )%      0.45 %(e) 
 

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

     

Total expenses

    4.90 %(g)      4.54     3.62 %(g)(h) 
 

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.00 %(g)      1.00     1.00 %(g) 
 

 

 

   

 

 

   

 

 

 

Net investment income

    2.66 %(g)      1.60     1.09 %(g) 
 

 

 

   

 

 

   

 

 

 

Supplemental Data

     

Net assets, end of period (000)

  $ 98     $ 102     $ 107  
 

 

 

   

 

 

   

 

 

 

Portfolio turnover rate(i)

    26     104     70
 

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.45%.

(i) 

Excludes underlying investments in total return swaps.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  55


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Infrastructure Sustainable Opportunities Fund (continued)  
    Investor A  
     

Six Months

Ended

11/30/23

(unaudited

 

 

 

   

Year Ended

05/31/23

 

 

   

Period from

09/30/21

to 05/31/22

 

(a) 

 

Net asset value, beginning of period

  $ 9.03     $ 9.96     $ 10.00  
 

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.10       0.13       0.06  

Net realized and unrealized loss

    (0.26     (0.69     (0.03
 

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.16     (0.56     0.03  
 

 

 

   

 

 

   

 

 

 

Distributions(c)

     

From net investment income

    (0.09     (0.11     (0.03

From net realized gain

          (0.26     (0.04
 

 

 

   

 

 

   

 

 

 

Total distributions

    (0.09     (0.37     (0.07
 

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 8.78     $ 9.03     $ 9.96  
 

 

 

   

 

 

   

 

 

 

Total Return(d)

     

Based on net asset value

    (1.84 )%(e)      (5.55 )%      0.29 %(e) 
 

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

     

Total expenses

    5.06 %(g)      4.75     3.88 %(g)(h) 
 

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.25 %(g)      1.25     1.25 %(g) 
 

 

 

   

 

 

   

 

 

 

Net investment income

    2.40 %(g)      1.41     0.84 %(g) 
 

 

 

   

 

 

   

 

 

 

Supplemental Data

     

Net assets, end of period (000)

  $ 185     $ 156     $ 109  
 

 

 

   

 

 

   

 

 

 

Portfolio turnover rate(i)

    26     104     70
 

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.71%.

(i) 

Excludes underlying investments in total return swaps.

See notes to financial statements.

 

 

56  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Infrastructure Sustainable Opportunities Fund (continued)  
    Class K  
     

Six Months

Ended

11/30/23

(unaudited

 

 

 

   

Year Ended

05/31/23

 

 

   

Period from

09/30/21

to 05/31/22

 

(a) 

 

Net asset value, beginning of period

  $ 9.04     $ 9.97     $ 10.00  
 

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.12       0.15       0.08  

Net realized and unrealized loss

    (0.26     (0.69     (0.03
 

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.14     (0.54     0.05  
 

 

 

   

 

 

   

 

 

 

Distributions(c)

     

From net investment income

    (0.10     (0.13     (0.04

From net realized gain

          (0.26     (0.04
 

 

 

   

 

 

   

 

 

 

Total distributions

    (0.10     (0.39     (0.08
 

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 8.80     $ 9.04     $ 9.97  
 

 

 

   

 

 

   

 

 

 

Total Return(d)

     

Based on net asset value

    (1.62 )%(e)      (5.27 )%      0.46 %(e) 
 

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

     

Total expenses

    4.50 %(g)      4.33     3.36 %(g)(h) 
 

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.95 %(g)      0.95     0.95 %(g) 
 

 

 

   

 

 

   

 

 

 

Net investment income

    2.72 %(g)      1.65     1.13 %(g) 
 

 

 

   

 

 

   

 

 

 

Supplemental Data

     

Net assets, end of period (000)

  $ 8,627     $ 8,866     $ 9,777  
 

 

 

   

 

 

   

 

 

 

Portfolio turnover rate(i)

    26     104     70
 

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.21%.

(i) 

Excludes underlying investments in total return swaps.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  57


Financial Highlights  

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio  
    Institutional  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 32.79     $ 32.83     $ 45.95     $ 36.56     $ 28.68     $ 27.87     $ 22.10  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.04     (0.08     (0.23     (0.15     (0.14     (0.09     (0.11

Net realized and unrealized gain (loss)

    2.94       0.04       (10.52     9.54       8.14       1.95       6.63  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    2.90       (0.04     (10.75     9.39       8.00       1.86       6.52  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (2.37           (0.12     (1.05     (0.75
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 35.69     $ 32.79     $ 32.83     $ 45.95     $ 36.56     $ 28.68     $ 27.87  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    8.84 %(d)      (0.12 )%      (24.87 )%      25.68 %(d)      27.98     7.43     30.34
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    0.85 %(f)      0.84     0.81     0.80 %(f)      0.85     0.87     0.93 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.80 %(f)      0.80     0.80     0.80 %(f)      0.80     0.80     0.86
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.23 )%(f)      (0.25 )%      (0.52 )%      (0.52 )%(f)      (0.43 )%      (0.34 )%      (0.45 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 5,199,993     $ 5,266,832     $ 7,095,644     $ 9,260,191     $ 6,003,280     $ 2,700,531     $ 1,063,328  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    21     46     28     22     35     38     43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2018, the expense ratio would have been 0.93%.

See notes to financial statements.

 

 

58  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Service  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 29.23     $ 29.34     $ 41.34     $ 32.95     $ 25.92     $ 25.30     $ 20.18  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.07     (0.14     (0.31     (0.20     (0.19     (0.15     (0.17

Net realized and unrealized gain (loss)

    2.62       0.03       (9.39     8.59       7.34       1.76       6.04  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    2.55       (0.11     (9.70     8.39       7.15       1.61       5.87  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (2.30           (0.12     (0.99     (0.75
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 31.78     $ 29.23     $ 29.34     $ 41.34     $ 32.95     $ 25.92     $ 25.30  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    8.72 %(d)      (0.38 )%      (25.06 )%      25.46 %(d)      27.68     7.15     30.03
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.10 %(f)      1.10     1.09     1.10 %(f)      1.11     1.16     1.25 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.05 %(f)      1.05     1.05     1.05 %(f)      1.05     1.05     1.12
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.48 )%(f)      (0.50 )%      (0.77 )%      (0.78 )%(f)      (0.67 )%      (0.59 )%      (0.73 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 61,885     $ 62,693     $ 81,276     $ 104,997     $ 83,680     $ 61,293     $ 33,768  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    21     46     28     22     35     38     43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2018, the expense ratio would have been 1.25%.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  59


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Investor A  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 27.85     $ 27.96     $ 39.50     $ 31.48     $ 24.78     $ 24.22     $ 19.30  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.07     (0.14     (0.29     (0.19     (0.18     (0.14     (0.18

Net realized and unrealized gain (loss)

    2.50       0.03       (8.94     8.21       7.00       1.68       5.79  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    2.43       (0.11     (9.23     8.02       6.82       1.54       5.61  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (2.31           (0.12     (0.98     (0.69
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 30.28     $ 27.85     $ 27.96     $ 39.50     $ 31.48     $ 24.78     $ 24.22  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    8.73 %(d)      (0.39 )%      (25.05 )%      25.48 %(d)      27.61     7.17     29.98
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.13 %(f)      1.13     1.09     1.09 %(f)      1.14     1.16     1.29 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.05 %(f)      1.05     1.05     1.05 %(f)      1.05     1.05     1.19
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.48 )%(f)      (0.50 )%      (0.78 )%      (0.78 )%(f)      (0.67 )%      (0.58 )%      (0.82 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 1,609,751     $ 1,637,289     $ 1,913,190     $ 2,577,151     $ 1,917,773     $ 1,335,467     $ 801,263  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    21     46     28     22     35     38     43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2018, the expense ratio would have been 1.26%

See notes to financial statements.

 

 

60  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Investor C  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 20.69     $ 20.93     $ 30.22     $ 24.20     $ 19.21     $ 19.04     $ 15.36  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.13     (0.25     (0.43     (0.29     (0.30     (0.24     (0.26

Net realized and unrealized gain (loss)

    1.85       0.01       (6.67     6.31       5.41       1.28       4.57  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    1.72       (0.24     (7.10     6.02       5.11       1.04       4.31  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (2.19           (0.12     (0.87     (0.63
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 22.41     $ 20.69     $ 20.93     $ 30.22     $ 24.20     $ 19.21     $ 19.04  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    8.31 %(d)      (1.15 )%      (25.61 )%      24.88 %(d)      26.72     6.33     29.05
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.84 %(f)      1.83     1.78     1.80 %(f)      1.84     1.86     1.94 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.80 %(f)      1.80     1.78     1.79 %(f)      1.80     1.80     1.88
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (1.23 )%(f)      (1.25 )%      (1.51 )%      (1.52 )%(f)      (1.42 )%      (1.33 )%      (1.49 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 190,583     $ 194,849     $ 243,284     $ 357,360     $ 280,143     $ 209,923     $ 164,083  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    21     46     28     22     35     38     43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2018, the expense ratio would have been 1.94%.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  61


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Class K  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 32.95     $ 32.96     $ 46.10     $ 36.66     $ 28.74     $ 27.93     $ 22.14  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.02     (0.05     (0.17     (0.12     (0.12     (0.09     (0.07

Net realized and unrealized gain (loss)

    2.95       0.04       (10.58     9.56       8.16       1.96       6.62  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    2.93       (0.01     (10.75     9.44       8.04       1.87       6.55  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (2.39           (0.12     (1.06     (0.76
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 35.88     $ 32.95     $ 32.96     $ 46.10     $ 36.66     $ 28.74     $ 27.93  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    8.89 %(d)      (0.03 )%      (24.79 )%      25.75 %(d)      28.06     7.47     30.46
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    0.71 %(f)      0.71     0.70     0.70 %(f)      0.73 %(g)      0.76 %(h)      0.80 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.71 %(f)      0.71     0.70     0.70 %(f)      0.73     0.75     0.76
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.14 )%(f)      (0.15 )%      (0.40 )%      (0.42 )%(f)      (0.36 )%      (0.31 )%      (0.29 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 4,362,854     $ 4,233,488     $ 4,376,642     $ 3,674,402     $ 2,011,727     $ 652,138     $ 139,138  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    21     46     28     22     35     38     43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees with no financial impact to the expense ratios.

(h) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2019, the expense ratio would have been 0.75%.

See notes to financial statements.

 

 

62  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Class R  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20 to
05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 27.11     $ 27.28     $ 38.65     $ 30.85     $ 24.34     $ 23.83     $ 19.02  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.10     (0.20     (0.37     (0.25     (0.24     (0.19     (0.22

Net realized and unrealized gain (loss)

    2.42       0.03       (8.73     8.05       6.87       1.65       5.69  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    2.32       (0.17     (9.10     7.80       6.63       1.46       5.47  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (2.27           (0.12     (0.95     (0.66
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 29.43     $ 27.11     $ 27.28     $ 38.65     $ 30.85     $ 24.34     $ 23.83  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    8.56 %(d)      (0.62 )%      (25.24 )%      25.28 %(d)      27.33     6.89     29.63
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.41 %(f)      1.42     1.40     1.39 %(f)      1.45     1.47     1.59 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.30 %(f)      1.30     1.30     1.30 %(f)      1.30     1.30     1.43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.73 )%(f)      (0.75 )%      (1.02 )%      (1.03 )%(f)      (0.92 )%      (0.83 )%      (1.05 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 91,710     $ 93,427     $ 93,527     $ 98,300     $ 59,411     $ 40,999     $ 22,880  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    21     46     28     22     35     38     43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2018, the expense ratio would have been 1.58%.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  63


Financial Highlights  

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund  
    Institutional  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 47.74     $ 45.31     $ 64.81     $ 55.33     $ 32.63     $ 31.83     $ 25.64  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.11     (0.13     (0.30     (0.28     (0.22     (0.10     (0.09

Net realized and unrealized gain (loss)

    5.93       2.56       (14.51     12.67       23.43       1.20       8.25  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    5.82       2.43       (14.81     12.39       23.21       1.10       8.16  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (4.69     (2.91     (0.51     (0.30     (1.97
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 53.56     $ 47.74     $ 45.31     $ 64.81     $ 55.33     $ 32.63     $ 31.83  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    12.19 %(d)      5.36     (25.09 )%      22.68 %(d)      72.07     3.63     34.02
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    0.97 %(f)      0.98     0.94     0.92 %(f)      0.98     1.02     1.10
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.92 %(f)      0.92     0.92     0.92 %(f)      0.92     0.92     0.99
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.46 )%(f)      (0.30 )%      (0.48 )%      (0.66 )%(f)      (0.50 )%      (0.32 )%      (0.32 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 2,405,812     $ 2,316,550     $ 2,943,616     $ 4,958,187     $ 3,641,519     $ 1,033,286     $ 584,654  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9     39     29     25     27     33     49
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

See notes to financial statements.

 

 

64  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Service  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 44.45     $ 42.30     $ 60.86     $ 52.20     $ 30.88     $ 30.22     $ 24.44  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.17     (0.21     (0.42     (0.37     (0.30     (0.17     (0.15

Net realized and unrealized gain (loss)

    5.53       2.36       (13.52     11.94       22.13       1.13       7.85  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    5.36       2.15       (13.94     11.57       21.83       0.96       7.70  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (4.62     (2.91     (0.51     (0.30     (1.92
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 49.81     $ 44.45     $ 42.30     $ 60.86     $ 52.20     $ 30.88     $ 30.22  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    12.06 %(d)      5.08     (25.28 )%      22.46 %(d)      71.68     3.36     33.74
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.20 %(f)      1.20     1.19     1.17 %(f)      1.19     1.25 %(g)      1.37
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.17 %(f)      1.17     1.17     1.16 %(f)      1.17     1.17     1.22
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.71 )%(f)      (0.55 )%      (0.73 )%      (0.90 )%(f)      (0.74 )%      (0.57 )%      (0.55 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 47,996     $ 47,332     $ 55,439     $ 83,886     $ 50,710     $ 20,429     $ 15,208  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9     39     29     25     27     33     49
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees with no financial impact to the expense ratios.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  65


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Investor A  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 43.37     $ 41.27     $ 59.47     $ 51.06     $ 30.22     $ 29.58     $ 23.95  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.16     (0.21     (0.41     (0.36     (0.29     (0.17     (0.16

Net realized and unrealized gain (loss)

    5.38       2.31       (13.19     11.68       21.64       1.11       7.69  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    5.22       2.10       (13.60     11.32       21.35       0.94       7.53  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (4.60     (2.91     (0.51     (0.30     (1.90
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 48.59     $ 43.37     $ 41.27     $ 59.47     $ 51.06     $ 30.22     $ 29.58  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    12.03 %(d)      5.09     (25.28 )%      22.48 %(d)      71.65     3.36     33.70
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.22 %(f)      1.23     1.21     1.19 %(f)      1.25     1.29     1.38 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.17 %(f)      1.17     1.17     1.17 %(f)      1.17     1.17     1.26
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.71 )%(f)      (0.54 )%      (0.73 )%      (0.91 )%(f)      (0.74 )%      (0.58 )%      (0.59 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 1,702,256     $ 1,572,976     $ 1,695,648     $ 2,524,052     $ 1,773,399     $ 672,110     $ 627,626  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9     39     29     25     27     33     49
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2018, the expense ratio would have been 1.37%.

See notes to financial statements.

 

 

66  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Investor C  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 34.58     $ 33.17     $ 48.77     $ 42.52     $ 25.43     $ 25.13     $ 20.72  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.26     (0.40     (0.68     (0.54     (0.48     (0.32     (0.31

Net realized and unrealized gain (loss)

    4.29       1.81       (10.52     9.70       18.08       0.92       6.57  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    4.03       1.41       (11.20     9.16       17.60       0.60       6.26  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (4.40     (2.91     (0.51     (0.30     (1.85
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 38.61     $ 34.58     $ 33.17     $ 48.77     $ 42.52     $ 25.43     $ 25.13  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    11.65 %(d)      4.25     (25.81 )%      21.89 %(d)      70.39     2.60     32.68
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.98 %(f)      1.98     1.92     1.91 %(f)      1.98     2.02     2.10 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.92 %(f)      1.92     1.91     1.90 %(f)      1.92     1.92     2.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (1.46 )%(f)      (1.30 )%      (1.47 )%      (1.65 )%(f)      (1.49 )%      (1.33 )%      (1.34 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 262,851     $ 259,247     $ 291,802     $ 427,435     $ 317,792     $ 152,505     $ 142,942  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9     39     29     25     27     33     49
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2018, the expense ratio would have been 2.09%.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  67


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Class K  
    Six Months          
    Ended           Period from       Period from  
    11/30/23       Year Ended       Year Ended       10/01/20       12/10/19 (a) 
      (unaudited     05/31/23       05/31/22       to 05/31/21       to 09/30/20  

Net asset value, beginning of period

  $ 47.83     $ 45.37     $ 64.89     $ 55.36     $ 34.59  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(b)

    (0.10     (0.10     (0.24     (0.24     (0.16

Net realized and unrealized gain (loss)

    5.95       2.56       (14.55     12.68       20.93  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    5.85       2.46       (14.79     12.44       20.77  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(c)

                (4.73     (2.91      
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 53.68     $ 47.83     $ 45.37     $ 64.89     $ 55.36  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    12.23 %(e)      5.42     (25.05 )%      22.77 %(e)      60.05 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

         

Total expenses

    0.86 %(g)      0.87     0.84     0.83 %(g)      0.87 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.86 %(g)      0.87     0.83     0.82 %(g)      0.86 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.40 )%(g)      (0.24 )%      (0.38 )%      (0.56 )%(g)      (0.46 )%(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $ 190,426     $ 157,185     $ 135,879     $ 122,568     $ 75,426  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9     39     29     25     27 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Portfolio turnover is representative of the Fund for the entire year.

See notes to financial statements.

 

 

68  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Class R  
    Six Months
Ended
11/30/23
(unaudited)
    Year Ended
05/31/23
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
 
               

Net asset value, beginning of period

  $ 43.44     $ 41.44     $ 59.75     $ 51.37     $ 30.48     $ 29.90     $ 24.20  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.22     (0.30     (0.56     (0.46     (0.38     (0.24     (0.23

Net realized and unrealized gain (loss)

    5.40       2.30       (13.25     11.75       21.78       1.12       7.78  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    5.18       2.00       (13.81     11.29       21.40       0.88       7.55  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(b)

                (4.50     (2.91     (0.51     (0.30     (1.85
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 48.62     $ 43.44     $ 41.44     $ 59.75     $ 51.37     $ 30.48     $ 29.90  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

             

Based on net asset value

    11.92 %(d)      4.83     (25.47 )%      22.28 %(d)      71.20     3.12     33.35
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

             

Total expenses

    1.55 %(f)      1.58     1.54     1.50 %(f)      1.57     1.60     1.69
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.42 %(f)      1.42     1.42     1.42 %(f)      1.42     1.42     1.53
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.96 )%(f)      (0.79 )%      (0.98 )%      (1.17 )%(f)      (0.99 )%      (0.83 )%      (0.87 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $ 37,254     $ 35,771     $ 35,001     $ 50,186     $ 38,907     $ 18,799     $ 13,577  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9     39     29     25     27     33     49
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  69


Notes to Financial Statements (unaudited)

 

1.

ORGANIZATION

BlackRock Capital Appreciation Fund, Inc. (the “Corporation”) and BlackRock FundsSM (the “Trust”) are each registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as open-end management investment companies. The Corporation is organized as a Maryland corporation. The Trust is organized as a Massachusetts business trust. BlackRock Capital Appreciation Fund, Inc. is the only series of the Corporation. BlackRock Health Sciences Opportunities Portfolio, BlackRock Infrastructure Sustainable Opportunities Fund, BlackRock Mid-Cap Growth Equity Portfolio and BlackRock Technology Opportunities Fund are series of the Trust. The following are referred to herein collectively as the “Funds” or individually as a “Fund”:

 

Fund Name   Herein Referred To As      Diversification Classification  

BlackRock Capital Appreciation Fund, Inc.

    Capital Appreciation        Diversified  

BlackRock Health Sciences Opportunities Portfolio

    Health Sciences Opportunities        Diversified  

BlackRock Infrastructure Sustainable Opportunities Fund

    Infrastructure Sustainable Opportunities        Non-Diversified  

BlackRock Mid-Cap Growth Equity Portfolio

    Mid-Cap Growth Equity        Diversified  

BlackRock Technology Opportunities Fund

    Technology Opportunities        Diversified  

Each Fund offers multiple classes of shares. All classes of shares have identical voting, dividend, liquidation and other rights and are subject to the same terms and conditions, except that certain classes bear expenses related to the shareholder servicing and distribution of such shares. Institutional, Service and Class K Shares are sold only to certain eligible investors. Service, Investor A, Investor C and Class R Shares bear certain expenses related to shareholder servicing of such shares, and Investor C and Class R Shares also bear certain expenses related to the distribution of such shares. Investor A and Investor C Shares are generally available through financial intermediaries. Class R Shares are sold only to certain employer-sponsored retirement plans. Each class has exclusive voting rights with respect to matters relating to its shareholder servicing and distribution expenditures (except that Investor C shareholders may vote on material changes to the Investor A Shares distribution and service plan).

 

Share Class   Initial Sales Charge    CDSC      Conversion Privilege

Institutional, Service and Class K Shares

  No      No      None

Investor A Shares

  Yes      No (a)     None

Investor C Shares

  No      Yes (b)     To Investor A Shares after approximately 8 years

 

  (a) 

Investor A Shares may be subject to a contingent deferred sales charge (“CDSC”) for certain redemptions where no initial sales charge was paid at the time of purchase.

 
  (b) 

A CDSC of 1.00% is assessed on certain redemptions of Investor C Shares made within one year after purchase.

 

The Board of Directors of the Corporation had previously approved an Agreement and Plan of Reorganization between the Corporation and BlackRock Large Cap Focus Growth Fund, Inc. (the “Acquiring Fund”), pursuant to which the Corporation will be reorganized into the Acquiring Fund (the “Reorganization”). The Reorganization was originally expected to occur during the fourth quarter of 2023, but has been postponed. Shareholders will be given at least 60 days’ notice in advance of the closing of the Reorganization.

The Board of Directors of the Corporation and the Board of Trustees of the Trust are collectively referred to throughout this report as the “Board”, and the directors/trustees thereof are collectively referred to throughout this report as “Directors”.

The Funds, together with certain other registered investment companies advised by BlackRock Advisors, LLC (the “Manager”) or its affiliates, are included in a complex of funds referred to as the BlackRock Multi-Asset Complex.

 

2.

SIGNIFICANT ACCOUNTING POLICIES

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:

Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recorded on the ex-dividend dates. Non-cash dividends, if any, are recorded on the ex-dividend dates at fair value. Dividends from foreign securities where the ex-dividend dates may have passed are subsequently recorded when the Funds are informed of the ex-dividend dates. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Upon notification from issuers, a portion of the dividend income received from a real estate investment trust may be redesignated as a reduction of cost of the related investment and/or realized gain. Income, expenses and realized and unrealized gains and losses are allocated daily to each class based on its relative net assets.

Foreign Currency Translation: Each Fund’s books and records are maintained in U.S. dollars. Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates determined as of the close of trading on the New York Stock Exchange (“NYSE”). Purchases and sales of investments are recorded at the rates of exchange prevailing on the respective dates of such transactions. Generally, when the U.S. dollar rises in value against a foreign currency, the investments denominated in that currency will lose value; the opposite effect occurs if the U.S. dollar falls in relative value.

Each Fund does not isolate the effect of fluctuations in foreign exchange rates from the effect of fluctuations in the market prices of investments for financial reporting purposes. Accordingly, the effects of changes in exchange rates on investments are not segregated in the Statements of Operations from the effects of changes in market prices of those

 

 

70  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

investments, but are included as a component of net realized and unrealized gain (loss) from investments. Each Fund reports realized currency gains (losses) on foreign currency related transactions as components of net realized gain (loss) for financial reporting purposes, whereas such components are generally treated as ordinary income for U.S. federal income tax purposes.

ForeignTaxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund invests. These foreign taxes, if any, are paid by each Fund and are reflected in its Statements of Operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “Foreign taxes withheld”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of November 30, 2023, if any, are disclosed in the Statements of Assets and Liabilities.

The Funds file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. The Funds may record a reclaim receivable based on collectability, which includes factors such as the jurisdiction’s applicable laws, payment history and market convention. The Statements of Operations include tax reclaims recorded as well as professional and other fees, if any, associated with recovery of foreign withholding taxes.

Bank Overdraft: Certain Funds had outstanding cash disbursements exceeding deposited cash amounts at the custodian during the reporting period. The Funds are obligated to repay the custodian for any overdraft, including any related costs or expenses, where applicable. For financial reporting purposes, overdraft fees, if any, are included in interest expense in the Statements of Operations.

Collateralization: If required by an exchange or counterparty agreement, the Funds may be required to deliver/deposit cash and/or securities to/with an exchange, or broker-dealer or custodian as collateral for certain investments.

Distributions: Distributions paid by the Funds are recorded on the ex-dividend dates. The character and timing of distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP.

Offering Costs: Offering costs are amortized over a 12-month period beginning with the commencement of operations of a class of shares.

Indemnifications: In the normal course of business, a Fund enters into contracts that contain a variety of representations that provide general indemnification. A Fund’s maximum exposure under these arrangements is unknown because it involves future potential claims against a Fund, which cannot be predicted with any certainty.

Other: Expenses directly related to a Fund or its classes are charged to that Fund or the applicable class. Expenses directly related to the Funds and other shared expenses prorated to the Funds are allocated daily to each class based on their relative net assets or other appropriate methods. Other operating expenses shared by several funds, including other funds managed by the Manager, are prorated among those funds on the basis of relative net assets or other appropriate methods.

The Funds have an arrangement with their custodian whereby credits are earned on uninvested cash balances, which could be used to reduce custody fees and/or overdraft charges. The Funds may incur charges on overdrafts, subject to certain conditions.

 

3.

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund is open for business and, for financial reporting purposes, as of the report date. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Board of each Fund has approved the designation of each Fund’s Manager as the valuation designee for each Fund. Each Fund determines the fair values of its financial instruments using various independent dealers or pricing services under the Manager’s policies. If a security’s market price is not readily available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with the Manager’s policies and procedures as reflecting fair value. The Manager has formed a committee (the “Valuation Committee”) to develop pricing policies and procedures and to oversee the pricing function for all financial instruments, with assistance from other BlackRock pricing committees.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:

 

   

Equity investments traded on a recognized securities exchange are valued at that day’s official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day may be valued at the last available bid (long positions) or ask (short positions) price.

 

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published net asset value (“NAV”).

 

   

The Funds value their investment in SL Liquidity Series, LLC, Money Market Series (the “Money Market Series”) at fair value, which is ordinarily based upon their pro rata ownership in the underlying fund’s net assets.

 

   

Forward foreign currency exchange contracts are valued at the mean between the bid and ask prices and are determined as of the close of trading on the NYSE based on that day’s prevailing forward exchange rate for the underlying currencies.

 

   

Swap agreements are valued utilizing quotes received daily by independent pricing services or through brokers, which are derived using daily swap curves and models that incorporate a number of market data factors, such as discounted cash flows, trades and values of the underlying reference instruments.

Generally, trading in foreign instruments is substantially completed each day at various times prior to the close of trading on the NYSE. Each business day, the Funds use current market factors supplied by independent pricing services to value certain foreign instruments (“Systematic Fair Value Price”). The Systematic Fair Value Price is designed to value such foreign securities at fair value as of the close of trading on the NYSE, which follows the close of the local markets.

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  71


Notes to Financial Statements (unaudited) (continued)

 

If events (e.g., market volatility, company announcement or a natural disaster) occur that are expected to materially affect the value of such investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Valuation Committee in accordance with the Manager’s policies and procedures as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Valuation Committee include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Valuation Committee seeks to determine the price that each Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Valuation Committee deems relevant and consistent with the principles of fair value measurement.

For investments in equity or debt issued by privately held companies or funds (“Private Company” or collectively, the “Private Companies”) and other Fair Valued Investments, the fair valuation approaches that are used by the Valuation Committee and third-party pricing services utilized by the Valuation Committee include one or a combination of, but not limited to, the following inputs.

 

Standard Inputs Generally Considered By The Valuation Committee And Third-Party Pricing Services

Market approach

 

(i)  recent market transactions, including subsequent rounds of financing, in the underlying investment or comparable issuers;

(ii) recapitalizations and other transactions across the capital structure; and

(iii)  market multiples of comparable issuers.

Income approach

 

(i)  future cash flows discounted to present and adjusted as appropriate for liquidity, credit, and/or market risks;

(ii) quoted prices for similar investments or assets in active markets; and

(iii)  other risk factors, such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, recovery rates, liquidation amounts and/or default rates.

Cost approach

 

(i)  audited or unaudited financial statements, investor communications and financial or operational metrics issued by the Private Company;

(ii) changes in the valuation of relevant indices or publicly traded companies comparable to the Private Company;

(iii)  relevant news and other public sources; and

(iv)  known secondary market transactions in the Private Company’s interests and merger or acquisition activity in companies comparable to the Private Company.

Investments in series of preferred stock issued by Private Companies are typically valued utilizing market approach in determining the enterprise value of the company. Such investments often contain rights and preferences that differ from other series of preferred and common stock of the same issuer. Enterprise valuation techniques such as an option pricing model (“OPM”), a probability weighted expected return model (“PWERM”), current value method or a hybrid of those techniques are used as deemed appropriate under the circumstances. The use of these valuation techniques involve a determination of the exit scenarios of the investment in order to appropriately allocate the enterprise value of the company among the various parts of its capital structure.

The Private Companies are not subject to the public company disclosure, timing, and reporting standards applicable to other investments held by a Fund. Typically, the most recently available information by a Private Company is as of a date that is earlier than the date a Fund is calculating its NAV. This factor may result in a difference between the value of the investment and the price a Fund could receive upon the sale of the investment.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

 

   

Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market–corroborated inputs); and

 

   

Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Valuation Committee’s assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by Private Companies that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

As of November 30, 2023, certain investments of the Funds were fair valued using NAV as a practical expedient as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

4.

SECURITIES AND OTHER INVESTMENTS

Preferred Stocks: Preferred stock has a preference over common stock in liquidation (and generally in receiving dividends as well), but is subordinated to the liabilities of the issuer in all respects. As a general rule, the market value of preferred stock with a fixed dividend rate and no conversion element varies inversely with interest rates and

 

 

72  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

perceived credit risk, while the market price of convertible preferred stock generally also reflects some element of conversion value. Because preferred stock is junior to debt securities and other obligations of the issuer, deterioration in the credit quality of the issuer will cause greater changes in the value of a preferred stock than in a more senior debt security with similar stated yield characteristics. Unlike interest payments on debt securities, preferred stock dividends are payable only if declared by the issuer’s board of directors. Preferred stock also may be subject to optional or mandatory redemption provisions.

Warrants: Warrants entitle a fund to purchase a specified number of shares of common stock and are non-income producing. The purchase price and number of shares are subject to adjustment under certain conditions until the expiration date of the warrants, if any. If the price of the underlying stock does not rise above the strike price before the warrant expires, the warrant generally expires without any value and a fund will lose any amount it paid for the warrant. Thus, investments in warrants may involve more risk than investments in common stock. Warrants may trade in the same markets as their underlying stock; however, the price of the warrant does not necessarily move with the price of the underlying stock.

Forward Commitments, When-Issued and Delayed Delivery Securities: The Funds may purchase securities on a when-issued basis and may purchase or sell securities on a forward commitment basis. Settlement of such transactions normally occurs within a month or more after the purchase or sale commitment is made. The Funds may purchase securities under such conditions with the intention of actually acquiring them but may enter into a separate agreement to sell the securities before the settlement date. Since the value of securities purchased may fluctuate prior to settlement, the Funds may be required to pay more at settlement than the security is worth. In addition, a fund is not entitled to any of the interest earned prior to settlement. When purchasing a security on a delayed delivery basis, the Funds assume the rights and risks of ownership of the security, including the risk of price and yield fluctuations. In the event of default by the counterparty, the Funds’ maximum amount of loss is the unrealized appreciation of unsettled when-issued transactions. These types of securities may be considered unfunded and may obligate the Funds to make future cash payments. An unfunded commitment is marked-to-market and any unrealized appreciation (depreciation) is separately presented in the Statements of Assets and Liabilities and Statements of Operations. As of period end, the Funds had the following unfunded commitments:

 

Fund Name      Investment Name       
Commitment
Amount
 
 
     Value       

Unrealized
Appreciation
(Depreciation)
 
 
 

Health Sciences Opportunities

     Neurogene, Inc.      $ 3,061,199      $ 1,952,834      $ (1,108,365
     

 

 

    

 

 

    

 

 

 

Securities Lending: The Funds may lend their securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Funds collateral consisting of cash, an irrevocable letter of credit issued by a bank, or securities issued or guaranteed by the U.S. Government. The initial collateral received by each Fund is required to have a value of at least 102% of the current value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current market value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund, or excess collateral returned by the Fund, on the next business day. During the term of the loan, the Fund is entitled to all distributions made on or in respect of the loaned securities, but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested by the securities lending agent, BlackRock Investment Management, LLC (“BIM”), if any, is disclosed in the Schedules of Investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan, if any, are disclosed in the Funds’ Schedules of Investments. The market value of any securities on loan and the value of related collateral, if any, are shown separately in the Statements of Assets and Liabilities as a component of investments at value – unaffiliated and collateral on securities loaned, respectively.

Securities lending transactions are entered into by the Funds under Master Securities Lending Agreements (each, an “MSLA”), which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and a Fund can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties’ obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  73


Notes to Financial Statements (unaudited) (continued)

 

As of period end, the following table is a summary of the Funds’ securities on loan by counterparty which are subject to offset under an MSLA:

 

Fund Name/Counterparty     
Securities
Loaned at Value
 
 
    
Cash
Collateral Received
 
(a) 
   

Non-Cash
Collateral Received,
at Fair Value
 
 
(a) 
   
Net
Amount
 
(b) 

Health Sciences Opportunities

         

Citigroup Global Markets, Inc.

   $ 32,828,295      $ (32,828,295   $     $  

Goldman Sachs & Co. LLC

     5,038,595        (5,038,595            

J.P. Morgan Securities LLC

     17,433,059        (17,433,059            

Jefferies LLC

     172,788        (172,788            

Morgan Stanley

     2,191,553        (2,158,850           32,703  

National Financial Services LLC

     754,800        (754,800            
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 58,419,090      $ (58,386,387   $     $ 32,703  
  

 

 

    

 

 

   

 

 

   

 

 

 

Mid-Cap Growth Equity

         

Citigroup Global Markets, Inc.

   $ 60,371,959      $ (60,371,959   $     $  

Goldman Sachs & Co. LLC

     163,493,312        (163,493,312            

J.P. Morgan Securities LLC

     48,408,405        (48,408,405            

Morgan Stanley

     112,776,767        (112,776,767            

National Financial Services LLC

     1,572,500        (1,572,500            

State Street Bank & Trust Co.

     5,212,275        (5,212,275            
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 391,835,218      $ (391,835,218   $     $  
  

 

 

    

 

 

   

 

 

   

 

 

 

Technology Opportunities

         

Citigroup Global Markets, Inc.

   $ 14,021,416      $ (14,021,416   $     $  

Goldman Sachs & Co. LLC

     18,295,325        (18,295,325            

J.P. Morgan Securities LLC

     350,880        (350,880            

Morgan Stanley

     21,656,979        (21,656,979            

National Financial Services LLC

     3,216,450        (3,216,450            

Toronto-Dominion Bank

     101,948        (101,948            
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 57,642,998      $ (57,642,998   $     $  
  

 

 

    

 

 

   

 

 

   

 

 

 

 

  (a) 

Collateral received, if any, in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Funds’ Statements of Assets and Liabilities.

 
  (b) 

The market value of the loaned securities is determined as of November 30, 2023. Additional collateral is delivered to the Fund on the next business day in accordance with the MSLA. The net amount would be subject to the borrower default indemnity in the event of default by the counterparty.

 

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, the Funds benefit from a borrower default indemnity provided by BIM. BIM’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value on the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by the Funds.

 

5.

DERIVATIVE FINANCIAL INSTRUMENTS

The Funds engage in various portfolio investment strategies using derivative contracts both to increase the returns of the Funds and/or to manage their exposure to certain risks such as credit risk, equity risk, interest rate risk, foreign currency exchange rate risk, commodity price risk or other risks (e.g., inflation risk). Derivative financial instruments categorized by risk exposure are included in the Schedules of Investments. These contracts may be transacted on an exchange or over-the-counter (“OTC”).

Forward Foreign Currency Exchange Contracts: Forward foreign currency exchange contracts are entered into to gain or reduce exposure to foreign currencies (foreign currency exchange rate risk).

A forward foreign currency exchange contract is an agreement between two parties to buy and sell a currency at a set exchange rate on a specified date. These contracts help to manage the overall exposure to the currencies in which some of the investments held by the Funds are denominated and in some cases, may be used to obtain exposure to a particular market. The contracts are traded OTC and not on an organized exchange.

The contract is marked-to-market daily and the change in market value is recorded as unrealized appreciation (depreciation) in the Statements of Assets and Liabilities. When a contract is closed, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the value at the time it was opened and the value at the time it was closed. Non-deliverable forward foreign currency exchange contracts are settled with the counterparty in cash without the delivery of foreign currency. The use of forward foreign currency exchange contracts involves the risk that the value of a forward foreign currency exchange contract changes unfavorably due to movements in the value of the referenced foreign currencies, and such value may exceed the amounts reflected in the Statements of Assets and Liabilities. Cash amounts pledged for forward foreign currency exchange contracts are considered restricted and are included in cash pledged as collateral for OTC derivatives in the Statements of Assets and Liabilities. A Fund’s risk of loss from counterparty credit risk on OTC derivatives is generally limited to the aggregate unrealized gain netted against any collateral held by the Fund.

 

 

74  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

Swaps: Swap contracts are entered into to manage exposure to issuers, markets and securities. Such contracts are agreements between the Funds and a counterparty to make periodic net payments on a specified notional amount or a net payment upon termination. Swap agreements are privately negotiated in the OTC market and may be entered into as a bilateral contract (“OTC swaps”) or centrally cleared (“centrally cleared swaps”).

For OTC swaps, any upfront premiums paid and any upfront fees received are shown as swap premiums paid and swap premiums received, respectively, in the Statements of Assets and Liabilities and amortized over the term of the contract. The daily fluctuation in market value is recorded as unrealized appreciation (depreciation) on OTC Swaps in the Statements of Assets and Liabilities. Payments received or paid are recorded in the Statements of Operations as realized gains or losses, respectively. When an OTC swap is terminated, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the proceeds from (or cost of) the closing transaction and the Funds’ basis in the contract, if any. Generally, the basis of the contract is the premium received or paid.

 

   

Total return swaps — Total return swaps are entered into to obtain exposure to a security or market without owning such security or investing directly in such market or to exchange the risk/return of one security or market (e.g., fixed-income) with another security or market (e.g., equity or commodity prices) (equity risk, commodity price risk and/or interest rate risk).

Total return swaps are agreements in which there is an exchange of cash flows whereby one party commits to make payments based on the total return (distributions plus capital gains/losses) of an underlying instrument, or basket of underlying instruments, in exchange for fixed or floating rate interest payments. If the total return of the instrument(s) or index underlying the transaction exceeds or falls short of the offsetting fixed or floating interest rate obligation, the Funds receive payment from or make a payment to the counterparty.

Certain total return swaps are designed to function as a portfolio of direct investments in long and short equity positions. This means that the Fund has the ability to trade in and out of these long and short positions within the swap and will receive the economic benefits and risks equivalent to direct investment in these positions, subject to certain adjustments due to events related to the counterparty. Benefits and risks include capital appreciation (depreciation), corporate actions and dividends received and paid, all of which are reflected in the swap’s market value. The market value also includes interest charges and credits (“financing fees”) related to the notional values of the long and short positions and cash balances within the swap. These interest charges and credits are based on a specified benchmark rate plus or minus a specified spread determined based upon the country and/or currency of the positions in the portfolio.

Positions within the swap and financing fees are reset periodically. During a reset, any unrealized appreciation (depreciation) on positions and accrued financing fees become available for cash settlement between the Funds and the counterparty. The amounts that are available for cash settlement are recorded as realized gains or losses in the Statements of Operations. Cash settlement in and out of the swap may occur at a reset date or any other date, at the discretion of the Funds and the counterparty, over the life of the agreement. Certain swaps have no stated expiration and can be terminated by either party at any time.

Swap transactions involve, to varying degrees, elements of interest rate, credit and market risks in excess of the amounts recognized in the Statements of Assets and Liabilities. Such risks involve the possibility that there will be no liquid market for these agreements, that the counterparty to the agreements may default on its obligation to perform or disagree as to the meaning of the contractual terms in the agreements, and that there may be unfavorable changes in interest rates and/or market values associated with these transactions.

Master Netting Arrangements: In order to define its contractual rights and to secure rights that will help it mitigate its counterparty risk, a Fund may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or similar agreement with its derivative contract counterparties. An ISDA Master Agreement is a bilateral agreement between a Fund and a counterparty that governs certain OTC derivatives and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, a Fund may, under certain circumstances, offset with the counterparty certain derivative financial instruments’ payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default including the bankruptcy or insolvency of the counterparty. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against the right of offset in bankruptcy, insolvency or other events.

Collateral Requirements: For derivatives traded under an ISDA Master Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty.

Cash collateral that has been pledged to cover obligations of the Funds and cash collateral received from the counterparty, if any, is reported separately in the Statements of Assets and Liabilities as cash pledged as collateral and cash received as collateral, respectively. Non-cash collateral pledged by the Funds, if any, is noted in the Schedules of Investments. Generally, the amount of collateral due from or to a counterparty is subject to a certain minimum transfer amount threshold before a transfer is required, which is determined at the close of business of the Funds. Any additional required collateral is delivered to/pledged by the Funds on the next business day. Typically, the counterparty is not permitted to sell, re-pledge or use cash and non-cash collateral it receives. A Fund generally agrees not to use non-cash collateral that it receives but may, absent default or certain other circumstances defined in the underlying ISDA Master Agreement, be permitted to use cash collateral received. In such cases, interest may be paid pursuant to the collateral arrangement with the counterparty. To the extent amounts due to the Funds from the counterparties are not fully collateralized, each Fund bears the risk of loss from counterparty non-performance. Likewise, to the extent the Funds have delivered collateral to a counterparty and stand ready to perform under the terms of their agreement with such counterparty, each Fund bears the risk of loss from a counterparty in the amount of the value of the collateral in the event the counterparty fails to return such collateral. Based on the terms of agreements, collateral may not be required for all derivative contracts.

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements, if any, in the Statements of Assets and Liabilities.

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  75


Notes to Financial Statements (unaudited) (continued)

 

6.

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory: The Corporation, on behalf of Capital Appreciation, and the Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into an Investment Advisory Agreement with the Manager, the Funds’ investment adviser and an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”), to provide investment advisory services and with respect to Capital Appreciation, administrative services. The Manager is responsible for the management of each Fund’s portfolio and provides the personnel, facilities, equipment and certain other services necessary to the operations of each Fund.

For such services, each Fund pays the Manager a monthly fee at an annual rate equal to the following percentages of the average daily value of each Fund’s net assets:

 

Average Daily Net Assets           Investment Advisory Fees
Capital Appreciation
 

First $1 billion

    0.650

$1 billion - $1.5 billion

    0.625  

$1.5 billion - $5 billion

    0.600  

$5 billion - $7.5 billion

    0.575  

Greater than $7.5 billion

    0.550  

 

Average Daily Net Assets           Investment Advisory Fees
Health Sciences  Opportunities
 

First $1 billion

    0.750

$1 billion - $2 billion

    0.700  

$2 billion - $3 billion

    0.675  

$3 billion - $10 billion

    0.650  

Greater than $10 billion

    0.640  

 

     Investment Advisory Fees  
Average Daily Net Assets           Infrastructure Sustainable Opportunities     Technology Opportunities  

First $1 billion

    0.800     0.820

$1 billion - $3 billion

    0.750       0.770  

$3 billion - $5 billion

    0.720       0.740  

$5 billion - $10 billion

    0.700       0.710  

Greater than $10 billion

    0.680       0.700  

 

Average Daily Net Assets  

        Investment Advisory Fees

Mid-Cap Growth Equity

 

First $1 billion

    0.700

$1 billion - $3 billion

    0.660  

$3 billion - $5 billion

    0.630  

$5 billion - $10 billion

    0.610  

$10 billion - $18 billion

    0.600  

Greater than $18 billion

    0.590  

With respect to Infrastructure Sustainable Opportunities, the Manager entered into separate sub-advisory agreements with each of BlackRock International Limited (“BIL”) and BlackRock (Singapore) Limited (“BSL”), each an affiliate of the Manager. The Manager pays BIL and BSL for services they provide, for that portion of the Fund for which BIL and BSL, as applicable, act as sub-adviser, a monthly fee that is equal to a percentage of the investment advisory fees paid by the Fund to the Manager.

Service and Distribution Fees: The Corporation, on behalf of Capital Appreciation, and the Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into a Distribution Agreement and a Distribution and Service Plan with BlackRock Investments, LLC (“BRIL”), an affiliate of the Manager. Pursuant to the Distribution and Service Plan and in accordance with Rule 12b-1 under the 1940 Act, each Fund pays BRIL ongoing service and distribution fees. The fees are accrued daily and paid monthly at annual rates based upon the average daily net assets of the relevant share class of each Fund as follows:

 

Share Class   Service Fees     Distribution Fees  

Service

    0.25     N/A  

Investor A

    0.25       N/A  

Investor C

    0.25       0.75

Class R

    0.25       0.25  

BRIL and broker-dealers, pursuant to sub-agreements with BRIL, provide shareholder servicing and distribution services to the Funds. The ongoing service and/or distribution fee compensates BRIL and each broker-dealer for providing shareholder servicing and/or distribution related services to shareholders.

 

 

76  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

For the six months ended November 30, 2023, the following table shows the class specific service and distribution fees borne directly by each share class of each Fund:

 

Fund Name   Service      Investor A      Investor C      Class R      Total  

Capital Appreciation

  $      $ 2,252,766      $ 197,510      $ 61,423      $ 2,511,699  

Health Sciences Opportunities

    40,344        3,551,001        1,874,283        596,166        6,061,794  

Infrastructure Sustainable Opportunities

           200                      200  

Mid-Cap Growth Equity

    79,472        2,035,260        975,851        234,730        3,325,313  

Technology Opportunities

    58,493        2,037,649        1,309,936        91,302        3,497,380  

Administration: The Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into an Administration Agreement with the Manager, an indirect, wholly-owned subsidiary of BlackRock, to provide administrative services. For these services, the Manager receives an administration fee computed daily and payable monthly, based on a percentage of the average daily net assets of each Fund. The administration fee, which is shown as administration in the Statements of Operations, is paid at the annual rates below.

 

Average Daily Net Assets   Administration Fees  

First $500 million

    0.0425

$500 million - $1 billion

    0.0400  

$1 billion - $2 billion

    0.0375  

$2 billion - $4 billion

    0.0350  

$4 billion - $13 billion

    0.0325  

Greater than $13 billion

    0.0300  

In addition, the Manager charges each of the share classes an administration fee, which is shown as administration — class specific in the Statements of Operations, at an annual rate of 0.02% of the average daily net assets of each respective class.

For the six months ended November 30, 2023, the following table shows the class specific administration fees borne directly by each share class of each Fund:

 

Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Health Sciences Opportunities

  $ 436,753      $ 3,223      $ 283,641      $ 37,455      $ 47,037      $ 23,809      $ 831,918  

Infrastructure Sustainable Opportunities

    10               16               844               870  

Mid-Cap Growth Equity

    531,373        6,347        162,563        19,486        432,670        9,373        1,161,812  

Technology Opportunities

    234,678        4,670        162,613        26,142        17,366        3,644        449,113  

Transfer Agent: Pursuant to written agreements, certain financial intermediaries, some of which may be affiliates, provide the Funds with sub-accounting, recordkeeping, sub-transfer agency and other administrative services with respect to servicing of underlying investor accounts. For these services, these entities receive an asset-based fee or an annual fee per shareholder account, which will vary depending on share class and/or net assets. For the six months ended November 30, 2023, the Funds paid the following amounts to affiliates of BlackRock in return for these services, which are included in transfer agent — class specific in the Statements of Operations:

 

Fund Name   Institutional      Total  

Capital Appreciation

  $ 69,864      $ 69,864  

The Manager maintains a call center that is responsible for providing certain shareholder services to the Funds. Shareholder services include responding to inquiries and processing purchases and sales based upon instructions from shareholders. For the six months ended November 30, 2023, each Fund reimbursed the Manager the following amounts for costs incurred in running the call center, which are included in transfer agent — class specific in the Statements of Operations:

 

Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Capital Appreciation

  $ 1,537      $      $ 46,506      $ 4,232      $ 1,618      $ 112      $ 54,005  

Health Sciences Opportunities

    13,203        351        69,254        12,808        1,519        996        98,131  

Infrastructure Sustainable Opportunities

    108               52               107               267  

Mid-Cap Growth Equity

    12,297        242        119,070        7,133        8,877        1,372        148,991  

Technology Opportunities

    9,648        35        38,277        8,542        573        367        57,442  

For the six months ended November 30, 2023, the following table shows the class specific transfer agent fees borne directly by each share class of each Fund:

 

Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Capital Appreciation

  $ 363,262      $      $ 936,329      $ 38,531      $ 18,559      $ 24,611      $ 1,381,292  

Health Sciences Opportunities

    2,160,984        23,311        1,369,192        222,198        14,737        256,464        4,046,886  

Infrastructure Sustainable Opportunities

    197               254               206               657  

Mid-Cap Growth Equity

    4,066,164        48,645        1,496,274        138,790        285,699        96,010        6,131,582  

Technology Opportunities

    1,431,470        24,498        938,519        166,661        9,654        36,372        2,607,174  

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  77


Notes to Financial Statements (unaudited) (continued)

 

Other Fees: For the six months ended November 30, 2023, affiliates earned underwriting discounts, direct commissions and dealer concessions on sales of each Fund’s Investor A Shares as follows:

 

Fund Name   Amounts  

Capital Appreciation

  $ 16,967  

Health Sciences Opportunities

    26,139  

Infrastructure Sustainable Opportunities

    87  

Mid-Cap Growth Equity

    20,830  

Technology Opportunities

    36,519  

For the six months ended November 30, 2023, affiliates received CDSCs as follows:

 

Share Class   Capital
Appreciation
     Health
Sciences
Opportunities
     Mid-Cap
Growth
Equity
     Technology
Opportunities
 

Investor A

  $ 3,224      $ 3,720      $ 2,333      $ 1,913  

Investor C

    528        8,595        3,437        5,397  

Expense Limitations, Waivers, Reimbursements, and Recoupments: With respect to each Fund, the Manager contractually agreed to waive its investment advisory fees by the amount of investment advisory fees each Fund pays to the Manager indirectly through its investment in affiliated money market funds (the “affiliated money market fund waiver”) through June 30, 2025. The contractual agreement may be terminated upon 90 days’ notice by a majority of the directors who are not “interested persons” of the Corporation or the Trust, as defined in the 1940 Act (“Independent Directors”), or by a vote of a majority of the outstanding voting securities of a Fund. The amount of waivers and/or reimbursements of fees and expenses made pursuant to the expense limitation described below will be reduced by the amount of the affiliated money market fund waiver. These amounts are included in fees waived and/or reimbursed by the Manager in the Statements of Operations. For the six months ended November 30, 2023, the amounts waived were as follows:

 

Fund Name   Amounts Waived  

Capital Appreciation

  $ 1,160  

Health Sciences Opportunities

    66,885  

Infrastructure Sustainable Opportunities

    180  

Mid-Cap Growth Equity

    5,423  

Technology Opportunities

    6,911  

The Manager has contractually agreed to waive its investment advisory fee with respect to any portion of each Fund’s assets invested in affiliated equity and fixed-income mutual funds and affiliated exchange-traded funds that have a contractual management fee through June 30, 2025. The contractual agreement may be terminated upon 90 days’ notice by a majority of the Independent Directors, or by a vote of a majority of the outstanding voting securities of a Fund. For the six months ended November 30, 2023, there were no fees waived and/or reimbursed by the Manager pursuant to this arrangement.

With respect to each Fund (except Health Sciences Opportunities), the Manager contractually agreed to waive and/or reimburse fees or expenses in order to limit expenses, excluding interest expense, dividend expense, tax expense, acquired fund fees and expenses, and certain other fund expenses, which constitute extraordinary expenses not incurred in the ordinary course of each Fund’s business (“expense limitation”). The expense limitations as a percentage of average daily net assets are as follows:

 

Share Class   Capital Appreciation     Infrastructure Sustainable Opportunities     Mid-Cap Growth Equity     Technology Opportunities  

Institutional

    N/A       1.00     0.80     0.92

Service

    N/A       N/A       1.05       1.17  

Investor A

    N/A       1.25       1.05       1.17  

Investor C

    1.94     N/A       1.80       1.92  

Class K

    0.72       0.95       0.75       0.87  

Class R

    N/A       N/A       1.30       1.42  

The Manager has agreed not to reduce or discontinue the contractual expense limitations through June 30, 2025 (or June 30, 2034 with respect to Capital Appreciation), unless approved by the Board, including a majority of the Independent Directors, or by a vote of a majority of the outstanding voting securities of a Fund.

For the six months ended November 30, 2023, Infrastructure Sustainable Opportunities waived and/or reimbursed the Manager investment advisory fees and other expenses of $151,132, which is included in fees waived and/or reimbursed by the Manager in the Statements of Operations.

In addition, these amounts waived and/or reimbursed by the Manager are included in administration fees waived by the Manager — class specific and transfer agent fees waived and/or reimbursed by the Manager — class specific, respectively, in the Statements of Operations. For the six months ended November 30, 2023, class specific expense waivers and/or reimbursements are as follows:

 

     Administration Fees Waived by the Manager - Class Specific  
Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Infrastructure Sustainable Opportunities

  $ 10      $      $ 16      $      $ 844      $      $ 870  

Mid-Cap Growth Equity

    531,373        6,346        162,563        19,486               9,373        729,141  

Technology Opportunities

    234,678        3,960        162,613        26,142               3,644        431,037  

 

 

78  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

     Transfer Agent Fees Waived and/or Reimbursed by the Manager - Class Specific  
Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Infrastructure Sustainable Opportunities

  $ 173      $      $ 214      $      $ 206      $      $ 593  

Mid-Cap Growth Equity

    864,469        10,571        521,806        23,628               39,898        1,460,372  

Technology Opportunities

    363,029        4,085        204,256        50,822               19,968        642,160  

Infrastructure Sustainable Opportunities also had a waiver of administration fees, which are included in Administration fees waived in the Statements of Operations. For the six months ended November 30, 2023, the amount was $1,849.

With respect to the contractual expense limitation of Infrastructure Sustainable Opportunities, if during the Fund’s fiscal year the operating expenses of a share class, that at any time during the prior two fiscal years received a waiver and/or reimbursement from the Manager, are less than the current expense limitation for that share class, the Manager is entitled to be reimbursed by such share class up to the lesser of: (a) the amount of fees waived and/or expenses reimbursed during those prior two fiscal years under the agreement and (b) an amount not to exceed either the current expense limitation of that share class or the expense limitation of the share class in effect at the time that the share class received the applicable waiver and/or reimbursement, provided that:

 

  (1)

the Fund, of which the share class is a part, has more than $50 million in assets for the fiscal year, and

 

  (2)

the Manager or an affiliate continues to serve as the Fund’s investment adviser or administrator.

This repayment applies only to the contractual expense limitation on net expenses and does not apply to the contractual investment advisory fee waiver described above or any voluntary waivers that may be in effect from time to time. Effective September 30, 2028 the repayment arrangement between the Fund and the Manager pursuant to which the Fund may be required to repay amounts waived and/or reimbursed under the Fund’s contractual caps on net expenses will be terminated.

As of November 30, 2023, the fund level and class specific waivers and/or reimbursements subject to possible future recoupment under the expense limitation agreement were as follows:

 

     Expiring May 31,  
Fund Name/Fund Level/Share Class   2024      2025      2026  

Infrastructure Sustainable Opportunities

       

Fund Level

    $198,233      $ 299,135      $ 152,981  

Institutional

    153        174        183  

Investor A

    151        40        230  

Class K

    1,479        1,854        1,050  

Securities Lending: The U.S. Securities and Exchange Commission (“SEC”) has issued an exemptive order which permits BIM, an affiliate of the Manager, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BIM bears all operational costs directly related to securities lending. The Funds are responsible for expenses in connection with the investment of cash collateral received for securities on loan (the “collateral investment expenses”). The cash collateral is invested in a private investment company Money Market Series, managed by the Manager or its affiliates. However, BIM has agreed to cap the collateral investment expenses of the Money Market Series to an annual rate of 0.04%. The investment adviser to the Money Market Series will not charge any advisory fees with respect to shares purchased by the Funds. The Money Market Series may impose a discretionary liquidity fee of up to 2% of the value withdrawn, if such fee is determined to be in the best interests of the Money Market Series. The Money Market Series seeks current income consistent with maintaining liquidity and preserving capital. Although the Money Market Series is not registered under the 1940 Act, its investments may follow the parameters of investments by a money market fund that is subject to Rule 2a-7 under the 1940 Act.

Securities lending income is equal to the total of income earned from the reinvestment of cash collateral, net of fees and other payments to and from borrowers of securities, and less the collateral investment expenses. Each Fund retains a portion of securities lending income and remits a remaining portion to BIM as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, Capital Appreciation, Health Sciences Opportunities, Mid-Cap Growth Equity and Technology Opportunities retain 81% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses. Pursuant to the current securities lending agreement, Infrastructure Sustainable Opportunities retains 82% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses.

In addition, commencing the business day following the date that the aggregate securities lending income earned across the BlackRock Multi-Asset Complex in a calendar year exceeds a specified threshold, Capital Appreciation, Health Sciences Opportunities, Mid-Cap Growth Equity and Technology Opportunities, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 81% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses. Infrastructure Sustainable Opportunities, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 85% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses.

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  79


Notes to Financial Statements (unaudited) (continued)

 

The share of securities lending income earned by each Fund is shown as securities lending income — affiliated — net in the Statements of Operations. For the six months ended November 30, 2023, each Fund paid BIM the following amounts for securities lending agent services:

 

Fund Name   Amounts  

Capital Appreciation

  $ 1,247  

Health Sciences Opportunities

    99,953  

Infrastructure Sustainable Opportunities

    3  

Mid-Cap Growth Equity

    68,387  

Technology Opportunities

    11,316  

Interfund Lending: In accordance with an exemptive order (the “Order”) from the SEC, Capital Appreciation and Infrastructure Sustainable Opportunities may participate in a joint lending and borrowing facility for temporary purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by Capital Appreciation’s and Infrastructure Sustainable Opportunities’s investment policies and restrictions. Capital Appreciation is currently permitted to borrow under the Interfund Lending Program. In addition, Infrastructure Sustainable Opportunities is currently permitted to borrow and lend under the Interfund Lending Program.

A lending BlackRock fund may lend in aggregate up to 15% of its net assets but may not lend more than 5% of its net assets to any one borrowing fund through the Interfund Lending Program. A borrowing BlackRock fund may not borrow through the Interfund Lending Program or from any other source more than 33 1/3% of its total assets (or any lower threshold provided for by the fund’s investment restrictions). If a borrowing BlackRock fund’s total outstanding borrowings exceed 10% of its total assets, each of its outstanding interfund loans will be subject to collateralization of at least 102% of the outstanding principal value of the loan. All interfund loans are for temporary or emergency purposes and the interest rate to be charged will be the average of the highest current overnight repurchase agreement rate available to a lending fund and the bank loan rate, as calculated according to a formula established by the Board.

During the six months ended November 30, 2023, Capital Appreciation and Infrastructure Sustainable Opportunities did not participate in the Interfund Lending Program.

Directors and Officers: Certain directors and/or officers of the Corporation and the Trust are directors and/or officers of BlackRock or its affiliates. The Funds reimburse the Manager for a portion of the compensation paid to the Corporation’s/Trust’s Chief Compliance Officer, which is included in Directors and Officer in the Statements of Operations.

 

7.

PURCHASES AND SALES

For the six months ended November 30, 2023, purchases and sales of investments, excluding short-term securities, were as follows:

 

Fund Name   Purchases      Sales  

Capital Appreciation

  $ 289,589,005      $ 581,856,820  

Health Sciences Opportunities

    1,397,366,319        2,154,481,470  

Infrastructure Sustainable Opportunities

    2,651,921        2,146,316  

Mid-Cap Growth Equity

    2,396,617,647        3,377,006,398  

Technology Opportunities

    401,237,458        629,543,843  

 

8.

INCOME TAX INFORMATION

It is each Fund’s policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.

Each Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on each Fund’s U.S. federal tax returns generally remains open for a period of three years after they are filed. The statutes of limitations on each Fund’s state and local tax returns may remain open for an additional year depending upon the jurisdiction.

Management has analyzed tax laws and regulations and their application to the Funds as of November 30, 2023, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements.

As of May 31, 2023, the Funds had non-expiring capital loss carryforwards available to offset future realized capital gains and qualified late-year losses as follows:

 

Fund Name   Non-Expiring Capital
Loss Carryforwards
       Qualified Late-Year
Ordinary Losses
 

Capital Appreciation

  $        $ 1,852,224  

Health Sciences Opportunities

             70,936  

Infrastructure Sustainable Opportunities

    618,241           

Mid-Cap Growth Equity

    2,288,206,843          20,531,216  

Technology Opportunities

    710,037,033          7,766,600  

 

 

80  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

As of November 30, 2023, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

Fund Name   Tax Cost      Gross Unrealized
Appreciation
     Gross Unrealized
Depreciation
    Net Unrealized
Appreciation
(Depreciation)
 

Capital Appreciation

  $ 1,577,212,297      $ 1,692,437,998      $ (17,023,817   $ 1,675,414,181  

Health Sciences Opportunities

    5,177,330,809        3,072,903,899        (271,608,354     2,801,295,545  

Infrastructure Sustainable Opportunities

    9,222,020        475,009        (866,023     (391,014

Mid-Cap Growth Equity

    8,780,212,661        3,407,210,880        (255,702,440     3,151,508,440  

Technology Opportunities

    2,532,805,056        2,229,706,895        (52,024,044     2,177,682,851  

 

9.

BANK BORROWINGS

The Corporation and the Trust, on behalf of the Funds, along with certain other funds managed by the Manager and its affiliates (“Participating Funds”), is party to a 364-day, $2.50 billion credit agreement with a group of lenders. Under this agreement, the Funds may borrow to fund shareholder redemptions. Excluding commitments designated for certain individual funds, the Participating Funds, including the Funds, can borrow up to an aggregate commitment amount of $1.75 billion at any time outstanding, subject to asset coverage and other limitations as specified in the agreement. The credit agreement has the following terms: a fee of 0.10% per annum on unused commitment amounts and interest at a rate equal to the higher of (a) Overnight Bank Funding Rate (“OBFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.80% per annum, (b) the Fed Funds rate (but, in any event, not less than 0.00%) in effect from time to time plus 0.80% per annum on amounts borrowed or (c) the sum of (x) Daily Simple Secured Overnight Financing Rate (“SOFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.10% and (y) 0.80% per annum. The agreement expires in April 2024 unless extended or renewed. These fees were allocated among such funds based upon portions of the aggregate commitment available to them and relative net assets of Participating Funds. During the six months ended November 30, 2023, the Funds did not borrow under the credit agreement.

 

10.

PRINCIPAL RISKS

In the normal course of business, the Funds invest in securities or other instruments and may enter into certain transactions, and such activities subject each Fund to various risks, including among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate and price fluctuations. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, recessions, or other events could have a significant impact on the Funds and their investments. Each Fund’s prospectus provides details of the risks to which each Fund is subject.

The Funds may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to discretionary liquidity fees under certain circumstances.

Infectious Illness Risk: An outbreak of an infectious illness, such as the COVID-19 pandemic, may adversely impact the economies of many nations and the global economy, and may impact individual issuers and capital markets in ways that cannot be foreseen. An infectious illness outbreak may result in, among other things, closed international borders, prolonged quarantines, supply chain disruptions, market volatility or disruptions and other significant economic, social and political impacts.

Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. A Fund may invest in illiquid investments. An illiquid investment is any investment that a Fund reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. A Fund may experience difficulty in selling illiquid investments in a timely manner at the price that it believes the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause each Fund’s NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of a Fund may lose value, regardless of the individual results of the securities and other instruments in which a Fund invests.

The price a Fund could receive upon the sale of any particular portfolio investment may differ from a Fund’s valuation of the investment, particularly for securities that trade in thin or volatile markets or that are valued using a fair valuation technique or a price provided by an independent pricing service. Changes to significant unobservable inputs and assumptions (i.e., publicly traded company multiples, growth rate, time to exit) due to the lack of observable inputs may significantly impact the resulting fair value and therefore a Fund’s results of operations. As a result, the price received upon the sale of an investment may be less than the value ascribed by a Fund, and a Fund could realize a greater than expected loss or lesser than expected gain upon the sale of the investment. A Fund’s ability to value its investments may also be impacted by technological issues and/or errors by pricing services or other third-party service providers.

Counterparty Credit Risk: The Funds may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions, including making timely interest and/or principal payments or otherwise honoring its obligations. The Funds manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Funds to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Funds’ exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Funds.

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  81


Notes to Financial Statements (unaudited) (continued)

 

A derivative contract may suffer a mark-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform under the contract.

With exchange-traded options purchased and exchange-traded futures, there is less counterparty credit risk to the Funds since the exchange or clearinghouse, as counterparty to such instruments, guarantees against a possible default. The clearinghouse stands between the buyer and the seller of the contract; therefore, credit risk is limited to failure of the clearinghouse. While offset rights may exist under applicable law, a Fund does not have a contractual right of offset against a clearing broker or clearinghouse in the event of a default (including the bankruptcy or insolvency). Additionally, credit risk exists in exchange-traded futures with respect to initial and variation margin that is held in a clearing broker’s customer accounts. While clearing brokers are required to segregate customer margin from their own assets, in the event that a clearing broker becomes insolvent or goes into bankruptcy and at that time there is a shortfall in the aggregate amount of margin held by the clearing broker for all its clients, typically the shortfall would be allocated on a pro rata basis across all the clearing broker’s customers, potentially resulting in losses to the Funds.

Geographic/Asset Class Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within the Fund’s portfolio are disclosed in its Schedule of Investments.

Certain Funds invest a significant portion of their assets in securities within a single or limited number of market sectors. When a fund concentrates its investments in this manner, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the Fund and could affect the income from, or the value or liquidity of, the Fund’s portfolio. Investment percentages in specific sectors are presented in the Schedules of Investments.

The Funds invest a significant portion of their assets in securities of issuers located in the United States. A decrease in imports or exports, changes in trade regulations, inflation and/or an economic recession in the United States may have a material adverse effect on the U.S. economy and the securities listed on U.S. exchanges. Proposed and adopted policy and legislative changes in the United States may also have a significant effect on U.S. markets generally, as well as on the value of certain securities. Governmental agencies project that the United States will continue to maintain elevated public debt levels for the foreseeable future which may constrain future economic growth. Circumstances could arise that could prevent the timely payment of interest or principal on U.S. government debt, such as reaching the legislative “debt ceiling.” Such non-payment would result in substantial negative consequences for the U.S. economy and the global financial system. If U.S. relations with certain countries deteriorate, it could adversely affect issuers that rely on the United States for trade. The United States has also experienced increased internal unrest and discord. If these trends were to continue, they may have an adverse impact on the U.S. economy and the issuers in which the Funds invest.

Significant Shareholder Redemption Risk: Certain shareholders may own or manage a substantial amount of fund shares and/or hold their fund investments for a limited period of time. Large redemptions of fund shares by these shareholders may force a fund to sell portfolio securities, which may negatively impact the fund’s NAV, increase the fund’s brokerage costs, and/or accelerate the realization of taxable income/gains and cause the fund to make additional taxable distributions to shareholders.

 

11.

CAPITAL SHARE TRANSACTIONS

Transactions in capital shares for each class were as follows:

 

     Six Months Ended 11/30/23     Year Ended 05/31/23  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Capital Appreciation

       

Institutional

       

Shares sold

    1,229,752     $ 41,045,413       5,716,023     $ 157,957,646  

Shares issued in reinvestment of distributions

    271,302       9,178,145       1,893,570       51,954,274  

Shares redeemed

    (2,926,262     (97,560,178     (15,681,629     (435,307,849
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,425,208   $ (47,336,620     (8,072,036   $ (225,395,929
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold and automatic conversion of shares

    1,766,494     $ 51,494,190       3,941,330     $ 97,836,995  

Shares issued in reinvestment of distributions

    1,003,491       29,663,201       5,278,960       127,222,770  

Shares redeemed

    (4,617,857     (135,096,969     (13,077,008     (322,318,537
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,847,872   $ (53,939,578     (3,856,718   $ (97,258,772
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor C

       

Shares sold

    122,655     $ 1,985,872       295,401     $ 4,190,433  

Shares issued in reinvestment of distributions

    78,950       1,285,304       415,970       5,707,720  

Shares redeemed and automatic conversion of shares

    (521,422     (8,405,515     (1,003,070     (14,231,042
 

 

 

   

 

 

   

 

 

   

 

 

 
    (319,817   $ (5,134,339     (291,699   $ (4,332,889
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

82  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

     Six Months Ended 11/30/23     Year Ended 05/31/23  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Capital Appreciation (continued)

       

Class K

       

Shares sold

    896,544     $ 30,225,975       2,780,441     $ 79,543,996  

Shares issued in reinvestment of distributions

    299,603       10,261,389       1,501,046       41,578,344  

Shares redeemed

    (5,052,062     (168,259,908     (4,141,499     (118,871,975
 

 

 

   

 

 

   

 

 

   

 

 

 
    (3,855,915   $ (127,772,544     139,988     $ 2,250,365  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class R

       

Shares sold

    103,468     $ 2,134,399       204,059     $ 3,695,774  

Shares issued in reinvestment of distributions

    29,675       622,572       142,318       2,473,411  

Shares redeemed

    (207,462     (4,453,506     (310,598     (5,527,276
 

 

 

   

 

 

   

 

 

   

 

 

 
    (74,319   $ (1,696,535     35,779     $ 641,909  
 

 

 

   

 

 

   

 

 

   

 

 

 
    (7,523,131   $ (235,879,616     (12,044,686   $ (324,095,316
 

 

 

   

 

 

   

 

 

   

 

 

 

Health Sciences Opportunities

       

Institutional

       

Shares sold

    3,590,199     $ 247,112,091       11,197,111     $ 765,047,695  

Shares issued in reinvestment of distributions

    1,152,305       81,272,036       5,046,141       332,953,033  

Shares redeemed

    (8,923,581     (612,460,758     (21,662,089     (1,475,511,418
 

 

 

   

 

 

   

 

 

   

 

 

 
    (4,181,077   $ (284,076,631     (5,418,837   $ (377,510,690
 

 

 

   

 

 

   

 

 

   

 

 

 

Service

       

Shares sold

    19,745     $ 1,278,029       57,200     $ 3,684,661  

Shares issued in reinvestment of distributions

    10,065       667,108       40,955       2,542,243  

Shares redeemed

    (61,222     (3,979,866     (122,578     (7,895,488
 

 

 

   

 

 

   

 

 

   

 

 

 
    (31,412   $ (2,034,729     (24,423   $ (1,668,584
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold and automatic conversion of shares

    1,662,660     $ 107,389,328       4,334,203     $ 278,606,468  

Shares issued in reinvestment of distributions

    861,423       56,802,265       3,522,117       217,567,391  

Shares redeemed

    (4,263,716     (274,600,146     (9,621,175     (618,119,887
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,739,633   $ (110,408,553     (1,764,855   $ (121,946,028
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor C

       

Shares sold

    167,430     $ 8,942,342       537,584     $ 28,698,873  

Shares issued in reinvestment of distributions

    177,161       9,625,174       832,560       42,677,038  

Shares redeemed and automatic conversion of shares

    (1,608,035     (85,468,729     (3,241,641     (172,577,850
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,263,444   $ (66,901,213     (1,871,497   $ (101,201,939
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    919,349     $ 63,666,969       2,134,729     $ 147,417,118  

Shares issued in reinvestment of distributions

    120,923       8,544,395       470,645       31,121,552  

Shares redeemed

    (1,616,138     (112,999,257     (1,551,519     (105,963,545
 

 

 

   

 

 

   

 

 

   

 

 

 
    (575,866   $ (40,787,893     1,053,855     $ 72,575,125  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class R

       

Shares sold

    152,153     $ 9,421,417       260,827     $ 16,205,620  

Shares issued in reinvestment of distributions

    79,945       5,102,900       305,568       18,277,362  

Shares redeemed

    (343,568     (21,500,224     (662,105     (41,318,683
 

 

 

   

 

 

   

 

 

   

 

 

 
    (111,470   $ (6,975,907     (95,710   $ (6,835,701
 

 

 

   

 

 

   

 

 

   

 

 

 
    (7,902,902   $ (511,184,926     (8,121,467   $ (536,587,817
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  83


Notes to Financial Statements (unaudited) (continued)

 

     Six Months Ended 11/30/23     Year Ended 05/31/23  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Infrastructure Sustainable Opportunities

       

Institutional

       

Shares sold

    146     $ 1,255       664     $ 5,769  

Shares issued in reinvestment of distributions

    13       124       32       282  

Shares redeemed

    (262     (2,192     (133     (1,200
 

 

 

   

 

 

   

 

 

   

 

 

 
    (103   $ (813     563     $ 4,851  
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold

    5,008     $ 42,411       6,368     $ 57,649  

Shares issued in reinvestment of distributions

    66       607       38       332  

Shares redeemed

    (1,344     (10,686     (54     (495
 

 

 

   

 

 

   

 

 

   

 

 

 
    3,730     $ 32,332       6,352     $ 57,486  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    61     $ 520       189     $ 1,620  

Shares issued in reinvestment of distributions

    6       56       16       142  
 

 

 

   

 

 

   

 

 

   

 

 

 
    67     $ 576       205     $ 1,762  
 

 

 

   

 

 

   

 

 

   

 

 

 
    3,694     $ 32,095       7,120     $ 64,099  
 

 

 

   

 

 

   

 

 

   

 

 

 

Mid-Cap Growth Equity

       

Institutional

       

Shares sold

    13,906,035     $ 477,656,786       47,917,656     $ 1,524,488,005  

Shares redeemed

    (28,837,238     (986,027,853     (103,429,603     (3,263,321,983
 

 

 

   

 

 

   

 

 

   

 

 

 
    (14,931,203   $ (508,371,067     (55,511,947   $ (1,738,833,978
 

 

 

   

 

 

   

 

 

   

 

 

 

Service

       

Shares sold

    97,886     $ 2,999,341       350,535     $ 9,881,277  

Shares redeemed

    (295,217     (8,843,161     (975,944     (27,755,309
 

 

 

   

 

 

   

 

 

   

 

 

 
    (197,331   $ (5,843,820     (625,409   $ (17,874,032
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold and automatic conversion of shares

    2,494,382     $ 72,950,389       7,397,275     $ 201,630,334  

Shares redeemed

    (8,115,402     (236,047,974     (17,049,170     (459,100,473
 

 

 

   

 

 

   

 

 

   

 

 

 
    (5,621,020   $ (163,097,585     (9,651,895   $ (257,470,139
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor C

       

Shares sold

    200,362     $ 4,366,259       596,600     $ 12,112,431  

Shares redeemed and automatic conversion of shares

    (1,112,843     (23,995,863     (2,806,057     (56,412,228
 

 

 

   

 

 

   

 

 

   

 

 

 
    (912,481   $ (19,629,604     (2,209,457   $ (44,299,797
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    11,572,784     $ 400,447,225       43,394,126     $ 1,373,927,107  

Shares redeemed

    (18,463,712     (637,840,789     (47,704,012     (1,522,478,195
 

 

 

   

 

 

   

 

 

   

 

 

 
    (6,890,928   $ (237,393,564     (4,309,886   $ (148,551,088
 

 

 

   

 

 

   

 

 

   

 

 

 

Class R

       

Shares sold

    284,882     $ 8,079,375       880,078     $ 23,445,508  

Shares redeemed

    (615,531     (17,473,336     (862,426     (22,678,994
 

 

 

   

 

 

   

 

 

   

 

 

 
    (330,649   $ (9,393,961     17,652     $ 766,514  
 

 

 

   

 

 

   

 

 

   

 

 

 
    (28,883,612   $ (943,729,601     (72,290,942   $ (2,206,262,520
 

 

 

   

 

 

   

 

 

   

 

 

 

Technology Opportunities

       

Institutional

       

Shares sold

    5,145,074     $ 258,124,062       16,615,851     $ 696,225,151  

Shares redeemed

    (8,753,871     (438,660,382     (33,058,906     (1,373,686,694
 

 

 

   

 

 

   

 

 

   

 

 

 
    (3,608,797   $ (180,536,320     (16,443,055   $ (677,461,543
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

84  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

     Six Months Ended 11/30/23     Year Ended 05/31/23  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Technology Opportunities (continued)

       

Service

       

Shares sold

    105,625     $ 5,010,319       171,238     $ 6,686,958  

Shares redeemed

    (206,850     (9,584,051     (417,065     (16,352,892
 

 

 

   

 

 

   

 

 

   

 

 

 
    (101,225   $ (4,573,732     (245,827   $ (9,665,934
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold and automatic conversion of shares

    2,518,205     $ 114,699,264       4,850,581     $ 188,138,502  

Shares redeemed

    (3,760,433     (171,293,837     (9,667,118     (366,443,166
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,242,228   $ (56,594,573     (4,816,537   $ (178,304,664
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor C

       

Shares sold

    372,483     $ 13,533,457       705,328     $ 21,723,660  

Shares redeemed and automatic conversion of shares

    (1,060,646     (38,380,684     (2,005,673     (60,699,308
 

 

 

   

 

 

   

 

 

   

 

 

 
    (688,163   $ (24,847,227     (1,300,345   $ (38,975,648
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    907,749     $ 45,826,688       1,866,384     $ 77,400,205  

Shares redeemed

    (646,647     (32,192,990     (1,574,873     (65,635,026
 

 

 

   

 

 

   

 

 

   

 

 

 
    261,102     $ 13,633,698       291,511     $ 11,765,179  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class R

       

Shares sold

    141,933     $ 6,455,240       250,388     $ 9,664,993  

Shares redeemed

    (199,093     (9,017,253     (271,520     (10,425,495
 

 

 

   

 

 

   

 

 

   

 

 

 
    (57,160   $ (2,562,013     (21,132   $ (760,502
 

 

 

   

 

 

   

 

 

   

 

 

 
    (5,436,471   $ (255,480,167     (22,535,385   $ (893,403,112
 

 

 

   

 

 

   

 

 

   

 

 

 

As of November 30, 2023, shares owned by BlackRock Financial Management, Inc., an affiliate of the Funds, were as follows:

 

Share Class   Infrastructure
Sustainable
Opportunities
     Technology
Opportunities
 

Institutional

    10,000         

Investor A

    10,000         

Class K

    980,000        8,673  

 

12.

SUBSEQUENT EVENTS

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  85


Statement Regarding Liquidity Risk Management Program

 

In compliance with Rule 22e-4 under the Investment Company Act of 1940, as amended (the “Liquidity Rule”), BlackRock Capital Appreciation Fund, Inc. (the “Corporation”) and BlackRock FundsSM (the “Trust”) have adopted and implemented a liquidity risk management program (the “Program”) for BlackRock Capital Appreciation Fund, Inc., BlackRock Health Sciences Opportunities Portfolio, BlackRock Infrastructure Sustainable Opportunities Fund, BlackRock Mid-Cap Growth Equity Portfolio and BlackRock Technology Opportunities Fund (the “Funds”), which is reasonably designed to assess and manage each Fund’s liquidity risk.

The Board of Directors of the Corporation and the Board of Trustees of the Trust (together, the “Board”), on behalf of the Funds, met on November 16-17, 2023 (the “Meeting”) to review the Program. The Board previously appointed BlackRock Advisors, LLC or BlackRock Fund Advisors (“BlackRock”), each an investment adviser to certain BlackRock funds, as the program administrator for each Fund’s Program, as applicable. BlackRock also previously delegated oversight of the Program to the 40 Act Liquidity Risk Management Committee (the “Committee”). At the Meeting, the Committee, on behalf of BlackRock, provided the Board with a report that addressed the operation of the Program and assessed its adequacy and effectiveness of implementation, including the management of each Fund’s Highly Liquid Investment Minimum (“HLIM”) where applicable, and any material changes to the Program (the “Report”). The Report covered the period from October 1, 2022 through September 30, 2023 (the “Program Reporting Period”).

The Report described the Program’s liquidity classification methodology for categorizing each Fund’s investments (including derivative transactions) into one of four liquidity buckets. It also referenced the methodology used by BlackRock to establish each Fund’s HLIM and noted that the Committee reviews and ratifies the HLIM assigned to each Fund no less frequently than annually. The Report also discussed notable events affecting liquidity over the Program Reporting Period, including the imposition of capital controls in certain countries.

The Report noted that the Program complied with the key factors for consideration under the Liquidity Rule for assessing, managing and periodically reviewing each Fund’s liquidity risk, as follows:

 

  a)

The Fund’s investment strategy and liquidity of portfolio investments during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed whether each Fund’s strategy is appropriate for an open-end fund structure with a focus on funds with more significant and consistent holdings of less liquid and illiquid assets. The Committee also factored a fund’s concentration in an issuer into the liquidity classification methodology by taking issuer position sizes into account. Where a fund participated in borrowings for investment purposes (such as tender option bonds or reverse repurchase agreements), such borrowings were factored into the Program’s calculation of a fund’s liquidity bucketing. A fund’s derivative exposure was also considered in such calculation.

 

  b)

Short-term and long-term cash flow projections during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed historical redemption activity and used this information as a component to establish each Fund’s reasonably anticipated trading size utilized for liquidity classifications. Each Fund has adopted an in-kind redemption policy which may be utilized to meet larger redemption requests. The Committee may also take into consideration a fund’s shareholder ownership concentration (which, depending on product type and distribution channel, may or may not be available), a fund’s distribution channels, and the degree of certainty associated with a fund’s short-term and long-term cash flow projections.

 

  c)

Holdings of cash and cash equivalents, as well as borrowing arrangements. The Committee considered the terms of the credit facility committed to each Fund, the financial health of the institution providing the facility and the fact that the credit facility is shared among multiple funds (including that a portion of the aggregate commitment amount is specifically designated for BlackRock Floating Rate Income Portfolio, a series of BlackRock Funds V, and BlackRock Floating Rate Loan ETF, a series of BlackRock ETF Trust II). The Committee also considered other types of borrowing available to the funds, such as the ability to use reverse repurchase agreements and interfund lending, as applicable.

There were no material changes to the Program during the Program Reporting Period other than the enhancement of certain model components in the Program’s classification methodology. The Report provided to the Board stated that the Committee concluded that based on the operation of the functions, as described in the Report, the Program is operating as intended and is effective in implementing the requirements of the Liquidity Rule.

 

 

86  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Additional Information

 

Tailored Shareholder Reports for Open-End Mutual Funds and ETFs

Effective January 24, 2023, the SEC adopted rule and form amendments to require open-end mutual funds and ETFs to transmit concise and visually engaging streamlined annual and semiannual reports to shareholders that highlight key information. Other information, including financial statements, will no longer appear in a streamlined shareholder report but must be available online, delivered free of charge upon request, and filed on a semiannual basis on Form N-CSR. The rule and form amendments have a compliance date of July 24, 2024. At this time, management is evaluating the impact of these amendments on the shareholder reports for the Funds.

General Information

Quarterly performance, semi-annual and annual reports, current net asset value and other information regarding the Funds may be found on BlackRock’s website, which can be accessed at blackrock.com. Any reference to BlackRock’s website in this report is intended to allow investors public access to information regarding the Funds and does not, and is not intended to, incorporate BlackRock’s website in this report.

Householding

The Funds will mail only one copy of shareholder documents, including prospectuses, annual and semi-annual reports, Rule 30e-3 notices and proxy statements, to shareholders with multiple accounts at the same address. This practice is commonly called “householding” and is intended to reduce expenses and eliminate duplicate mailings of shareholder documents. Mailings of your shareholder documents may be householded indefinitely unless you instruct us otherwise. If you do not want the mailing of these documents to be combined with those for other members of your household, please call the Funds at (800) 441-7762.

Availability of Quarterly Schedule of Investments

The Funds file their complete schedules of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to their reports on Form N-PORT. The Funds’ Forms N-PORT are available on the SEC’s website at sec.gov. Additionally, each Fund makes its portfolio holdings for the first and third quarters of each fiscal year available at blackrock.com/fundreports.

Availability of Proxy Voting Policies, Procedures and Voting Records

A description of the policies and procedures that the Funds use to determine how to vote proxies relating to portfolio securities and information about how the Funds voted proxies relating to securities held in the Funds’ portfolios during the most recent 12-month period ended June 30 is available without charge, upon request (1) by calling (800) 441-7762; (2) on the BlackRock website at blackrock.com; and (3) on the SEC’s website at sec.gov.

BlackRock’s Mutual Fund Family

BlackRock offers a diverse lineup of open-end mutual funds crossing all investment styles and managed by experts in equity, fixed-income and tax-exempt investing. Visit blackrock.com for more information.

Shareholder Privileges

Account Information

Call us at (800) 441-7762 from 8:00 AM to 6:00 PM ET on any business day to get information about your account balances, recent transactions and share prices. You can also visit blackrock.com for more information.

Automatic Investment Plans

Investor class shareholders who want to invest regularly can arrange to have $50 or more automatically deducted from their checking or savings account and invested in any of the BlackRock funds.

Systematic Withdrawal Plans

Investor class shareholders can establish a systematic withdrawal plan and receive periodic payments of $50 or more from their BlackRock funds, as long as their account balance is at least $10,000.

Retirement Plans

Shareholders may make investments in conjunction with Traditional, Rollover, Roth, Coverdell, Simple IRAs, SEP IRAs and 403(b) Plans.

BlackRock Privacy Principles

BlackRock is committed to maintaining the privacy of its current and former fund investors and individual clients (collectively, “Clients”) and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information BlackRock collects, how we protect that information and why in certain cases we share such information with select parties.

 

 

D D I T I O N A L   I N F O R M A T I O N

  87


Additional Information  (continued)

 

If you are located in a jurisdiction where specific laws, rules or regulations require BlackRock to provide you with additional or different privacy-related rights beyond what is set forth below, then BlackRock will comply with those specific laws, rules or regulations.

BlackRock obtains or verifies personal non-public information from and about you from different sources, including the following: (i) information we receive from you or, if applicable, your financial intermediary, on applications, forms or other documents; (ii) information about your transactions with us, our affiliates, or others; (iii) information we receive from a consumer reporting agency; and (iv) from visits to our websites.

BlackRock does not sell or disclose to non-affiliated third parties any non-public personal information about its Clients, except as permitted by law or as is necessary to respond to regulatory requests or to service Client accounts. These non-affiliated third parties are required to protect the confidentiality and security of this information and to use it only for its intended purpose.

We may share information with our affiliates to service your account or to provide you with information about other BlackRock products or services that may be of interest to you. In addition, BlackRock restricts access to non-public personal information about its Clients to those BlackRock employees with a legitimate business need for the information. BlackRock maintains physical, electronic and procedural safeguards that are designed to protect the non-public personal information of its Clients, including procedures relating to the proper storage and disposal of such information.

 

Fund and Service Providers  
Investment Adviser and Administrator   Independent Registered Public Accounting Firm
BlackRock Advisors, LLC   Deloitte & Touche LLP
Wilmington, DE 19809   Boston, MA 02116
Sub-Advisers(a)   Distributor
BlackRock International Limited   BlackRock Investments, LLC
Edinburgh, EH3 8BL   New York, NY 10001
United Kingdom  
  Legal Counsel
BlackRock (Singapore) Limited   Sidley Austin LLP
079912 Singapore   New York, NY 10019
Accounting Agent and Transfer Agent   Address of the Corporation/Trust
BNY Mellon Investment Servicing (US) Inc.   100 Bellevue Parkway
Wilmington, DE 19809   Wilmington, DE 19809
Custodian  
The Bank of New York Mellon  
New York, NY 10286  

 

(a) 

For BlackRock Infrastructure Sustainable Opportunities Fund.

 

 

88  

2 0 2 3   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Glossary of Terms Used in this Report

 

Currency Abbreviation

 

CAD   

Canadian Dollar

 

EUR   

Euro

 

GBP   

British Pound

 

USD    United States Dollar

Portfolio Abbreviation

 

ADR   

American Depositary Receipt

 

CVR   

Contingent Value Rights

 

NVS   

Non-Voting Shares

 

S&P    Standard & Poor’s
 

 

 

L O S S A R Y   O F   T E R M S   U S E D   I N   T H I S   R E P O R T

  89


 

THIS PAGE INTENTIONALLY LEFT BLANK.

 

 

 


 

THIS PAGE INTENTIONALLY LEFT BLANK.

 

 

 


 

 

 

Want to know more?

blackrock.com | 800-441-7762

This report is intended for current holders. It is not authorized for use as an offer of sale or a solicitation of an offer to buy shares of the Funds unless preceded or accompanied by the Funds’ current prospectus. Past performance results shown in this report should not be considered a representation of future performance. Investment returns and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are as dated and are subject to change.

GROPPS-11/23-SAR

 

 

LOGO

   LOGO


(b) Not Applicable

 

Item 2 –

Code of Ethics – Not Applicable to this semi-annual report

 

Item 3 –

Audit Committee Financial Expert – Not Applicable to this semi-annual report

 

Item 4 –

Principal Accountant Fees and Services – Not Applicable to this semi-annual report

 

Item 5 –

Audit Committee of Listed Registrant – Not Applicable

 

Item 6 –

Investments

(a) The registrant’s Schedule of Investments is included as part of the Report to Stockholders filed under Item 1(a) of this Form.

(b) Not Applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.

 

Item 7 –

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies – Not Applicable

 

Item 8 –

Portfolio Managers of Closed-End Management Investment Companies – Not Applicable

 

Item 9 –

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers – Not Applicable

 

Item 10 –

Submission of Matters to a Vote of Security Holders –There have been no material changes to these procedures.

 

Item 11 –

Controls and Procedures

(a) The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing of this report based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 15d-15(b) under the Securities Exchange Act of 1934, as amended.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 12 –

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies – Not Applicable

 

Item 13 –

Recovery of Erroneously Awarded Compensation – Not Applicable

 

Item 14 –

Exhibits attached hereto

(a)(1) Code of Ethics – Not Applicable to this semi-annual report

(a)(2) Section 302 Certifications are attached


(a)(3) Any written solicitation to purchase securities under Rule 23c-1 – Not Applicable

(a)(4) Change in Registrant’s independent public accountant – Not Applicable

(b) Section 906 Certifications are attached


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BlackRock Capital Appreciation Fund, Inc.

 

 

By:

    

/s/ John M. Perlowski                             

      

John M. Perlowski

      

Chief Executive Officer (principal executive officer) of

      

BlackRock Capital Appreciation Fund, Inc.

Date: January 19, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:

    

/s/ John M. Perlowski                            

      

John M. Perlowski

      

Chief Executive Officer (principal executive officer) of

      

BlackRock Capital Appreciation Fund, Inc.

Date: January 19, 2024

 

 

By:

    

/s/ Trent Walker                            

      

Trent Walker

      

Chief Financial Officer (principal financial officer) of

      

BlackRock Capital Appreciation Fund, Inc.

Date: January 19, 2024